data_2nbn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nbn _Structure_validation_residue.Date_analyzed 2017-03-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.95 0.405 . . . . 70.219999999999999 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.131 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 111.128 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.400000000000006 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.134 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 73.209999999999994 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 70.510000000000005 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 74.340000000000003 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 71.319999999999993 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 75.120000000000005 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 111.073 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 75.340000000000003 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.907 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.113 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.349999999999994 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 71.099999999999994 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' H ' ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.905 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 62.020000000000003 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.310000000000002 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 111.122 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 73.140000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 75.349999999999994 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 110.931 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.133 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 71.319999999999993 110.852 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 110.904 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 73.120000000000005 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 53.350000000000001 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.209999999999994 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 74.109999999999999 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.239999999999995 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 70.519999999999996 110.903 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 70.530000000000001 111.093 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 111.163 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.838 0.351 . . . . 70.219999999999999 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.096 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 111.121 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 111.128 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 73.209999999999994 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 70.510000000000005 111.084 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 74.340000000000003 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 75.120000000000005 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.200000000000003 111.158 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 75.340000000000003 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HB2' HG22 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.937 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.171 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 110.959 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 71.099999999999994 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 61.329999999999998 110.955 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.922 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 62.020000000000003 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 111.102 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 73.140000000000001 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 74.329999999999998 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 75.349999999999994 110.883 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 74.200000000000003 110.927 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.112 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.824 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 75.239999999999995 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 73.120000000000005 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 75.219999999999999 110.928 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.129999999999995 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 53.350000000000001 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 74.109999999999999 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.994 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 73.239999999999995 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 70.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 70.530000000000001 111.12 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.111 179.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.895 0.379 . . . . 70.219999999999999 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.068 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.010000000000005 111.098 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 111.149 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 73.209999999999994 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 70.510000000000005 111.144 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 74.340000000000003 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 71.319999999999993 110.855 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.120000000000005 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.200000000000003 111.148 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.871 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.402 ' HB2' HG23 ' A' ' 44' ' ' VAL . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 74.430000000000007 110.929 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.430000000000007 111.142 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 74.349999999999994 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 71.099999999999994 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 61.329999999999998 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.120000000000005 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 62.020000000000003 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 72.140000000000001 111.117 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.420000000000002 111.109 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 74.329999999999998 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 75.349999999999994 110.936 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.885 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.135 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 73.120000000000005 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.963 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 53.350000000000001 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 74.109999999999999 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 73.239999999999995 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 70.519999999999996 110.894 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 71.040000000000006 111.146 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 73.510000000000005 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.430000000000007 110.926 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 70.530000000000001 111.151 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.168 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.109999999999999 111.151 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.09 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 73.400000000000006 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.155 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 73.209999999999994 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 70.510000000000005 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 74.340000000000003 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 71.319999999999993 110.92 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 75.120000000000005 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 111.115 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 75.340000000000003 110.933 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 74.430000000000007 110.888 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.188 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 71.099999999999994 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 61.329999999999998 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.120000000000005 110.872 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 62.020000000000003 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 72.140000000000001 111.185 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.144 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 74.329999999999998 112.51 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 75.349999999999994 110.895 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 74.200000000000003 110.865 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 111.119 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 71.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 74.340000000000003 111.164 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 110.913 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 73.120000000000005 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.883 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 53.350000000000001 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 74.109999999999999 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 73.239999999999995 111.038 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 70.519999999999996 110.953 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 71.040000000000006 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 110.891 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 70.530000000000001 111.049 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.439999999999998 111.103 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.922 0.392 . . . . 70.219999999999999 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.162 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 111.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.400000000000006 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 111.127 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 73.209999999999994 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 74.340000000000003 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 71.319999999999993 110.92 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 75.120000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.200000000000003 111.09 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 75.340000000000003 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HB2' HG21 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.902 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 111.12 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 71.099999999999994 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 61.329999999999998 110.826 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.140000000000001 110.92 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 62.020000000000003 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.140000000000001 111.114 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 111.163 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 74.329999999999998 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 75.349999999999994 110.909 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 74.200000000000003 110.931 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.134 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.892 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 74.340000000000003 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 110.894 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 53.350000000000001 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.209999999999994 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 74.109999999999999 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 111.022 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 73.239999999999995 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 70.519999999999996 110.862 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.040000000000006 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 70.530000000000001 111.069 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.439999999999998 111.124 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.109999999999999 111.14 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 74.010000000000005 111.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 73.109999999999999 111.135 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.510000000000005 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 74.340000000000003 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.319999999999993 110.883 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.200000000000003 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG23 ' A' ' 44' ' ' VAL . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.878 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 111.152 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.349999999999994 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 71.099999999999994 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 61.329999999999998 110.833 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 62.020000000000003 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 111.162 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.156 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.052 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 74.329999999999998 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 75.349999999999994 110.93 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.953 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.18 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.865 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 110.879 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 73.120000000000005 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 75.219999999999999 110.889 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.350000000000001 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.855 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 74.109999999999999 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 70.519999999999996 110.896 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 71.040000000000006 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.919 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 70.530000000000001 111.153 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 111.103 179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.933 0.397 . . . . 70.219999999999999 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 74.109999999999999 111.144 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 111.047 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 73.400000000000006 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 111.122 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 73.209999999999994 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.194 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 74.340000000000003 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.874 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.144 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 75.340000000000003 110.904 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 74.430000000000007 110.896 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 111.095 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 71.099999999999994 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 61.329999999999998 110.918 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 62.020000000000003 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 111.103 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.420000000000002 111.143 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 74.329999999999998 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 75.349999999999994 110.96 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 110.953 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 75.430000000000007 111.074 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.904 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 75.239999999999995 110.917 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 73.120000000000005 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 53.350000000000001 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 74.439999999999998 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.109999999999999 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 73.239999999999995 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 70.519999999999996 110.886 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.040000000000006 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 110.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 110.929 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 70.530000000000001 111.122 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 111.132 179.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.96 0.41 . . . . 70.219999999999999 110.863 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 74.109999999999999 111.124 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 111.16 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 73.400000000000006 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 73.209999999999994 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 70.510000000000005 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 74.340000000000003 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 71.319999999999993 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.120000000000005 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.200000000000003 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.933 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 111.118 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.918 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 71.099999999999994 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.875 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 62.020000000000003 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 75.310000000000002 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.17 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.420000000000002 111.177 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 74.329999999999998 112.506 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 75.349999999999994 110.985 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 74.200000000000003 110.939 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 71.319999999999993 110.902 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 111.207 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 110.992 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.219999999999999 110.921 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 53.350000000000001 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 74.109999999999999 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 111.101 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 110.878 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 71.040000000000006 111.123 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 110.921 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 70.530000000000001 111.148 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.135 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.088 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 74.010000000000005 111.099 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 73.400000000000006 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.181 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 73.209999999999994 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 70.510000000000005 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 74.340000000000003 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.872 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.200000000000003 111.175 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 75.340000000000003 110.899 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG21 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 74.430000000000007 110.911 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 111.143 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 71.099999999999994 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 61.329999999999998 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.901 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.967 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 62.020000000000003 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 73.329999999999998 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.140000000000001 111.119 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 111.146 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 74.329999999999998 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 75.349999999999994 110.895 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 74.200000000000003 110.953 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.128 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.913 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 74.340000000000003 111.194 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 75.239999999999995 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 73.120000000000005 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.93 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 53.350000000000001 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 73.239999999999995 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 73.239999999999995 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 70.519999999999996 110.977 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 71.040000000000006 111.206 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.430000000000007 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 70.530000000000001 111.134 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 111.091 179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.918 0.389 . . . . 70.219999999999999 110.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 74.010000000000005 111.082 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.109999999999999 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 70.510000000000005 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 74.340000000000003 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.319999999999993 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.200000000000003 111.194 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 44' ' ' VAL . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.897 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 111.112 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 71.099999999999994 111.102 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 61.329999999999998 110.872 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.928 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 62.020000000000003 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 75.310000000000002 110.85 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.329999999999998 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 111.149 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 111.14 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.183 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 75.349999999999994 110.978 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 74.200000000000003 110.942 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.340000000000003 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 110.909 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 73.120000000000005 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 110.844 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.129999999999995 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.350000000000001 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 74.109999999999999 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 111.096 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 70.519999999999996 110.981 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.040000000000006 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.510000000000005 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 110.909 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 70.530000000000001 111.094 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.092 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.916 0.389 . . . . 70.219999999999999 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.107 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.091 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 73.400000000000006 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.09 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 73.209999999999994 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 70.510000000000005 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 74.340000000000003 110.876 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 71.319999999999993 110.916 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 75.120000000000005 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.116 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.42 ' HB2' HG21 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.92 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 111.087 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 71.099999999999994 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.89 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.915 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 62.020000000000003 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.866 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.158 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.122 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.117 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 74.329999999999998 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 75.349999999999994 110.986 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 110.913 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.195 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 71.319999999999993 110.862 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 110.907 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 73.120000000000005 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.948 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 53.350000000000001 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.209999999999994 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 74.109999999999999 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 111.07 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 70.519999999999996 110.91 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 71.040000000000006 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.897 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 111.104 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 111.112 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.186 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.11 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.109999999999999 111.094 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 70.510000000000005 111.154 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 74.340000000000003 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.834 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.128 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 75.340000000000003 110.846 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 74.430000000000007 110.886 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 111.147 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 71.099999999999994 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.935 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 73.329999999999998 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 111.092 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.420000000000002 111.138 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 34' ' ' LYS . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.329999999999998 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 75.349999999999994 110.865 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.954 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.430000000000007 111.175 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.81 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 74.340000000000003 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 110.907 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 73.120000000000005 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 75.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 53.350000000000001 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 74.109999999999999 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.065 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 70.519999999999996 110.885 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.040000000000006 111.084 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.510000000000005 110.856 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 74.430000000000007 110.909 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 70.530000000000001 111.095 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 111.127 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 74.109999999999999 111.154 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 111.204 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 73.400000000000006 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 111.163 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 73.209999999999994 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 70.510000000000005 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 74.340000000000003 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.200000000000003 111.154 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 110.87 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' CE2' HD23 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.926 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 111.192 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 74.349999999999994 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 71.099999999999994 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 61.329999999999998 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.120000000000005 110.913 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.913 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 62.020000000000003 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 111.158 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 111.099 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 74.329999999999998 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 75.349999999999994 110.882 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.901 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 75.430000000000007 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 110.942 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 111.09 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 110.966 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 73.120000000000005 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 53.350000000000001 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 74.109999999999999 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 73.239999999999995 111.105 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 70.519999999999996 110.953 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 71.040000000000006 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 73.510000000000005 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.898 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.094 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 111.166 179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.919 0.39 . . . . 70.219999999999999 110.852 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.109999999999999 111.2 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 74.010000000000005 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 73.400000000000006 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.12 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 70.510000000000005 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 74.340000000000003 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.885 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 111.187 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.879 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 73.430000000000007 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 71.099999999999994 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.851 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.120000000000005 110.95 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 62.020000000000003 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 75.310000000000002 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.140000000000001 111.179 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 111.111 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 74.329999999999998 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 75.349999999999994 110.925 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 74.200000000000003 110.834 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 75.430000000000007 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 110.904 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 73.120000000000005 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 75.219999999999999 110.898 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 53.350000000000001 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.209999999999994 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 74.439999999999998 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.109999999999999 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.021 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 73.239999999999995 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.969 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 71.040000000000006 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.895 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 70.530000000000001 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.121 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 74.109999999999999 111.137 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 74.010000000000005 111.117 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.400000000000006 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 111.158 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 70.510000000000005 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 74.340000000000003 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 71.319999999999993 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 75.120000000000005 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.200000000000003 111.121 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.430000000000007 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 71.099999999999994 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 61.329999999999998 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.140000000000001 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 62.020000000000003 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.310000000000002 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 73.329999999999998 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 111.105 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.140000000000001 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.12 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 74.329999999999998 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.349999999999994 110.956 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 74.200000000000003 110.912 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 111.128 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.882 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.91 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 73.120000000000005 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 75.219999999999999 110.893 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 53.350000000000001 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.109999999999999 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 111.07 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 111.038 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 71.040000000000006 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 74.430000000000007 110.801 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 70.530000000000001 111.129 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 111.151 179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.867 0.365 . . . . 70.219999999999999 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 111.137 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 111.083 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 74.340000000000003 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 71.319999999999993 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 75.120000000000005 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.200000000000003 111.167 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.912 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 111.148 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 71.099999999999994 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 61.329999999999998 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.120000000000005 110.951 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 62.020000000000003 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 111.039 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 73.140000000000001 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.420000000000002 111.071 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 74.329999999999998 112.543 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 75.349999999999994 110.945 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.962 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 111.133 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 111.174 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 75.239999999999995 110.883 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 75.219999999999999 110.904 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 53.350000000000001 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.209999999999994 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 74.109999999999999 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.131 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.519999999999996 110.947 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.040000000000006 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.510000000000005 110.937 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.909 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 70.530000000000001 111.077 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 111.095 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.914 0.388 . . . . 70.219999999999999 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 74.109999999999999 111.095 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.117 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 73.400000000000006 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 73.209999999999994 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 70.510000000000005 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 74.340000000000003 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.319999999999993 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.200000000000003 111.095 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.918 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.430000000000007 111.128 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 71.099999999999994 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 61.329999999999998 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.886 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 75.140000000000001 110.893 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 62.020000000000003 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 75.310000000000002 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 73.329999999999998 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 111.146 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.138 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 74.329999999999998 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 75.349999999999994 110.945 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.89 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 75.430000000000007 111.08 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 110.926 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 73.120000000000005 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 75.219999999999999 110.929 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 53.350000000000001 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 74.109999999999999 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.096 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 73.239999999999995 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 70.519999999999996 110.906 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.981 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 70.530000000000001 111.108 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.106 179.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.854 0.359 . . . . 70.219999999999999 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.121 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 74.010000000000005 111.139 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.400000000000006 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 73.209999999999994 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 70.510000000000005 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 74.340000000000003 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.200000000000003 111.051 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 75.340000000000003 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.474 ' HB2' HG23 ' A' ' 44' ' ' VAL . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.893 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 71.099999999999994 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 61.329999999999998 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.120000000000005 110.87 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 75.140000000000001 110.928 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 62.020000000000003 112.519 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 75.310000000000002 110.956 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 73.329999999999998 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.074 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 73.140000000000001 111.139 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.146 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 74.329999999999998 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 75.349999999999994 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.869 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.149 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.319999999999993 110.836 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 110.962 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 73.120000000000005 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.955 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 53.350000000000001 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.209999999999994 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 74.109999999999999 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 70.519999999999996 110.951 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 71.040000000000006 111.145 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.818 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 70.530000000000001 111.046 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.154 179.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 111.113 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.102 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 111.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 73.209999999999994 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 70.510000000000005 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 74.340000000000003 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 111.11 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 75.340000000000003 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.409 ' CE2' HD21 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.935 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 111.129 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 71.099999999999994 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.120000000000005 110.902 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' H ' ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 75.140000000000001 110.85 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 62.020000000000003 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 72.140000000000001 111.09 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 73.140000000000001 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.149 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 74.329999999999998 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 75.349999999999994 110.862 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.163 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 71.319999999999993 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 111.133 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 110.961 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 73.120000000000005 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 53.350000000000001 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 110.915 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 74.109999999999999 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 70.519999999999996 110.882 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.904 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 111.101 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.17 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 70.219999999999999 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.109999999999999 111.068 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 74.010000000000005 111.133 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 73.400000000000006 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 111.153 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 73.209999999999994 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 70.510000000000005 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 74.340000000000003 110.858 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 71.319999999999993 110.909 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.200000000000003 111.105 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 75.340000000000003 110.969 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' HG11 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 71.099999999999994 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 61.329999999999998 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.120000000000005 110.91 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 62.020000000000003 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.153 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.156 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 HG11 ' HA ' ' A' ' 31' ' ' LEU . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 74.329999999999998 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.349999999999994 110.862 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.897 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 75.239999999999995 110.971 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.120000000000005 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 53.350000000000001 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 74.109999999999999 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 111.09 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 70.519999999999996 110.94 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.943 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 70.530000000000001 111.152 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 105' ' ' ILE . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.408 ' N ' HG11 ' A' ' 104' ' ' VAL . 96.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.81 0.338 . . . . 70.129999999999995 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -103.98 -168.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 110.805 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.131 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 111.128 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.400000000000006 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 73.109999999999999 111.134 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 73.209999999999994 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 70.510000000000005 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 74.340000000000003 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 71.319999999999993 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 75.120000000000005 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 111.073 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 75.340000000000003 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.113 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 74.349999999999994 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 71.099999999999994 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' H ' ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.905 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 62.020000000000003 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 75.310000000000002 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 111.122 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 73.140000000000001 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.121 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 75.349999999999994 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 110.931 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.133 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 71.319999999999993 110.852 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 110.904 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 73.120000000000005 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.944 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 53.350000000000001 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 202' ' ' PLM . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.209999999999994 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.422 HD21 ' CG ' ' A' ' 202' ' ' PLM . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 74.109999999999999 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 73.239999999999995 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 70.519999999999996 110.903 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 74.430000000000007 110.913 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 70.530000000000001 111.093 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mt -82.07 -46.81 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.439999999999998 111.163 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -67.35 90.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 75.530000000000001 110.865 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 -170.2 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.863 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -59.84 150.51 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 73.099999999999994 110.871 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -69.68 -175.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.519999999999996 110.868 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 62.81 67.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.540000000000006 110.859 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.859 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.292 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.286 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.753 0.311 . . . . 70.129999999999995 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m 64.29 171.13 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 70.219999999999999 110.843 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.096 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 111.121 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 111.128 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 73.209999999999994 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 70.510000000000005 111.084 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 74.340000000000003 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 75.120000000000005 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.200000000000003 111.158 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 75.340000000000003 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HB2' HG22 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.937 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 73.430000000000007 111.171 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 110.959 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 71.099999999999994 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 61.329999999999998 110.955 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.120000000000005 110.922 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 75.140000000000001 110.896 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 62.020000000000003 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 72.140000000000001 111.102 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 73.140000000000001 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.420000000000002 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 74.329999999999998 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 75.349999999999994 110.883 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.427 ' HE1' ' C8 ' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 74.200000000000003 110.927 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.112 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.824 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 75.239999999999995 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 73.120000000000005 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 75.219999999999999 110.928 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.129999999999995 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 53.350000000000001 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.54 HD13 ' CA ' ' A' ' 202' ' ' PLM . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 74.109999999999999 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.994 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 73.239999999999995 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 70.519999999999996 110.955 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.435 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 111.06 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.912 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 70.530000000000001 111.12 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 82.2 mt -73.7 -35.12 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.111 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.88 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 75.530000000000001 110.809 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.12 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.798 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.93 -170.4 2.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.84 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -58.09 150.71 20.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 110.831 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.41 178.78 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 71.540000000000006 110.879 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.7 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.773 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.263 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.277 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 70.129999999999995 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -111.2 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 70.219999999999999 110.898 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.068 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.010000000000005 111.098 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 111.149 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 73.209999999999994 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 70.510000000000005 111.144 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 74.340000000000003 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 71.319999999999993 110.855 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 75.120000000000005 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.200000000000003 111.148 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.871 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' HB2' HG23 ' A' ' 44' ' ' VAL . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.547 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 74.430000000000007 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.430000000000007 111.142 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 74.349999999999994 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 71.099999999999994 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 61.329999999999998 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.120000000000005 110.906 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 62.020000000000003 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 72.140000000000001 111.117 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.420000000000002 111.109 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 74.329999999999998 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 75.349999999999994 110.936 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.200000000000003 110.885 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.407 ' HB ' ' H71' ' A' ' 202' ' ' PLM . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.135 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 71.319999999999993 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 75.239999999999995 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 73.120000000000005 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.963 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.129999999999995 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 53.350000000000001 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 74.109999999999999 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 73.239999999999995 111.044 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 73.239999999999995 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 70.519999999999996 110.894 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 71.040000000000006 111.146 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 73.510000000000005 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 74.430000000000007 110.926 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 70.530000000000001 111.151 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.61 -40.88 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.168 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -78.65 61.46 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 75.530000000000001 110.826 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -156.85 -50.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.848 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.32 148.96 30.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 73.099999999999994 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -162.06 103.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 74.519999999999996 110.881 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -105.03 104.01 13.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 71.540000000000006 110.854 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.91 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.274 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.27 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.759 0.314 . . . . 70.129999999999995 110.901 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -144.48 -169.44 3.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 74.109999999999999 111.151 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 111.09 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 73.400000000000006 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.155 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 73.209999999999994 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 70.510000000000005 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 74.340000000000003 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 71.319999999999993 110.92 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 75.120000000000005 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.200000000000003 111.115 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 75.340000000000003 110.933 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 74.430000000000007 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.188 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.349999999999994 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 71.099999999999994 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 61.329999999999998 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.120000000000005 110.872 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 62.020000000000003 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.310000000000002 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 72.140000000000001 111.185 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.144 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 74.329999999999998 112.51 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 75.349999999999994 110.895 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 74.200000000000003 110.865 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 111.119 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 71.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.464 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 74.340000000000003 111.164 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 110.913 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 73.120000000000005 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.883 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 53.350000000000001 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.439999999999998 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 74.109999999999999 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 73.239999999999995 111.038 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 73.239999999999995 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 70.519999999999996 110.953 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 71.040000000000006 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 74.430000000000007 110.891 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 70.530000000000001 111.049 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.26 -24.38 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.439999999999998 111.103 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.53 -169.54 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.88 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -53.15 -58.4 7.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.816 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -148.03 -49.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 73.099999999999994 110.839 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.84 137.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.904 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.35 -75.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 71.540000000000006 110.86 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 71.209999999999994 110.825 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.288 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.258 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 70.129999999999995 110.865 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.29 -169.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.219999999999999 110.858 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.162 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 111.178 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.400000000000006 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 111.127 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 73.209999999999994 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 74.340000000000003 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 71.319999999999993 110.92 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 75.120000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.200000000000003 111.09 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 75.340000000000003 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' HB2' HG21 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.497 HD11 ' CE ' ' A' ' 201' ' ' PLM . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.902 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 111.12 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 71.099999999999994 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 61.329999999999998 110.826 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 111.013 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 75.140000000000001 110.92 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 62.020000000000003 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 72.140000000000001 111.114 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HB ' ' HG3' ' A' ' 201' ' ' PLM . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.420000000000002 111.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 74.329999999999998 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 75.349999999999994 110.909 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.45 ' HE1' ' C8 ' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 74.200000000000003 110.931 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.407 HD13 ' C8 ' ' A' ' 202' ' ' PLM . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.134 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.892 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 74.340000000000003 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.924 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 110.894 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 53.350000000000001 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.209999999999994 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 74.109999999999999 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.239999999999995 111.022 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 73.239999999999995 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 70.519999999999996 110.862 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 71.040000000000006 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 HD23 ' C4 ' ' A' ' 201' ' ' PLM . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 110.925 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 70.530000000000001 111.069 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 85.5 mt -79.41 -37.13 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.439999999999998 111.124 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -53.56 103.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 75.530000000000001 110.865 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -98.47 37.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.239999999999995 110.788 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 166.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 73.099999999999994 110.854 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -96.18 27.26 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 110.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 -170.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 71.540000000000006 110.797 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.209999999999994 110.854 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.264 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.28 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.812 0.339 . . . . 70.129999999999995 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t -120.72 -178.51 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.219999999999999 110.92 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 74.109999999999999 111.14 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 74.010000000000005 111.163 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 73.109999999999999 111.135 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 73.209999999999994 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.510000000000005 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 74.340000000000003 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 71.319999999999993 110.883 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.200000000000003 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG23 ' A' ' 44' ' ' VAL . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.878 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.430000000000007 111.152 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.349999999999994 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 71.099999999999994 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 61.329999999999998 110.833 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 62.020000000000003 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 111.162 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.156 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.052 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 74.329999999999998 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 75.349999999999994 110.93 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.953 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.18 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 110.865 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 110.879 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 73.120000000000005 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 75.219999999999999 110.889 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 53.350000000000001 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.855 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 74.109999999999999 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 70.519999999999996 110.896 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 71.040000000000006 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.919 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 70.530000000000001 111.153 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -52.04 -33.8 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 102.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 75.530000000000001 110.821 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.6 -169.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.772 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -62.08 159.44 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 73.099999999999994 110.893 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -108.33 -176.94 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.519999999999996 110.891 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -162.51 141.26 8.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 71.540000000000006 110.856 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 71.209999999999994 110.91 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.259 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.286 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 70.129999999999995 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m -104.49 -170.78 1.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 70.219999999999999 110.842 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 74.109999999999999 111.144 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 111.047 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 73.400000000000006 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 111.122 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 73.209999999999994 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 70.510000000000005 111.194 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 74.340000000000003 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.874 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.200000000000003 111.144 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 75.340000000000003 110.904 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 74.430000000000007 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 111.095 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 74.349999999999994 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 71.099999999999994 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 61.329999999999998 110.918 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.120000000000005 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 75.140000000000001 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 62.020000000000003 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 111.103 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 73.140000000000001 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.420000000000002 111.143 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 74.329999999999998 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 75.349999999999994 110.96 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 110.953 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 75.430000000000007 111.074 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.904 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 75.239999999999995 110.917 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 73.120000000000005 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 53.350000000000001 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 74.439999999999998 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 74.109999999999999 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 73.239999999999995 111.105 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 70.519999999999996 110.886 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 71.040000000000006 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.510000000000005 110.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 110.929 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 70.530000000000001 111.122 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' A' ' 103' ' ' GLU . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.4 mt -58.74 -30.94 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 111.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 75.530000000000001 110.864 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 104.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 110.855 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -59.29 -176.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 73.099999999999994 110.865 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.46 -170.02 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.519999999999996 110.928 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.36 -75.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 71.540000000000006 110.871 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.209999999999994 110.883 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.257 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.269 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.751 0.31 . . . . 70.129999999999995 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -169.22 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 70.219999999999999 110.863 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 74.109999999999999 111.124 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 111.16 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 73.400000000000006 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 73.109999999999999 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 73.209999999999994 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 70.510000000000005 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 74.340000000000003 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 71.319999999999993 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.120000000000005 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.200000000000003 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 201' ' ' PLM . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 111.118 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.918 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 71.099999999999994 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.875 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 62.020000000000003 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 75.310000000000002 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 111.17 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' HB ' ' HG1' ' A' ' 201' ' ' PLM . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.420000000000002 111.177 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 74.329999999999998 112.506 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 75.349999999999994 110.985 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 74.200000000000003 110.939 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 71.319999999999993 110.902 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 111.207 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 110.992 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 73.120000000000005 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.219999999999999 110.921 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.129999999999995 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 53.350000000000001 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.561 HD12 ' CA ' ' A' ' 202' ' ' PLM . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 202' ' ' PLM . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 74.109999999999999 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 111.101 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 70.519999999999996 110.878 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 71.040000000000006 111.123 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 110.921 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 70.530000000000001 111.148 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -52.81 -31.33 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -52.75 102.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 75.530000000000001 110.869 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -175.86 -177.39 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -107.54 136.52 47.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.818 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.29 166.86 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.519999999999996 110.91 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -96.87 -34.96 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 71.540000000000006 110.867 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.787 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.278 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.273 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 70.129999999999995 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t -149.44 -169.22 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 70.219999999999999 110.895 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.088 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 74.010000000000005 111.099 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 73.400000000000006 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.181 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 73.209999999999994 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 70.510000000000005 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 74.340000000000003 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.872 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.200000000000003 111.175 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 75.340000000000003 110.899 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HB2' HG21 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 74.430000000000007 110.911 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 73.430000000000007 111.143 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 71.099999999999994 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 61.329999999999998 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.120000000000005 110.901 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.967 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 62.020000000000003 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 73.329999999999998 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 72.140000000000001 111.119 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 111.146 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 74.329999999999998 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 75.349999999999994 110.895 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 74.200000000000003 110.953 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.128 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 71.319999999999993 110.913 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 74.340000000000003 111.194 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 75.239999999999995 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 73.120000000000005 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.93 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 53.350000000000001 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.636 HD13 ' CA ' ' A' ' 202' ' ' PLM . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 73.239999999999995 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 73.239999999999995 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 70.519999999999996 110.977 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.424 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 71.040000000000006 111.206 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 73.510000000000005 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.430000000000007 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 70.530000000000001 111.134 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.0 mt -70.54 -29.62 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -54.14 171.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 110.867 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 114.38 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.875 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.68 -64.38 0.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 73.099999999999994 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -175.36 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 74.519999999999996 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -120.03 27.84 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.540000000000006 110.895 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.864 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.278 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.283 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 70.129999999999995 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m 62.07 177.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.907 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 74.010000000000005 111.082 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 73.109999999999999 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 73.209999999999994 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 70.510000000000005 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 74.340000000000003 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 71.319999999999993 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 75.120000000000005 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.200000000000003 111.194 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 44' ' ' VAL . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.55 HD12 ' CE ' ' A' ' 201' ' ' PLM . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.897 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 111.112 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 71.099999999999994 111.102 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 61.329999999999998 110.872 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.928 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 62.020000000000003 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 75.310000000000002 110.85 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 73.329999999999998 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 72.140000000000001 111.149 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 111.14 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.183 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 74.329999999999998 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 75.349999999999994 110.978 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 74.200000000000003 110.942 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 74.340000000000003 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 110.909 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 73.120000000000005 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 110.844 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.129999999999995 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.350000000000001 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.565 HD11 ' CA ' ' A' ' 202' ' ' PLM . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' CG ' ' A' ' 202' ' ' PLM . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 74.109999999999999 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 111.096 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 70.519999999999996 110.981 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.040000000000006 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 73.510000000000005 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 110.909 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 70.530000000000001 111.094 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.9 mt -73.07 -30.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.092 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -79.95 58.51 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 75.530000000000001 110.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.89 157.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.875 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t60 60.83 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 110.894 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 97.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 74.519999999999996 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -65.68 176.71 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 71.540000000000006 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 71.209999999999994 110.936 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.267 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.277 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 70.129999999999995 110.933 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t -110.87 -169.67 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 110.88 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.107 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 111.091 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 73.400000000000006 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 73.109999999999999 111.09 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 73.209999999999994 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 70.510000000000005 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 74.340000000000003 110.876 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 71.319999999999993 110.916 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 75.120000000000005 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 111.116 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.42 ' HB2' HG21 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.583 ' HG ' ' CG ' ' A' ' 201' ' ' PLM . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.92 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 111.087 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.909 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 71.099999999999994 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.89 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.915 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 62.020000000000003 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.866 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 111.158 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.122 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 111.117 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 74.329999999999998 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 75.349999999999994 110.986 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 110.913 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.195 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 71.319999999999993 110.862 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 110.907 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 73.120000000000005 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 202' ' ' PLM . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.948 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 53.350000000000001 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.209999999999994 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 74.109999999999999 110.863 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 111.07 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 73.239999999999995 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 70.519999999999996 110.91 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 71.040000000000006 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.510000000000005 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.897 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HB1' ' CE ' ' A' ' 202' ' ' PLM . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 70.530000000000001 111.104 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.92 -30.14 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 111.112 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -52.09 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 75.530000000000001 110.808 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 52.05 -169.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.874 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -67.45 -169.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 73.099999999999994 110.91 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -52.0 111.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 74.519999999999996 110.904 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -169.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.888 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.849 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.275 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.28 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.783 0.325 . . . . 70.129999999999995 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 63.28 -175.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 70.219999999999999 110.863 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.186 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.11 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 73.400000000000006 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' HD2' ' C8 ' ' A' ' 201' ' ' PLM . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.109999999999999 111.094 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 70.510000000000005 111.154 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 74.340000000000003 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 110.834 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 111.128 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 75.340000000000003 110.846 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 74.430000000000007 110.886 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 111.147 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 71.099999999999994 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.329999999999998 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.935 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 62.020000000000003 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 73.329999999999998 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 111.092 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.420000000000002 111.138 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 34' ' ' LYS . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 74.329999999999998 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 75.349999999999994 110.865 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.954 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.430000000000007 111.175 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 71.319999999999993 110.81 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 74.340000000000003 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 110.907 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 73.120000000000005 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 75.219999999999999 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 53.350000000000001 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.451 HD23 ' CG ' ' A' ' 202' ' ' PLM . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 74.439999999999998 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 74.109999999999999 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.065 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 70.519999999999996 110.885 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.459 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.040000000000006 111.084 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.510000000000005 110.856 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 74.430000000000007 110.909 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 70.530000000000001 111.095 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.2 mt -76.19 -27.52 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 111.127 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -54.56 172.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 75.530000000000001 110.872 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -55.92 176.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.793 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t60 60.74 34.95 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.099999999999994 110.841 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.7 122.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -129.47 -42.92 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 71.540000000000006 110.841 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 71.209999999999994 110.863 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.271 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.275 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.801 0.334 . . . . 70.129999999999995 110.886 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -101.77 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 70.219999999999999 110.861 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 74.109999999999999 111.154 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 111.204 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 73.400000000000006 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 111.163 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 73.209999999999994 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 70.510000000000005 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 74.340000000000003 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.200000000000003 111.154 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 110.87 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' CE2' HD23 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.475 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.926 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 73.430000000000007 111.192 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 74.349999999999994 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 71.099999999999994 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 61.329999999999998 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.120000000000005 110.913 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.913 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 62.020000000000003 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.310000000000002 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 111.158 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 111.099 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 74.329999999999998 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 75.349999999999994 110.882 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.59 ' HE1' ' C8 ' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.901 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 75.430000000000007 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 71.319999999999993 110.942 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 111.09 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 110.966 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 73.120000000000005 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.129999999999995 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 53.350000000000001 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 74.109999999999999 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 73.239999999999995 111.105 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 70.519999999999996 110.953 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 71.040000000000006 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 73.510000000000005 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.898 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 70.530000000000001 111.094 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.27 -30.3 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 111.166 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -51.74 103.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 75.530000000000001 110.87 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.44 -171.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 74.239999999999995 110.86 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -149.27 156.46 42.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 73.099999999999994 110.852 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.6 m170 57.48 77.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.519999999999996 110.864 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.75 147.64 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 71.540000000000006 110.805 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.867 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.272 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.285 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 70.129999999999995 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.57 173.38 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 70.219999999999999 110.852 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.109999999999999 111.2 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 74.010000000000005 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 73.400000000000006 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.12 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 70.510000000000005 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.437 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 74.340000000000003 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 110.885 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 111.187 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 75.340000000000003 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.879 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 73.430000000000007 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 71.099999999999994 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 61.329999999999998 110.851 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.120000000000005 110.95 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 75.140000000000001 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 62.020000000000003 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 75.310000000000002 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 72.140000000000001 111.179 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.420000000000002 111.111 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 74.329999999999998 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 75.349999999999994 110.925 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 74.200000000000003 110.834 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 75.430000000000007 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 110.904 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 73.120000000000005 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 75.219999999999999 110.898 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 53.350000000000001 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 HD13 ' CA ' ' A' ' 202' ' ' PLM . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.209999999999994 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 74.439999999999998 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.109999999999999 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.021 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 73.239999999999995 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.969 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 71.040000000000006 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.895 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 70.530000000000001 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt -86.05 -39.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.121 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -51.87 122.07 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 75.530000000000001 110.891 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 m80 63.3 82.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.916 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -169.9 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 110.845 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.5 m80 63.19 87.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 110.902 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -172.81 63.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 71.540000000000006 110.81 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 71.209999999999994 110.87 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.273 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.292 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 70.129999999999995 110.818 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m -135.14 -169.48 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 70.219999999999999 110.892 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 74.109999999999999 111.137 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 74.010000000000005 111.117 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.400000000000006 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 111.158 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 70.510000000000005 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 74.340000000000003 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 71.319999999999993 110.906 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 75.120000000000005 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.200000000000003 111.121 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 75.340000000000003 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 74.430000000000007 110.902 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 73.430000000000007 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 71.099999999999994 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 61.329999999999998 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.877 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 75.140000000000001 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 62.020000000000003 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 75.310000000000002 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 73.329999999999998 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 111.105 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.140000000000001 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.12 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 74.329999999999998 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 75.349999999999994 110.956 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 74.200000000000003 110.912 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.495 HG23 ' C6 ' ' A' ' 202' ' ' PLM . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 111.128 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.882 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.91 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 73.120000000000005 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 75.219999999999999 110.893 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 53.350000000000001 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.209999999999994 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 74.109999999999999 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 111.07 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 111.038 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 71.040000000000006 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 74.430000000000007 110.801 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 70.530000000000001 111.129 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.535 HD13 ' C8 ' ' A' ' 202' ' ' PLM . 23.5 mt -79.04 -42.2 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 111.151 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -51.56 103.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.894 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -173.77 118.97 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.792 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 52.7 33.75 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.801 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 149.58 29.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.519999999999996 110.867 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -55.66 101.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 71.540000000000006 110.773 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.209999999999994 110.845 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.288 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.273 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.793 0.33 . . . . 70.129999999999995 110.801 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -153.87 171.33 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 110.88 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 111.137 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 111.083 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.463 HG21 ' CA ' ' A' ' 201' ' ' PLM . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 73.109999999999999 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 73.209999999999994 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 74.340000000000003 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 71.319999999999993 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 75.120000000000005 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.200000000000003 111.167 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.912 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 111.148 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 74.349999999999994 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 71.099999999999994 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 61.329999999999998 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.120000000000005 110.951 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 62.020000000000003 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 73.329999999999998 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 111.039 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 73.140000000000001 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.420000000000002 111.071 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 74.329999999999998 112.543 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 75.349999999999994 110.945 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.962 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 111.133 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.473 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 111.174 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 75.239999999999995 110.883 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 73.120000000000005 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD22 ' CE ' ' A' ' 202' ' ' PLM . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 75.219999999999999 110.904 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 53.350000000000001 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.209999999999994 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 74.109999999999999 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.131 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 70.519999999999996 110.947 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.040000000000006 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.510000000000005 110.937 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.909 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 70.530000000000001 111.077 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 72.3 mt -60.5 -29.28 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 111.095 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -61.87 95.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 110.82 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.36 -170.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -104.09 156.08 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 73.099999999999994 110.846 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -170.06 -170.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.875 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 68.9 t60 63.24 104.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 71.540000000000006 110.908 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 71.209999999999994 110.801 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.283 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.267 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.761 0.315 . . . . 70.129999999999995 110.886 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -116.86 -170.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 110.891 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 74.109999999999999 111.095 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.117 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 73.400000000000006 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 73.209999999999994 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 70.510000000000005 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.426 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 74.340000000000003 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 71.319999999999993 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.200000000000003 111.095 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' HB2' ' CG ' ' A' ' 201' ' ' PLM . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.918 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 73.430000000000007 111.128 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 71.099999999999994 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 61.329999999999998 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.467 HG22 ' CC ' ' A' ' 201' ' ' PLM . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.120000000000005 110.886 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 75.140000000000001 110.893 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 62.020000000000003 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 75.310000000000002 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 73.329999999999998 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 111.146 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 73.140000000000001 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.138 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 74.329999999999998 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 75.349999999999994 110.945 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.89 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 75.430000000000007 111.08 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 110.926 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 73.120000000000005 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.479 HD23 ' CE ' ' A' ' 202' ' ' PLM . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 75.219999999999999 110.929 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 53.350000000000001 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 74.109999999999999 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.096 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 73.239999999999995 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 70.519999999999996 110.906 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 73.510000000000005 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.981 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 70.530000000000001 111.108 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mt -54.76 -31.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.439999999999998 111.106 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -52.05 -58.86 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 75.530000000000001 110.768 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.34 -170.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.833 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -75.81 -71.48 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 73.099999999999994 110.837 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -176.37 -68.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 163.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.540000000000006 110.817 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.209999999999994 110.837 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.268 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.275 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.308 . . . . 70.129999999999995 110.86 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 65.3 179.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 70.219999999999999 110.875 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 111.121 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 74.010000000000005 111.139 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.400000000000006 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 11' ' ' LYS . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 73.209999999999994 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 70.510000000000005 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 74.340000000000003 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.200000000000003 111.051 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 75.340000000000003 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.5 ' HB3' ' CG ' ' A' ' 201' ' ' PLM . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD1' ' CE ' ' A' ' 201' ' ' PLM . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.893 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 71.099999999999994 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 61.329999999999998 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.474 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.120000000000005 110.87 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 75.140000000000001 110.928 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 62.020000000000003 112.519 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 75.310000000000002 110.956 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 73.329999999999998 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 111.074 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 73.140000000000001 111.139 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.146 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 74.329999999999998 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 75.349999999999994 110.905 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.869 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.149 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 71.319999999999993 110.836 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 110.962 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 73.120000000000005 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.955 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 53.350000000000001 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.209999999999994 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 74.109999999999999 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 70.519999999999996 110.951 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.438 ' HA ' ' HF1' ' A' ' 202' ' ' PLM . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 71.040000000000006 111.145 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 73.510000000000005 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.818 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 70.530000000000001 111.046 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.55 -35.45 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.154 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -169.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.863 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 101.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.239999999999995 110.828 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.47 37.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 73.099999999999994 110.835 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -53.8 155.07 3.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.846 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -175.15 40.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.540000000000006 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.843 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.274 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.28 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 70.129999999999995 110.852 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.98 179.06 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 70.219999999999999 110.813 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 111.113 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.102 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 73.400000000000006 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 111.161 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 73.209999999999994 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 70.510000000000005 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 74.340000000000003 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 71.319999999999993 110.903 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 111.11 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 75.340000000000003 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.409 ' CE2' HD21 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD13 ' CE ' ' A' ' 201' ' ' PLM . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.935 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 73.430000000000007 111.129 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 71.099999999999994 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.409 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.120000000000005 110.902 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' H ' ' NE2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 75.140000000000001 110.85 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 62.020000000000003 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 72.140000000000001 111.09 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 73.140000000000001 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' HB ' ' CG ' ' A' ' 201' ' ' PLM . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.149 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 74.329999999999998 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 75.349999999999994 110.862 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 110.965 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.163 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 71.319999999999993 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 111.133 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 110.961 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 73.120000000000005 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 75.219999999999999 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 53.350000000000001 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 110.915 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 74.109999999999999 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 70.519999999999996 110.882 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.904 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 70.530000000000001 111.101 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.98 -52.47 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 111.17 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 52.22 -169.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 75.530000000000001 110.905 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -79.92 -49.98 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 74.239999999999995 110.898 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.03 157.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 73.099999999999994 110.846 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -123.39 179.11 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 74.519999999999996 110.888 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -116.92 -63.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 71.540000000000006 110.914 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 71.209999999999994 110.836 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.261 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.286 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.356 . . . . 70.129999999999995 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -118.75 -172.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 70.219999999999999 110.83 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 74.109999999999999 111.068 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 74.010000000000005 111.133 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 73.400000000000006 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 111.153 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 73.209999999999994 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 70.510000000000005 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 74.340000000000003 110.858 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 71.319999999999993 110.909 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.200000000000003 111.105 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 75.340000000000003 110.969 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HA ' HG11 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 111.077 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 71.099999999999994 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 61.329999999999998 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 HD21 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.120000000000005 110.91 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 62.020000000000003 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 111.153 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.156 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.675 HG13 ' CG ' ' A' ' 201' ' ' PLM . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 74.329999999999998 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 75.349999999999994 110.862 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.897 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 71.319999999999993 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 75.239999999999995 110.971 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.120000000000005 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 53.350000000000001 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 74.109999999999999 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 73.239999999999995 111.09 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 70.519999999999996 110.94 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 73.510000000000005 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 110.943 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 70.530000000000001 111.152 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 105' ' ' ILE . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.408 ' N ' HG11 ' A' ' 104' ' ' VAL . 96.0 mt -75.23 -27.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 111.105 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -74.24 74.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.848 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -165.26 -68.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.874 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.05 176.82 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 110.837 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -135.38 -174.12 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.519999999999996 110.883 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -169.82 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 71.540000000000006 110.932 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 71.209999999999994 110.824 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PLM . . . . . 1.268 ' H22' ' C2 ' ' A' ' 201' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PLM . . . . . 1.27 ' C2 ' ' H22' ' A' ' 202' ' ' PLM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.95 0.405 . . . . 70.219999999999999 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.773 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 111.131 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 10' ' ' ILE . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 70.25 111.128 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 14' ' ' VAL . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 10' ' ' ILE . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.134 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 51.25 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 65.319999999999993 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 53.119999999999997 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 65.519999999999996 110.9 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.073 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 53.310000000000002 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 32' ' ' ASN . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 65.019999999999996 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.594 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.113 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 53.340000000000003 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 53.130000000000003 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 60.43 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.837 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' ' 11' ' ' LYS . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.049999999999997 110.905 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 61.119999999999997 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 45.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 97' ' ' LEU . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 33.43 111.122 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.239999999999995 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.121 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 33' ' ' ILE . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.773 HD23 HD11 ' A' ' 6' ' ' ILE . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 80' ' ' VAL . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 43.530000000000001 110.852 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.409999999999997 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.904 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 78' ' ' LEU . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 73' ' ' ILE . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 72.430000000000007 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.742 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.654 HD23 HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.944 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.654 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 62.130000000000003 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 53.030000000000001 110.903 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.439999999999998 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 110.913 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 64.239999999999995 111.093 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 102' ' ' ALA . 18.0 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.163 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.838 0.351 . . . . 70.219999999999999 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG11 ' OE2' ' A' ' 40' ' ' GLU . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.61 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.096 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.677 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 70.25 111.121 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 63.409999999999997 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 14' ' ' VAL . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.748 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.128 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 51.25 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 65.319999999999993 111.084 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 53.119999999999997 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 71.129999999999995 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 46' ' ' LEU . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.158 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 53.310000000000002 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 32' ' ' ASN . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 65.019999999999996 110.937 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 31' ' ' LEU . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.171 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 53.340000000000003 110.959 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 53.130000000000003 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.726 ' OE2' HG11 ' A' ' 3' ' ' VAL . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 60.43 110.955 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.099999999999994 110.922 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.049999999999997 110.896 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 61.119999999999997 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 45.140000000000001 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 97' ' ' LEU . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 33.43 111.102 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' CG1' HG23 ' A' ' 89' ' ' ILE . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 73.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 34' ' ' LYS . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 52.229999999999997 110.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 6' ' ' ILE . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 73.329999999999998 110.927 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 80' ' ' VAL . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 111.112 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 43.530000000000001 110.824 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 105' ' ' ILE . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.61 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.928 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 44.420000000000002 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 84' ' ' LEU . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.466 HD13 ' HB1' ' A' ' 95' ' ' ALA . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.240000000000002 110.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 53.030000000000001 110.955 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.450000000000003 110.912 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 64.239999999999995 111.12 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 80' ' ' VAL . 82.2 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 111.111 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.895 0.379 . . . . 70.219999999999999 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 71' ' ' LEU . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.068 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 10' ' ' ILE . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 70.25 111.098 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 14' ' ' VAL . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 10' ' ' ILE . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 65.129999999999995 111.149 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 51.25 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 65.319999999999993 111.144 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 53.119999999999997 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 65.519999999999996 110.855 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.587 ' CG2' HD12 ' A' ' 46' ' ' LEU . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.148 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 26' ' ' LEU . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.310000000000002 110.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CE1' HD22 ' A' ' 46' ' ' LEU . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 7' ' ' ILE . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 65.019999999999996 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.516 HD22 HG23 ' A' ' 64' ' ' THR . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.634 HG21 HD12 ' A' ' 67' ' ' LEU . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.142 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 53.340000000000003 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 53.130000000000003 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.836 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.099999999999994 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 61.119999999999997 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 45.140000000000001 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 98' ' ' ALA . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 33.43 111.117 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 64.239999999999995 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 89' ' ' ILE . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.109 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG23 ' A' ' 89' ' ' ILE . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 73.140000000000001 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 33' ' ' ILE . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 52.229999999999997 110.936 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 71' ' ' LEU . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.403 ' CE ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.885 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 80' ' ' VAL . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 111.135 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 43.530000000000001 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' CD1' ' A' ' 105' ' ' ILE . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 72.430000000000007 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.963 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 65' ' ' VAL . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.414 HD13 ' HB1' ' A' ' 95' ' ' ALA . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 62.299999999999997 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 111.044 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 71.109999999999999 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.668 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.894 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.615 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 64.450000000000003 111.146 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 62.450000000000003 110.926 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 64.239999999999995 111.151 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.721 ' CD1' HG21 ' A' ' 80' ' ' VAL . 52.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.168 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.048 HD11 HD23 ' A' ' 71' ' ' LEU . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.151 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 10' ' ' ILE . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 70.25 111.09 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 63.409999999999997 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 14' ' ' VAL . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.825 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 10' ' ' ILE . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 51.25 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 53.119999999999997 110.911 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 65.519999999999996 110.92 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 111.115 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.566 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.933 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 32' ' ' ASN . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 65.019999999999996 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 111.188 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 60.43 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.751 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 110.872 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.049999999999997 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 61.119999999999997 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 45.140000000000001 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG11 ' HB2' ' A' ' 98' ' ' ALA . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 33.43 111.185 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.144 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 73.140000000000001 112.51 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 33' ' ' ILE . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.895 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' HB2' HG22 ' A' ' 65' ' ' VAL . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.773 ' HG2' HG21 ' A' ' 6' ' ' ILE . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.865 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 70.439999999999998 111.119 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.729 ' CB ' HG23 ' A' ' 6' ' ' ILE . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 43.530000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' THR . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 71.409999999999997 111.164 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.913 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 78' ' ' LEU . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.906 HG22 HD13 ' A' ' 73' ' ' ILE . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 72.430000000000007 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.883 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 44.420000000000002 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 84' ' ' LEU . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' HB1' ' A' ' 95' ' ' ALA . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 62.299999999999997 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 62.130000000000003 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.621 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 63.240000000000002 111.038 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 71.109999999999999 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 53.030000000000001 110.953 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.627 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 64.450000000000003 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.651 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 62.450000000000003 110.891 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 111.049 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.841 HD13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.010000000000005 111.103 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.922 0.392 . . . . 70.219999999999999 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' CG2' HD11 ' A' ' 67' ' ' LEU . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' A' ' 70' ' ' MET . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.162 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.401 HD13 HD12 ' A' ' 10' ' ' ILE . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 70.25 111.178 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 63.409999999999997 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 14' ' ' VAL . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.81 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 10' ' ' ILE . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 111.127 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 51.25 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 53.119999999999997 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 65.519999999999996 110.92 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 71.129999999999995 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.09 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 53.310000000000002 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.775 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.019999999999996 110.902 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.45 ' HB2' HG23 ' A' ' 64' ' ' THR . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.741 HG21 HD12 ' A' ' 67' ' ' LEU . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.46 ' OE1' HG21 ' A' ' 3' ' ' VAL . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.826 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.013 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.81 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 63.049999999999997 110.92 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 61.119999999999997 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 72.319999999999993 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 45.140000000000001 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 33.43 111.114 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 64.239999999999995 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 111.163 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 69' ' ' ASP . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 73.140000000000001 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 33' ' ' ILE . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 52.229999999999997 110.909 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.808 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.775 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 68' ' ' GLU . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.931 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 70.439999999999998 111.134 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 43.530000000000001 110.892 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.924 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.542 ' O ' HD23 ' A' ' 78' ' ' LEU . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 73' ' ' ILE . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 44.420000000000002 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 84' ' ' LEU . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 62.299999999999997 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 62.130000000000003 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 63.240000000000002 111.022 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 53.030000000000001 110.862 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 64.450000000000003 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 62.450000000000003 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.069 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 ' CG2' ' A' ' 80' ' ' VAL . 85.5 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.010000000000005 111.124 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.642 ' O ' HG22 ' A' ' 5' ' ' THR . 2.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.92 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CD ' ' A' ' 40' ' ' GLU . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.7 HG23 HD13 ' A' ' 6' ' ' ILE . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 HG23 ' A' ' 5' ' ' THR . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 73.349999999999994 111.14 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.63 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.25 111.163 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 14' ' ' VAL . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' HG21 ' A' ' 51' ' ' VAL . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 10' ' ' ILE . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 111.135 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 51.25 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 65.319999999999993 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 53.119999999999997 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.883 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.109999999999999 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.310000000000002 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE1' HD22 ' A' ' 46' ' ' LEU . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.019999999999996 110.878 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.527 HD21 HG22 ' A' ' 62' ' ' THR . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.72 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 111.152 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 53.340000000000003 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 53.130000000000003 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' CD ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 60.43 110.833 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.099999999999994 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 44' ' ' VAL . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 63.049999999999997 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 61.119999999999997 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' LEU . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 33.43 111.162 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.527 HG22 HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 64.239999999999995 111.156 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.052 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.762 HG22 ' HA ' ' A' ' 89' ' ' ILE . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 73.140000000000001 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 52.229999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 71' ' ' LEU . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' OD2' HG13 ' A' ' 65' ' ' VAL . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.677 ' HE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 68' ' ' GLU . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.18 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.65 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 43.530000000000001 110.865 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 71.409999999999997 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.879 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.125 HG21 HD13 ' A' ' 105' ' ' ILE . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 89' ' ' ILE . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 72.409999999999997 110.889 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' A' ' 65' ' ' VAL . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.481 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.855 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 90' ' ' GLU . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 62.299999999999997 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 62.130000000000003 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 53.030000000000001 110.896 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 104' ' ' VAL . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 110.881 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.534 HD11 ' CE1' ' A' ' 29' ' ' PHE . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.919 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 64.239999999999995 111.153 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 100' ' ' LYS . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.125 HD13 HG21 ' A' ' 80' ' ' VAL . 80.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.010000000000005 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.933 0.397 . . . . 70.219999999999999 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.692 HD11 HD23 ' A' ' 71' ' ' LEU . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 111.144 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.073 HD13 HD12 ' A' ' 10' ' ' ILE . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.047 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.073 HD12 HD13 ' A' ' 7' ' ' ILE . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 65.129999999999995 111.122 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 51.25 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 65.319999999999993 111.194 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 65.519999999999996 110.874 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.144 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 46' ' ' LEU . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.428 ' CD2' HD11 ' A' ' 7' ' ' ILE . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 65.019999999999996 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.095 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 53.340000000000003 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' OE2' ' A' ' 40' ' ' GLU . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' OE2' HG21 ' A' ' 35' ' ' THR . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 60.43 110.918 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.786 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.496 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.099999999999994 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 44' ' ' VAL . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 63.049999999999997 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 61.119999999999997 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 45.140000000000001 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 98' ' ' ALA . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 33.43 111.103 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 89' ' ' ILE . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.143 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 69' ' ' ASP . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 73.140000000000001 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.96 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HB2' HG22 ' A' ' 65' ' ' VAL . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 6' ' ' ILE . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.953 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 80' ' ' VAL . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 111.074 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.523 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 43.530000000000001 110.904 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 64.409999999999997 110.917 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 73' ' ' ILE . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 72.430000000000007 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 88' ' ' LYS . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.109999999999999 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 44.420000000000002 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 95' ' ' ALA . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 62.299999999999997 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 63.240000000000002 111.105 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 53.030000000000001 110.886 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 110.916 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 62.450000000000003 110.929 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 64.239999999999995 111.122 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 100' ' ' LYS . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 80' ' ' VAL . 93.4 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.010000000000005 111.132 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.445 ' N ' ' HG1' ' A' ' 5' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.96 0.41 . . . . 70.219999999999999 110.863 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 2' ' ' SER . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 74' ' ' SER . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 111.124 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 10' ' ' ILE . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 70.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.409999999999997 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 65.129999999999995 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 51.25 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 65.319999999999993 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 53.119999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 65.519999999999996 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.923 HG23 HD12 ' A' ' 46' ' ' LEU . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 53.310000000000002 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.789 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.644 HD11 HG13 ' A' ' 33' ' ' ILE . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 111.118 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 53.130000000000003 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.923 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.099999999999994 110.875 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 63.049999999999997 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 61.119999999999997 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 45.140000000000001 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 98' ' ' ALA . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 33.43 111.17 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 111.177 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.813 HG22 ' HA ' ' A' ' 89' ' ' ILE . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.506 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 52.229999999999997 110.985 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 68' ' ' GLU . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 110.939 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 43.530000000000001 110.902 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' THR . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.207 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 64.409999999999997 110.992 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.58 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 105' ' ' ILE . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 72.430000000000007 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.685 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.109999999999999 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 44.420000000000002 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.813 ' HA ' HG22 ' A' ' 65' ' ' VAL . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.423 HD13 ' HB1' ' A' ' 95' ' ' ALA . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 62.299999999999997 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 62.130000000000003 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.101 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.109999999999999 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 53.030000000000001 110.878 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.123 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 62.450000000000003 110.921 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.77 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 111.148 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 102' ' ' ALA . 64.6 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 70' ' ' MET . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 111.088 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.808 ' HA ' HD12 ' A' ' 10' ' ' ILE . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 70.25 111.099 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 7' ' ' ILE . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 111.181 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 51.25 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 53.119999999999997 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 65.519999999999996 110.872 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 111.175 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 25' ' ' VAL . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 53.310000000000002 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.808 ' HB2' HG23 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' ASN . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 65.019999999999996 110.911 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.658 ' N ' HD12 ' A' ' 31' ' ' LEU . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.143 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 53.130000000000003 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 46' ' ' LEU . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.901 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 44' ' ' VAL . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 63.049999999999997 110.967 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 61.119999999999997 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 45.140000000000001 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 97' ' ' LEU . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 33.43 111.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.146 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' CG1' HG23 ' A' ' 89' ' ' ILE . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 73.140000000000001 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.659 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 52.229999999999997 110.895 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.732 ' HG2' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 6' ' ' ILE . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 73.329999999999998 110.953 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 77' ' ' THR . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 80' ' ' VAL . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.128 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.672 ' CB ' HG23 ' A' ' 6' ' ' ILE . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 43.530000000000001 110.913 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 71.409999999999997 111.194 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 73' ' ' ILE . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.93 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 84' ' ' LEU . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 62.299999999999997 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 62.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 63.240000000000002 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.109999999999999 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.768 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 53.030000000000001 110.977 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.450000000000003 111.206 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.450000000000003 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.134 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 102' ' ' ALA . 84.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.091 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.58 ' HA ' HD21 ' A' ' 71' ' ' LEU . 1.5 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.918 0.389 . . . . 70.219999999999999 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG21 ' OE2' ' A' ' 40' ' ' GLU . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 10' ' ' ILE . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 70.25 111.082 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 14' ' ' VAL . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HB3' HG11 ' A' ' 51' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 51.25 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 53.119999999999997 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.739 HG23 HD12 ' A' ' 46' ' ' LEU . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.194 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 53.310000000000002 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 56' ' ' PHE . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.553 ' HB3' HG23 ' A' ' 62' ' ' THR . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD11 ' CE ' ' A' ' 70' ' ' MET . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 65.019999999999996 110.897 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.543 ' N ' HD23 ' A' ' 31' ' ' LEU . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.647 ' CG2' HD12 ' A' ' 67' ' ' LEU . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 111.112 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 HD13 ' A' ' 67' ' ' LEU . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 53.130000000000003 111.102 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' OE2' HG21 ' A' ' 3' ' ' VAL . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 60.43 110.872 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 48' ' ' GLN . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.099999999999994 110.928 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 61.119999999999997 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 28' ' ' VAL . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.85 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 45.140000000000001 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 33.43 111.149 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.14 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.183 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 89' ' ' ILE . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 73.140000000000001 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 33' ' ' ILE . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 52.229999999999997 110.978 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.777 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.663 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 68' ' ' GLU . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.942 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 71.409999999999997 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.909 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 78' ' ' LEU . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 110.844 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.109999999999999 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 44.420000000000002 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 65' ' ' VAL . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.109999999999999 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.682 HD13 ' HB1' ' A' ' 95' ' ' ALA . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 62.130000000000003 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.096 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.981 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 62.450000000000003 110.909 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.572 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 64.239999999999995 111.094 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 102' ' ' ALA . 69.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.092 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.916 0.389 . . . . 70.219999999999999 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.486 HG11 ' OE2' ' A' ' 40' ' ' GLU . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 70' ' ' MET . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.107 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 10' ' ' ILE . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 70.25 111.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 7' ' ' ILE . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.834 ' HB3' HG11 ' A' ' 51' ' ' VAL . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 10' ' ' ILE . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 51.25 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 53.119999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.916 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.129999999999995 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 23' ' ' ARG . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.659 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.749 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.696 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 65.019999999999996 110.92 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 111.087 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.909 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 53.130000000000003 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' OE2' HG11 ' A' ' 3' ' ' VAL . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 56' ' ' PHE . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.714 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 63.049999999999997 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 61.119999999999997 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.866 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 45.140000000000001 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.43 111.158 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.122 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.117 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 69' ' ' ASP . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 52.229999999999997 110.986 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' HG22 ' A' ' 65' ' ' VAL . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 HD11 ' A' ' 6' ' ' ILE . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 110.913 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.195 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.621 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 43.530000000000001 110.862 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 64.409999999999997 110.907 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 105' ' ' ILE . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 78' ' ' LEU . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.948 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 44.420000000000002 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.555 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 95' ' ' ALA . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' CB ' HG22 ' A' ' 61' ' ' VAL . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 62.130000000000003 110.863 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.07 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.583 ' HB3' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 53.030000000000001 110.91 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 62.450000000000003 110.897 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 111.104 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 80' ' ' VAL . 65.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 111.112 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 HD23 ' A' ' 71' ' ' LEU . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 73.349999999999994 111.186 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.577 HD11 HD23 ' A' ' 31' ' ' LEU . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 70.25 111.11 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 63.409999999999997 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.82 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HB3' HG11 ' A' ' 51' ' ' VAL . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' NH2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 10' ' ' ILE . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 65.129999999999995 111.094 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 51.25 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 49' ' ' LEU . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.154 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 53.119999999999997 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.834 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 23' ' ' ARG . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.128 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' O ' HD11 ' A' ' 46' ' ' LEU . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.846 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 7' ' ' ILE . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 65.019999999999996 110.886 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.147 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 53.340000000000003 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 53.130000000000003 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 60.43 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.427 ' HG ' HG21 ' A' ' 17' ' ' VAL . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.935 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 61.119999999999997 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 45.140000000000001 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 98' ' ' ALA . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 33.43 111.092 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.239999999999995 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG13 ' CG2' ' A' ' 89' ' ' ILE . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.329999999999998 111.138 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 89' ' ' ILE . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 73.140000000000001 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 33' ' ' ILE . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 52.229999999999997 110.865 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 70.439999999999998 111.175 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.761 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 43.530000000000001 110.81 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.907 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 78' ' ' LEU . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 72.430000000000007 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 44.420000000000002 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.836 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.784 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 62.299999999999997 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 62.130000000000003 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.784 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.065 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 71.109999999999999 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 53.030000000000001 110.885 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 64.450000000000003 111.084 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.856 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 62.450000000000003 110.909 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 64.239999999999995 111.095 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 100' ' ' LYS . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.127 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' ILE . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.75 HD11 HD23 ' A' ' 71' ' ' LEU . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 111.154 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD13 HD12 ' A' ' 10' ' ' ILE . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.25 111.204 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 63.409999999999997 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HD13 ' A' ' 7' ' ' ILE . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.75 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 10' ' ' ILE . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.129999999999995 111.163 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 51.25 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 65.319999999999993 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 53.119999999999997 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG23 HD12 ' A' ' 46' ' ' LEU . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 111.154 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 53.310000000000002 110.87 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 33' ' ' ILE . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.926 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.63 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 31' ' ' LEU . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.192 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 53.130000000000003 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 60.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' C ' HG12 ' A' ' 14' ' ' VAL . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 110.913 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.049999999999997 110.913 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 61.119999999999997 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 45.140000000000001 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 97' ' ' LEU . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.158 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.412 HG13 ' CG2' ' A' ' 89' ' ' ILE . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 69' ' ' ASP . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 33' ' ' ILE . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 52.229999999999997 110.882 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.698 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.75 HD23 HD11 ' A' ' 6' ' ' ILE . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.901 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 70.439999999999998 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 78' ' ' LEU . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.09 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 64.409999999999997 110.966 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 105' ' ' ILE . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.409999999999997 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.109999999999999 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 95' ' ' ALA . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 62.299999999999997 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 62.130000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 63.240000000000002 111.105 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.109999999999999 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 53.030000000000001 110.953 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 110.898 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 80' ' ' VAL . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 111.094 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 80' ' ' VAL . 66.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 111.166 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.721 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.919 0.39 . . . . 70.219999999999999 110.852 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.557 HG21 ' OE1' ' A' ' 40' ' ' GLU . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.457 HG21 ' SD ' ' A' ' 70' ' ' MET . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.2 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 70.25 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 63.409999999999997 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.723 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.12 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 51.25 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.519999999999996 110.885 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.109999999999999 111.187 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 53.310000000000002 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 46' ' ' LEU . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 33' ' ' ILE . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 65.019999999999996 110.879 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.587 ' N ' HD12 ' A' ' 31' ' ' LEU . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 HD21 ' A' ' 31' ' ' LEU . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 53.130000000000003 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' OE1' HG21 ' A' ' 3' ' ' VAL . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.851 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' C ' HG12 ' A' ' 14' ' ' VAL . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 110.95 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.049999999999997 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 61.119999999999997 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 72.319999999999993 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 45.140000000000001 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 97' ' ' LEU . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 33.43 111.179 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.111 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 33' ' ' ILE . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 52.229999999999997 110.925 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 71' ' ' LEU . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 65' ' ' VAL . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 6' ' ' ILE . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 2' ' ' SER . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.834 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 43.530000000000001 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.904 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.898 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.420000000000002 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 84' ' ' LEU . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.109999999999999 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 95' ' ' ALA . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 62.299999999999997 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 62.130000000000003 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.747 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.030000000000001 110.969 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.697 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 62.450000000000003 110.895 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 64.239999999999995 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 111.121 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.634 HD11 HD23 ' A' ' 71' ' ' LEU . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 73.349999999999994 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.02 HD13 HD12 ' A' ' 10' ' ' ILE . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.25 111.117 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.02 HD12 HD13 ' A' ' 7' ' ' ILE . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.158 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 51.25 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 65.319999999999993 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 53.119999999999997 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 65.519999999999996 110.906 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.109999999999999 111.121 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 53.310000000000002 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.413 ' CD2' HD11 ' A' ' 7' ' ' ILE . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 65.019999999999996 110.902 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.676 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 60.43 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.877 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 44' ' ' VAL . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 61.119999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 45.140000000000001 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 98' ' ' ALA . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 33.43 111.105 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 111.12 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 73.140000000000001 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.676 HD12 HG21 ' A' ' 33' ' ' ILE . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 52.229999999999997 110.956 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 6' ' ' ILE . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 78' ' ' LEU . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 111.128 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.462 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 43.530000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 71.409999999999997 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 110.91 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 72.430000000000007 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.893 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 44.420000000000002 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 84' ' ' LEU . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 95' ' ' ALA . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 62.130000000000003 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 63.240000000000002 111.07 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 71.109999999999999 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.539 ' CB ' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.038 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.747 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 64.450000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 62.450000000000003 110.801 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 64.239999999999995 111.129 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 102' ' ' ALA . 23.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.8 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.867 0.365 . . . . 70.219999999999999 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 111.137 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.568 HD13 HD12 ' A' ' 10' ' ' ILE . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.083 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 14' ' ' VAL . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 51.25 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 53.119999999999997 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 65.519999999999996 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.129999999999995 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.792 HG23 HD12 ' A' ' 46' ' ' LEU . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.167 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 53.310000000000002 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 46' ' ' LEU . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 33' ' ' ILE . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 65.019999999999996 110.912 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 67' ' ' LEU . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 111.148 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 53.130000000000003 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 60.43 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.792 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.099999999999994 110.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 63.049999999999997 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 61.119999999999997 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 45.140000000000001 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 98' ' ' ALA . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.039 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG13 ' CG2' ' A' ' 89' ' ' ILE . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.071 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 69' ' ' ASP . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 73.140000000000001 112.543 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 52.229999999999997 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 65' ' ' VAL . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 68' ' ' GLU . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.962 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 80' ' ' VAL . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 111.133 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' THR . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 75' ' ' GLY . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 111.174 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 64.409999999999997 110.883 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 78' ' ' LEU . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 73' ' ' ILE . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.430000000000007 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 110.904 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.429 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.66 HD13 ' CB ' ' A' ' 95' ' ' ALA . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 62.299999999999997 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 62.130000000000003 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.109999999999999 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 53.030000000000001 110.947 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.450000000000003 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 72.439999999999998 110.937 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.909 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 111.077 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' LYS . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 102' ' ' ALA . 72.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.095 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.914 0.388 . . . . 70.219999999999999 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 71' ' ' LEU . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 111.095 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 10' ' ' ILE . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 70.25 111.117 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 63.409999999999997 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 7' ' ' ILE . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 51.25 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 65.319999999999993 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 53.119999999999997 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 46' ' ' LEU . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.095 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 53.310000000000002 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 33' ' ' ILE . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 65.019999999999996 110.918 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 53.340000000000003 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 53.130000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.099999999999994 110.886 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 44' ' ' VAL . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 63.049999999999997 110.893 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 61.119999999999997 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 45.140000000000001 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 97' ' ' LEU . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 33.43 111.146 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.138 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 73.140000000000001 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HG ' HD11 ' A' ' 71' ' ' LEU . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 52.229999999999997 110.945 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 6' ' ' ILE . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 110.89 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.72 HG21 HG22 ' A' ' 80' ' ' VAL . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 70.439999999999998 111.08 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 43.530000000000001 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.926 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.583 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 73' ' ' ILE . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 72.430000000000007 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.688 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 110.929 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 44.420000000000002 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 62.299999999999997 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 62.130000000000003 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.096 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 53.030000000000001 110.906 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 64.450000000000003 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 62.450000000000003 110.981 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.108 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 102' ' ' ALA . 17.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 111.106 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.854 0.359 . . . . 70.219999999999999 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.767 HG21 ' CG ' ' A' ' 70' ' ' MET . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.121 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 10' ' ' ILE . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.139 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.825 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 51.25 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 53.119999999999997 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 65.519999999999996 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD12 ' A' ' 46' ' ' LEU . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.109999999999999 111.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 56' ' ' PHE . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE1' HD22 ' A' ' 46' ' ' LEU . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 62' ' ' THR . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.719 HD11 ' CE ' ' A' ' 70' ' ' MET . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 65.019999999999996 110.893 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 53.340000000000003 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 53.130000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 60.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 54' ' ' GLY . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.81 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 49' ' ' LEU . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.099999999999994 110.87 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 63.049999999999997 110.928 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 43' ' ' ILE . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 61.119999999999997 112.519 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 28' ' ' VAL . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.956 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 45.140000000000001 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 98' ' ' ALA . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 33.43 111.074 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.139 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 111.146 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.748 HG22 ' HA ' ' A' ' 89' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 73.140000000000001 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.905 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' A' ' 65' ' ' VAL . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.767 ' CG ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.574 HD23 HD11 ' A' ' 6' ' ' ILE . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 110.869 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 70.439999999999998 111.149 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.682 ' CB ' HG23 ' A' ' 6' ' ' ILE . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 43.530000000000001 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.962 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 78' ' ' LEU . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.634 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.955 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 44.420000000000002 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.748 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.299999999999997 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 53.030000000000001 110.951 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.145 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.818 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.734 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 64.239999999999995 111.046 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 102' ' ' ALA . 80.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 111.154 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.512 ' CA ' HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 110.813 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 10' ' ' ILE . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.102 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' HG22 ' A' ' 14' ' ' VAL . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB3' HG11 ' A' ' 51' ' ' VAL . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 65.129999999999995 111.161 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 51.25 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 53.119999999999997 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.11 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.732 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 65.019999999999996 110.935 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' N ' HD23 ' A' ' 31' ' ' LEU . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 67' ' ' LEU . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 72.219999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 53.340000000000003 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 53.130000000000003 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.049999999999997 110.85 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 61.119999999999997 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 45.140000000000001 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 33.43 111.09 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 64.239999999999995 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.149 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 ' SD ' ' A' ' 70' ' ' MET . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 73.140000000000001 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG21 ' A' ' 33' ' ' ILE . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.862 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.732 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 68' ' ' GLU . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.965 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.658 HD13 HG22 ' A' ' 80' ' ' VAL . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.163 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 43.530000000000001 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.598 ' O ' HD22 ' A' ' 78' ' ' LEU . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.133 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.961 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 73' ' ' ILE . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 72.430000000000007 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.615 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 72.409999999999997 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 44.420000000000002 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.615 HD12 ' CD2' ' A' ' 84' ' ' LEU . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.915 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.299999999999997 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 62.130000000000003 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 111.077 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 53.030000000000001 110.882 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 64.450000000000003 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.904 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.239999999999995 111.101 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.17 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 70.219999999999999 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.827 HD11 HD23 ' A' ' 71' ' ' LEU . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.068 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 10' ' ' ILE . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 70.25 111.133 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.409999999999997 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 14' ' ' VAL . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 10' ' ' ILE . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 111.153 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 51.25 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 53.119999999999997 110.858 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 65.519999999999996 110.909 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.109999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 53.310000000000002 110.969 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.785 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB3' HG23 ' A' ' 62' ' ' THR . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 65.019999999999996 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.438 HD21 HG23 ' A' ' 62' ' ' THR . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 67' ' ' LEU . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.077 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 53.340000000000003 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 53.130000000000003 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 60.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.599 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.099999999999994 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 44' ' ' VAL . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 63.049999999999997 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 61.119999999999997 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 45.140000000000001 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 30' ' ' GLN . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 33.43 111.153 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.438 HG23 HD21 ' A' ' 32' ' ' ASN . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.156 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 31' ' ' LEU . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 89' ' ' ILE . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.595 HD12 HG21 ' A' ' 33' ' ' ILE . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.862 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.764 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.767 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.827 HD23 HD11 ' A' ' 6' ' ' ILE . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.897 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.439999999999998 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.530000000000001 110.868 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 64.409999999999997 110.971 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 72.430000000000007 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.723 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.933 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 44.420000000000002 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.791 ' HA ' HG22 ' A' ' 65' ' ' VAL . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.109999999999999 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.015 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 62.299999999999997 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 62.130000000000003 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 1.015 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.09 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 71.109999999999999 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CB ' HG21 ' A' ' 61' ' ' VAL . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 53.030000000000001 110.94 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.658 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 64.450000000000003 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.686 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.943 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 64.239999999999995 111.152 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 101' ' ' LEU . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 102' ' ' ALA . 96.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.010000000000005 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.81 0.338 . . . . 61.530000000000001 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -103.98 -168.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 110.805 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.773 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 111.131 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 10' ' ' ILE . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 70.25 111.128 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 14' ' ' VAL . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 10' ' ' ILE . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.134 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 51.25 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 65.319999999999993 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 53.119999999999997 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 65.519999999999996 110.9 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.073 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 53.310000000000002 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 65.019999999999996 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.594 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.113 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 53.340000000000003 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 53.130000000000003 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 60.43 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG21 ' HD1' ' A' ' 201' ' ' PLM . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.837 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.975 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' ' 11' ' ' LYS . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.049999999999997 110.905 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 61.119999999999997 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 45.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 97' ' ' LEU . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 33.43 111.122 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.239999999999995 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG21 ' HG1' ' A' ' 201' ' ' PLM . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.121 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 33' ' ' ILE . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.773 HD23 HD11 ' A' ' 6' ' ' ILE . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 80' ' ' VAL . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 43.530000000000001 110.852 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.409999999999997 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.904 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 78' ' ' LEU . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 73' ' ' ILE . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 72.430000000000007 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.742 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.654 HD23 HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.944 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.654 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD13 ' HA1' ' A' ' 202' ' ' PLM . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' A' ' 202' ' ' PLM . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 62.130000000000003 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 53.030000000000001 110.903 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.439999999999998 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 110.913 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.541 ' HB2' ' HD2' ' A' ' 202' ' ' PLM . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 64.239999999999995 111.093 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 102' ' ' ALA . 18.0 mt -82.07 -46.81 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.163 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -67.35 90.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.865 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.9 -170.2 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.863 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -59.84 150.51 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.871 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -69.68 -175.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 63.420000000000002 110.868 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 62.81 67.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.859 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.667 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.541 ' H71' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.753 0.311 . . . . 61.530000000000001 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m 64.29 171.13 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 70.219999999999999 110.843 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.726 HG11 ' OE2' ' A' ' 40' ' ' GLU . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.61 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.096 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.677 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 70.25 111.121 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 63.409999999999997 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 14' ' ' VAL . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.748 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.128 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 51.25 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 65.319999999999993 111.084 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 53.119999999999997 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 71.129999999999995 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 46' ' ' LEU . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.158 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 53.310000000000002 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 65.019999999999996 110.937 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 31' ' ' LEU . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.171 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 53.340000000000003 110.959 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 53.130000000000003 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.726 ' OE2' HG11 ' A' ' 3' ' ' VAL . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 60.43 110.955 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.099999999999994 110.922 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.049999999999997 110.896 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 61.119999999999997 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 45.140000000000001 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 97' ' ' LEU . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 33.43 111.102 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' CG1' HG23 ' A' ' 89' ' ' ILE . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 73.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 34' ' ' LYS . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 52.229999999999997 110.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.515 ' HE2' ' C8 ' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 6' ' ' ILE . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 73.329999999999998 110.927 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.637 HD12 ' H71' ' A' ' 202' ' ' PLM . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 111.112 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 43.530000000000001 110.824 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 105' ' ' ILE . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.61 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.928 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 44.420000000000002 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.613 HD13 ' HA1' ' A' ' 202' ' ' PLM . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.498 HD21 ' CG ' ' A' ' 202' ' ' PLM . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.240000000000002 110.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 53.030000000000001 110.955 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.06 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.450000000000003 110.912 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 64.239999999999995 111.12 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 80' ' ' VAL . 82.2 mt -73.7 -35.12 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 111.111 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.88 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.809 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.12 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.798 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.93 -170.4 2.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.219999999999999 110.84 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -58.09 150.71 20.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.831 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.41 178.78 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.25 110.879 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.7 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.773 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.781 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.637 ' H71' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 61.530000000000001 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -111.2 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 70.219999999999999 110.898 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 71' ' ' LEU . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.068 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 10' ' ' ILE . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 70.25 111.098 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 14' ' ' VAL . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 10' ' ' ILE . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 65.129999999999995 111.149 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 51.25 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.406 HG22 ' H51' ' A' ' 201' ' ' PLM . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 65.319999999999993 111.144 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 53.119999999999997 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 65.519999999999996 110.855 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.587 ' CG2' HD12 ' A' ' 46' ' ' LEU . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.148 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 26' ' ' LEU . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.310000000000002 110.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CE1' HD22 ' A' ' 46' ' ' LEU . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 65.019999999999996 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.516 HD22 HG23 ' A' ' 64' ' ' THR . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.634 HG21 HD12 ' A' ' 67' ' ' LEU . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.142 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 53.340000000000003 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 53.130000000000003 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.836 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.099999999999994 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 61.119999999999997 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 45.140000000000001 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 98' ' ' ALA . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 33.43 111.117 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 64.239999999999995 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG21 ' HG1' ' A' ' 201' ' ' PLM . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.109 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG23 ' A' ' 89' ' ' ILE . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 73.140000000000001 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 33' ' ' ILE . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 52.229999999999997 110.936 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 71' ' ' LEU . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.454 ' HE3' ' H81' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.885 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.728 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 111.135 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 43.530000000000001 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' CD1' ' A' ' 105' ' ' ILE . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 72.430000000000007 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.963 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 65' ' ' VAL . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.487 HD21 ' CG ' ' A' ' 202' ' ' PLM . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 62.299999999999997 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 111.044 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 71.109999999999999 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.668 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.894 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.615 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 64.450000000000003 111.146 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 62.450000000000003 110.926 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 64.239999999999995 111.151 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG11 ' H52' ' A' ' 201' ' ' PLM . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.721 ' CD1' HG21 ' A' ' 80' ' ' VAL . 52.9 mt -76.61 -40.88 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.168 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -78.65 61.46 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 72.239999999999995 110.826 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -156.85 -50.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.848 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.32 148.96 30.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 72.219999999999999 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -162.06 103.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 110.881 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -105.03 104.01 13.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 63.25 110.854 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.91 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.751 ' HD2' HD13 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.728 ' C8 ' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.759 0.314 . . . . 61.530000000000001 110.901 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -144.48 -169.44 3.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.048 HD11 HD23 ' A' ' 71' ' ' LEU . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.151 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 10' ' ' ILE . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 70.25 111.09 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 63.409999999999997 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 14' ' ' VAL . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.825 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 10' ' ' ILE . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 51.25 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 53.119999999999997 110.911 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 65.519999999999996 110.92 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 111.115 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.566 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.933 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 65.019999999999996 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 111.188 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 60.43 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.751 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.621 HD11 ' C1 ' ' A' ' 201' ' ' PLM . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 110.872 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.049999999999997 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 61.119999999999997 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 45.140000000000001 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG11 ' HB2' ' A' ' 98' ' ' ALA . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 33.43 111.185 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.69 HG21 ' HG1' ' A' ' 201' ' ' PLM . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.144 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 73.140000000000001 112.51 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 33' ' ' ILE . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.895 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' HB2' HG22 ' A' ' 65' ' ' VAL . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.773 ' HG2' HG21 ' A' ' 6' ' ' ILE . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.865 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 70.439999999999998 111.119 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.729 ' CB ' HG23 ' A' ' 6' ' ' ILE . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 43.530000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' THR . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 71.409999999999997 111.164 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.913 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 78' ' ' LEU . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.906 HG22 HD13 ' A' ' 73' ' ' ILE . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 72.430000000000007 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.883 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 44.420000000000002 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.823 HD13 ' HC2' ' A' ' 202' ' ' PLM . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' HB1' ' A' ' 95' ' ' ALA . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 62.299999999999997 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 62.130000000000003 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.621 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 63.240000000000002 111.038 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 71.109999999999999 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 53.030000000000001 110.953 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.627 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 64.450000000000003 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.651 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 62.450000000000003 110.891 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HD2' ' A' ' 202' ' ' PLM . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 111.049 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.841 HD13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -54.26 -24.38 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.010000000000005 111.103 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.496 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.0 OUTLIER 63.53 -169.54 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 72.239999999999995 110.88 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -53.15 -58.4 7.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.816 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -148.03 -49.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.219999999999999 110.839 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.84 137.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.904 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.35 -75.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 63.25 110.86 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 71.209999999999994 110.825 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.756 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.823 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 61.530000000000001 110.865 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.29 -169.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.219999999999999 110.858 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' CG2' HD11 ' A' ' 67' ' ' LEU . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' A' ' 70' ' ' MET . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.162 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD13 HD12 ' A' ' 10' ' ' ILE . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 70.25 111.178 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 63.409999999999997 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 14' ' ' VAL . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.81 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 10' ' ' ILE . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 111.127 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 51.25 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 53.119999999999997 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 65.519999999999996 110.92 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 71.129999999999995 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.09 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 53.310000000000002 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.019999999999996 110.902 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.45 ' HB2' HG23 ' A' ' 64' ' ' THR . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.741 HG21 HD12 ' A' ' 67' ' ' LEU . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.46 ' OE1' HG21 ' A' ' 3' ' ' VAL . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.826 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.63 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.013 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.81 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 63.049999999999997 110.92 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 61.119999999999997 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 72.319999999999993 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 45.140000000000001 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 33.43 111.114 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 64.239999999999995 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' ' HG3' ' A' ' 201' ' ' PLM . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 111.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 69' ' ' ASP . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 73.140000000000001 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 33' ' ' ILE . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 52.229999999999997 110.909 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.808 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.775 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 68' ' ' GLU . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.931 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 70.439999999999998 111.134 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 43.530000000000001 110.892 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.924 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.542 ' O ' HD23 ' A' ' 78' ' ' LEU . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 73' ' ' ILE . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 44.420000000000002 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD13 ' HC2' ' A' ' 202' ' ' PLM . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 62.299999999999997 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 62.130000000000003 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 63.240000000000002 111.022 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 53.030000000000001 110.862 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 64.450000000000003 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 ' H62' ' A' ' 201' ' ' PLM . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 62.450000000000003 110.925 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.069 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG21 ' H41' ' A' ' 201' ' ' PLM . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 ' CG2' ' A' ' 80' ' ' VAL . 85.5 mt -79.41 -37.13 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.010000000000005 111.124 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -53.56 103.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 110.865 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -98.47 37.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.239999999999995 110.788 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 166.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.219999999999999 110.854 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -96.18 27.26 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 110.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 -170.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.797 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.209999999999994 110.854 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.846 ' H62' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.612 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.812 0.339 . . . . 61.530000000000001 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.642 ' O ' HG22 ' A' ' 5' ' ' THR . 2.9 t -120.72 -178.51 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.219999999999999 110.92 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CD ' ' A' ' 40' ' ' GLU . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.7 HG23 HD13 ' A' ' 6' ' ' ILE . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 HG23 ' A' ' 5' ' ' THR . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 73.349999999999994 111.14 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.63 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.25 111.163 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 14' ' ' VAL . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' HG21 ' A' ' 51' ' ' VAL . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 10' ' ' ILE . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 111.135 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 51.25 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 65.319999999999993 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 53.119999999999997 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.883 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.109999999999999 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.310000000000002 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE1' HD22 ' A' ' 46' ' ' LEU . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD21 ' HE3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.019999999999996 110.878 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.527 HD21 HG22 ' A' ' 62' ' ' THR . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.72 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 111.152 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 53.340000000000003 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 53.130000000000003 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' CD ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 60.43 110.833 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.099999999999994 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 44' ' ' VAL . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 63.049999999999997 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 61.119999999999997 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' LEU . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 33.43 111.162 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.527 HG22 HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 64.239999999999995 111.156 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.652 HG21 ' HG1' ' A' ' 201' ' ' PLM . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.052 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.762 HG22 ' HA ' ' A' ' 89' ' ' ILE . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 73.140000000000001 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 52.229999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 71' ' ' LEU . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' OD2' HG13 ' A' ' 65' ' ' VAL . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.632 ' HE3' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 68' ' ' GLU . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.54 HG21 ' H81' ' A' ' 202' ' ' PLM . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.18 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.65 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 43.530000000000001 110.865 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 71.409999999999997 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.879 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.125 HG21 HD13 ' A' ' 105' ' ' ILE . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 89' ' ' ILE . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.809 ' CD2' ' HG3' ' A' ' 202' ' ' PLM . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 72.409999999999997 110.889 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.784 HD13 ' HC2' ' A' ' 202' ' ' PLM . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.481 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.855 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 90' ' ' GLU . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 62.299999999999997 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 62.130000000000003 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 53.030000000000001 110.896 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 104' ' ' VAL . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 110.881 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.534 HD11 ' CE1' ' A' ' 29' ' ' PHE . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.919 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 64.239999999999995 111.153 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.711 HG11 ' H32' ' A' ' 201' ' ' PLM . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.125 HD13 HG21 ' A' ' 80' ' ' VAL . 80.5 mt -52.04 -33.8 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.010000000000005 111.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 102.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 110.821 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.6 -169.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.772 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -62.08 159.44 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -108.33 -176.94 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.891 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -162.51 141.26 8.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 63.25 110.856 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 71.209999999999994 110.91 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.711 ' H32' HG11 ' A' ' 104' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.809 ' HG3' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 61.530000000000001 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m -104.49 -170.78 1.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 70.219999999999999 110.842 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.692 HD11 HD23 ' A' ' 71' ' ' LEU . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 111.144 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.073 HD13 HD12 ' A' ' 10' ' ' ILE . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.047 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.073 HD12 HD13 ' A' ' 7' ' ' ILE . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 65.129999999999995 111.122 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 51.25 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' H51' ' A' ' 201' ' ' PLM . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 65.319999999999993 111.194 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 65.519999999999996 110.874 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.144 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 46' ' ' LEU . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 65.019999999999996 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.095 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 53.340000000000003 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' OE2' ' A' ' 40' ' ' GLU . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' OE2' HG21 ' A' ' 35' ' ' THR . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 60.43 110.918 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.786 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.496 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.099999999999994 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 44' ' ' VAL . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 63.049999999999997 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 61.119999999999997 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 45.140000000000001 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 98' ' ' ALA . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 33.43 111.103 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.743 HG21 ' HG1' ' A' ' 201' ' ' PLM . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.143 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 69' ' ' ASP . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 73.140000000000001 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.96 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HB2' HG22 ' A' ' 65' ' ' VAL . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 6' ' ' ILE . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.953 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 111.074 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.523 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 43.530000000000001 110.904 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 64.409999999999997 110.917 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 73' ' ' ILE . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 72.430000000000007 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 88' ' ' LYS . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.463 HD21 ' HG3' ' A' ' 202' ' ' PLM . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.941 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.109999999999999 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 44.420000000000002 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.44 HD13 ' HC2' ' A' ' 202' ' ' PLM . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 95' ' ' ALA . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 62.299999999999997 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 63.240000000000002 111.105 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 53.030000000000001 110.886 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 110.916 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.729 HD21 ' H61' ' A' ' 201' ' ' PLM . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 62.450000000000003 110.929 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.618 ' HB2' ' HE2' ' A' ' 202' ' ' PLM . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 64.239999999999995 111.122 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 100' ' ' LYS . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 80' ' ' VAL . 93.4 mt -58.74 -30.94 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.010000000000005 111.132 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.239999999999995 110.864 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 104.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 110.855 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -59.29 -176.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 72.219999999999999 110.865 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.46 -170.02 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 63.420000000000002 110.928 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.36 -75.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 63.25 110.871 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.209999999999994 110.883 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.771 ' H72' HG22 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.679 ' C8 ' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.751 0.31 . . . . 61.530000000000001 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -169.22 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 70.219999999999999 110.863 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 74' ' ' SER . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 111.124 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 10' ' ' ILE . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 70.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.409999999999997 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 65.129999999999995 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 51.25 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 65.319999999999993 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 53.119999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 65.519999999999996 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.923 HG23 HD12 ' A' ' 46' ' ' LEU . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 53.310000000000002 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.789 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.644 HD11 HG13 ' A' ' 33' ' ' ILE . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 111.118 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 53.130000000000003 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.619 HG21 ' HE1' ' A' ' 201' ' ' PLM . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.923 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.099999999999994 110.875 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 63.049999999999997 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 61.119999999999997 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 45.140000000000001 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 98' ' ' ALA . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 33.43 111.17 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.727 HG21 ' HG1' ' A' ' 201' ' ' PLM . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 111.177 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.813 HG22 ' HA ' ' A' ' 89' ' ' ILE . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.506 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 52.229999999999997 110.985 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 68' ' ' GLU . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 110.939 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 43.530000000000001 110.902 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' THR . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.207 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 64.409999999999997 110.992 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.58 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 105' ' ' ILE . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 72.430000000000007 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.685 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.109999999999999 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 44.420000000000002 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.813 ' HA ' HG22 ' A' ' 65' ' ' VAL . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 202' ' ' PLM . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 62.299999999999997 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 62.130000000000003 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.101 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.109999999999999 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 53.030000000000001 110.878 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.802 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 62.450000000000003 110.921 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.77 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 111.148 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 102' ' ' ALA . 64.6 mt -52.81 -31.33 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 111.135 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -52.75 102.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.869 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -175.86 -177.39 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -107.54 136.52 47.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 110.818 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.29 166.86 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.91 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -96.87 -34.96 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.25 110.867 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.787 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.802 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.593 ' HA1' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 61.530000000000001 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t -149.44 -169.22 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 70.219999999999999 110.895 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 70' ' ' MET . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 111.088 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.808 ' HA ' HD12 ' A' ' 10' ' ' ILE . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 70.25 111.099 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 7' ' ' ILE . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 111.181 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 51.25 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 53.119999999999997 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 65.519999999999996 110.872 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 111.175 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 25' ' ' VAL . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 53.310000000000002 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.808 ' HB2' HG23 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' ASN . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 65.019999999999996 110.911 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.658 ' N ' HD12 ' A' ' 31' ' ' LEU . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.143 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 53.130000000000003 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.901 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 44' ' ' VAL . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 63.049999999999997 110.967 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 61.119999999999997 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 45.140000000000001 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 97' ' ' LEU . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 33.43 111.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG21 ' HG1' ' A' ' 201' ' ' PLM . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.146 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' CG1' HG23 ' A' ' 89' ' ' ILE . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 73.140000000000001 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.659 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 52.229999999999997 110.895 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.732 ' HG2' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 6' ' ' ILE . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 73.329999999999998 110.953 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 77' ' ' THR . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.586 HD12 ' H72' ' A' ' 202' ' ' PLM . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.128 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.672 ' CB ' HG23 ' A' ' 6' ' ' ILE . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 43.530000000000001 110.913 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 71.409999999999997 111.194 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 73' ' ' ILE . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.93 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 84' ' ' LEU . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 62.299999999999997 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 62.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 63.240000000000002 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.109999999999999 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.768 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 53.030000000000001 110.977 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.450000000000003 111.206 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.450000000000003 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB2' ' HF1' ' A' ' 202' ' ' PLM . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.134 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.553 HG11 ' H52' ' A' ' 201' ' ' PLM . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 102' ' ' ALA . 84.0 mt -70.54 -29.62 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -54.14 171.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.867 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 114.38 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.875 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.68 -64.38 0.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -175.36 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 63.420000000000002 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -120.03 27.84 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.895 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.864 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.732 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.664 ' HC2' HG21 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 61.530000000000001 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.58 ' HA ' HD21 ' A' ' 71' ' ' LEU . 1.5 m 62.07 177.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.907 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG21 ' OE2' ' A' ' 40' ' ' GLU . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 10' ' ' ILE . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 70.25 111.082 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 14' ' ' VAL . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HB3' HG11 ' A' ' 51' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 51.25 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 53.119999999999997 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.739 HG23 HD12 ' A' ' 46' ' ' LEU . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.194 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 53.310000000000002 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 56' ' ' PHE . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.553 ' HB3' HG23 ' A' ' 62' ' ' THR . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.72 HD11 ' HE2' ' A' ' 70' ' ' MET . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 65.019999999999996 110.897 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.543 ' N ' HD23 ' A' ' 31' ' ' LEU . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.647 ' CG2' HD12 ' A' ' 67' ' ' LEU . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 111.112 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 HD13 ' A' ' 67' ' ' LEU . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 53.130000000000003 111.102 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' OE2' HG21 ' A' ' 3' ' ' VAL . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 60.43 110.872 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 48' ' ' GLN . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.099999999999994 110.928 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 61.119999999999997 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 28' ' ' VAL . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.85 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 45.140000000000001 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 33.43 111.149 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.14 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.749 HG21 ' HG1' ' A' ' 201' ' ' PLM . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.183 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 89' ' ' ILE . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 73.140000000000001 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 33' ' ' ILE . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 52.229999999999997 110.978 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.777 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.72 ' HE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 68' ' ' GLU . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.942 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 71.409999999999997 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.909 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 111' ' ' HIS . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 110.844 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.109999999999999 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 44.420000000000002 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.572 HD13 ' HC2' ' A' ' 202' ' ' PLM . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.109999999999999 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD13 ' HB1' ' A' ' 95' ' ' ALA . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 62.130000000000003 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.096 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.981 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.576 HD21 ' HA1' ' A' ' 201' ' ' PLM . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 62.450000000000003 110.909 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 64.239999999999995 111.094 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 102' ' ' ALA . 69.9 mt -73.07 -30.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.092 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -79.95 58.51 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.89 157.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.875 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t60 60.83 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.894 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 97.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 63.420000000000002 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -65.68 176.71 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 79' ' ' THR . 22.0 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 71.209999999999994 110.936 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.749 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.708 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 61.530000000000001 110.933 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t -110.87 -169.67 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 110.88 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG11 ' OE2' ' A' ' 40' ' ' GLU . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 70' ' ' MET . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.107 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 10' ' ' ILE . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 70.25 111.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 7' ' ' ILE . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.834 ' HB3' HG11 ' A' ' 51' ' ' VAL . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 10' ' ' ILE . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 51.25 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 53.119999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.916 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.129999999999995 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 23' ' ' ARG . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.659 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.749 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 65.019999999999996 110.92 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 111.087 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.909 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 53.130000000000003 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' OE2' HG11 ' A' ' 3' ' ' VAL . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 56' ' ' PHE . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.714 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 63.049999999999997 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 61.119999999999997 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.866 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 45.140000000000001 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.43 111.158 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.122 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 HG21 ' HG1' ' A' ' 201' ' ' PLM . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.117 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 69' ' ' ASP . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 52.229999999999997 110.986 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' HG22 ' A' ' 65' ' ' VAL . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.855 ' HE1' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 HD11 ' A' ' 6' ' ' ILE . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 110.913 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.698 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.195 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.621 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 43.530000000000001 110.862 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 64.409999999999997 110.907 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 105' ' ' ILE . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 78' ' ' LEU . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 202' ' ' PLM . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.948 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 44.420000000000002 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' HC2' ' A' ' 202' ' ' PLM . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 95' ' ' ALA . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' CB ' HG22 ' A' ' 61' ' ' VAL . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 62.130000000000003 110.863 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.07 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' HB3' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 53.030000000000001 110.91 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 62.450000000000003 110.897 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 111.104 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 80' ' ' VAL . 65.9 mt -68.92 -30.14 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 111.112 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -52.09 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.808 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 52.05 -169.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.874 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -67.45 -169.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 110.91 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -52.0 111.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 63.420000000000002 110.904 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -169.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 63.25 110.888 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.849 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.828 ' HG3' ' HG ' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.718 ' HG3' HD21 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' HG2' HG21 ' A' ' 5' ' ' THR . 1.9 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.783 0.325 . . . . 61.530000000000001 110.853 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 63.28 -175.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 70.219999999999999 110.863 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 1' ' ' MET . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 HD23 ' A' ' 71' ' ' LEU . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 73.349999999999994 111.186 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.577 HD11 HD23 ' A' ' 31' ' ' LEU . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 70.25 111.11 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 63.409999999999997 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.82 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HB3' HG11 ' A' ' 51' ' ' VAL . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' C8 ' ' A' ' 201' ' ' PLM . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 10' ' ' ILE . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 65.129999999999995 111.094 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 51.25 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 49' ' ' LEU . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.154 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 53.119999999999997 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.834 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 23' ' ' ARG . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.128 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' O ' HD11 ' A' ' 46' ' ' LEU . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.846 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 65.019999999999996 110.886 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.147 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 53.340000000000003 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 53.130000000000003 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 60.43 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.935 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 61.119999999999997 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 45.140000000000001 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 98' ' ' ALA . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 33.43 111.092 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.239999999999995 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.625 HG21 ' HG1' ' A' ' 201' ' ' PLM . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.329999999999998 111.138 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 89' ' ' ILE . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 73.140000000000001 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 33' ' ' ILE . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 52.229999999999997 110.865 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' H92' ' A' ' 202' ' ' PLM . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 70.439999999999998 111.175 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.761 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 43.530000000000001 110.81 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.907 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 78' ' ' LEU . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 72.430000000000007 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 44.420000000000002 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.836 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.784 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 62.299999999999997 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 62.130000000000003 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.784 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.065 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 71.109999999999999 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 53.030000000000001 110.885 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 64.450000000000003 111.084 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.856 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.744 HD11 ' H71' ' A' ' 201' ' ' PLM . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 62.450000000000003 110.909 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB2' ' CF ' ' A' ' 202' ' ' PLM . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 64.239999999999995 111.095 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 100' ' ' LYS . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.435 HD13 ' H82' ' A' ' 202' ' ' PLM . 24.2 mt -76.19 -27.52 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.127 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -54.56 172.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.872 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -55.92 176.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.793 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t60 60.74 34.95 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 72.219999999999999 110.841 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.7 122.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.420000000000002 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -129.47 -42.92 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 63.25 110.841 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 71.209999999999994 110.863 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.744 ' H71' HD11 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.743 ' CD ' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.801 0.334 . . . . 61.530000000000001 110.886 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -101.77 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 70.219999999999999 110.861 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' ILE . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 1' ' ' MET . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.75 HD11 HD23 ' A' ' 71' ' ' LEU . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 111.154 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD13 HD12 ' A' ' 10' ' ' ILE . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.25 111.204 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 63.409999999999997 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HD13 ' A' ' 7' ' ' ILE . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.75 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 10' ' ' ILE . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.129999999999995 111.163 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 51.25 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 65.319999999999993 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 53.119999999999997 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG23 HD12 ' A' ' 46' ' ' LEU . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 111.154 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 53.310000000000002 110.87 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.828 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.926 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.63 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 31' ' ' LEU . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.192 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 53.130000000000003 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 60.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.514 HG21 ' HD1' ' A' ' 201' ' ' PLM . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.713 HD11 ' H32' ' A' ' 201' ' ' PLM . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 110.913 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.049999999999997 110.913 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 61.119999999999997 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 45.140000000000001 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 97' ' ' LEU . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.158 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG21 ' HG1' ' A' ' 201' ' ' PLM . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 69' ' ' ASP . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 33' ' ' ILE . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 52.229999999999997 110.882 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.698 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.75 HD23 HD11 ' A' ' 6' ' ' ILE . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.901 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 70.439999999999998 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 78' ' ' LEU . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.09 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 64.409999999999997 110.966 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 105' ' ' ILE . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.409999999999997 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.109999999999999 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.585 HD13 ' CD ' ' A' ' 202' ' ' PLM . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 95' ' ' ALA . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 62.299999999999997 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 62.130000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 63.240000000000002 111.105 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.109999999999999 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 53.030000000000001 110.953 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.65 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 110.898 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 80' ' ' VAL . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 111.094 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 80' ' ' VAL . 66.4 mt -87.27 -30.3 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 111.166 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -51.74 103.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 72.239999999999995 110.87 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.44 -171.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 74.239999999999995 110.86 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -149.27 156.46 42.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.6 m170 57.48 77.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 63.420000000000002 110.864 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.75 147.64 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 63.25 110.805 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.867 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.828 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.585 ' CD ' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 61.530000000000001 110.867 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.721 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -176.57 173.38 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 70.219999999999999 110.852 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.557 HG21 ' OE1' ' A' ' 40' ' ' GLU . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.457 HG21 ' SD ' ' A' ' 70' ' ' MET . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.2 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 70.25 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 63.409999999999997 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.723 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.12 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 51.25 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.519999999999996 110.885 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.109999999999999 111.187 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 53.310000000000002 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 46' ' ' LEU . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 33' ' ' ILE . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 65.019999999999996 110.879 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.587 ' N ' HD12 ' A' ' 31' ' ' LEU . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 HD21 ' A' ' 31' ' ' LEU . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 53.130000000000003 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' OE1' HG21 ' A' ' 3' ' ' VAL . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.851 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 110.95 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.049999999999997 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 61.119999999999997 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 72.319999999999993 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 45.140000000000001 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 97' ' ' LEU . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 33.43 111.179 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.475 HG21 ' HG1' ' A' ' 201' ' ' PLM . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.111 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 33' ' ' ILE . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 52.229999999999997 110.925 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 71' ' ' LEU . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 65' ' ' VAL . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 6' ' ' ILE . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 2' ' ' SER . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.834 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 43.530000000000001 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.904 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.517 HG13 ' HB1' ' A' ' 202' ' ' PLM . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.898 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.420000000000002 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.62 HD13 ' HA1' ' A' ' 202' ' ' PLM . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.109999999999999 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 95' ' ' ALA . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 62.299999999999997 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 62.130000000000003 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.747 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.030000000000001 110.969 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.84 HD21 ' H62' ' A' ' 201' ' ' PLM . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 62.450000000000003 110.895 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB2' ' HD1' ' A' ' 202' ' ' PLM . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 64.239999999999995 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt -86.05 -39.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 111.121 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -51.87 122.07 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 110.891 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 m80 63.3 82.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.916 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -169.9 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.845 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.5 m80 63.19 87.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.902 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -172.81 63.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 63.25 110.81 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 71.209999999999994 110.87 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.84 ' H62' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.62 ' HA1' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 61.530000000000001 110.818 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m -135.14 -169.48 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 70.219999999999999 110.892 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.634 HD11 HD23 ' A' ' 71' ' ' LEU . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 73.349999999999994 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.02 HD13 HD12 ' A' ' 10' ' ' ILE . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.25 111.117 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.02 HD12 HD13 ' A' ' 7' ' ' ILE . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.158 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 51.25 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 65.319999999999993 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 53.119999999999997 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 65.519999999999996 110.906 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.109999999999999 111.121 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 53.310000000000002 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.665 HD22 ' CD ' ' A' ' 201' ' ' PLM . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 65.019999999999996 110.902 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.676 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 60.43 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.877 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 44' ' ' VAL . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 61.119999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 45.140000000000001 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 98' ' ' ALA . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 33.43 111.105 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.578 HG21 ' HG1' ' A' ' 201' ' ' PLM . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 111.12 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 73.140000000000001 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.676 HD12 HG21 ' A' ' 33' ' ' ILE . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 52.229999999999997 110.956 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 6' ' ' ILE . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 78' ' ' LEU . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.604 HG21 ' H71' ' A' ' 202' ' ' PLM . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 111.128 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.462 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 43.530000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 71.409999999999997 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 110.91 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.678 HG13 ' HC2' ' A' ' 202' ' ' PLM . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 72.430000000000007 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.893 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 44.420000000000002 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.678 HD13 ' CC ' ' A' ' 202' ' ' PLM . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 95' ' ' ALA . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 62.130000000000003 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 63.240000000000002 111.07 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 71.109999999999999 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.539 ' CB ' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.038 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.747 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 64.450000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 62.450000000000003 110.801 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB2' ' HD1' ' A' ' 202' ' ' PLM . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 64.239999999999995 111.129 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.55 HD13 ' C8 ' ' A' ' 202' ' ' PLM . 23.5 mt -79.04 -42.2 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.151 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -51.56 103.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -173.77 118.97 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.792 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.7 m170 52.7 33.75 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 72.219999999999999 110.801 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 149.58 29.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 110.867 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -55.66 101.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.773 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.209999999999994 110.845 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.665 ' CD ' HD22 ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.732 ' HD1' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.55 ' HG3' HD22 ' A' ' 71' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.793 0.33 . . . . 61.530000000000001 110.801 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.8 m -153.87 171.33 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 110.88 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 111.137 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.568 HD13 HD12 ' A' ' 10' ' ' ILE . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.083 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 14' ' ' VAL . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 51.25 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 53.119999999999997 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 65.519999999999996 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.129999999999995 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.792 HG23 HD12 ' A' ' 46' ' ' LEU . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.167 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 53.310000000000002 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 46' ' ' LEU . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 33' ' ' ILE . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 65.019999999999996 110.912 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 67' ' ' LEU . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 111.148 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 53.130000000000003 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 60.43 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.792 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.099999999999994 110.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 63.049999999999997 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 61.119999999999997 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 45.140000000000001 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 98' ' ' ALA . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.039 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 ' HG1' ' A' ' 201' ' ' PLM . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.071 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 69' ' ' ASP . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 73.140000000000001 112.543 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 52.229999999999997 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 65' ' ' VAL . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.55 HD22 ' HG3' ' A' ' 1' ' ' MET . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.962 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 80' ' ' VAL . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 111.133 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' THR . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 75' ' ' GLY . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 111.174 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 64.409999999999997 110.883 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 78' ' ' LEU . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 73' ' ' ILE . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.430000000000007 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 110.904 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.517 HD13 ' HC2' ' A' ' 202' ' ' PLM . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.66 HD13 ' CB ' ' A' ' 95' ' ' ALA . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 62.299999999999997 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 62.130000000000003 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.109999999999999 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 53.030000000000001 110.947 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.450000000000003 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 72.439999999999998 110.937 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD23 ' H51' ' A' ' 201' ' ' PLM . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.909 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB2' ' CD ' ' A' ' 202' ' ' PLM . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 111.077 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' LYS . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 102' ' ' ALA . 72.3 mt -60.5 -29.28 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.095 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -61.87 95.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 72.239999999999995 110.82 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.36 -170.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -104.09 156.08 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 72.219999999999999 110.846 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -170.06 -170.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 63.420000000000002 110.875 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 68.9 t60 63.24 104.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 63.25 110.908 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 71.209999999999994 110.801 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.588 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.537 ' CD ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.761 0.315 . . . . 61.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -116.86 -170.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 110.891 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 71' ' ' LEU . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 111.095 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 10' ' ' ILE . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 70.25 111.117 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 63.409999999999997 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 7' ' ' ILE . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 51.25 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 65.319999999999993 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 53.119999999999997 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 46' ' ' LEU . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.095 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 53.310000000000002 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 65.019999999999996 110.918 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 53.340000000000003 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 53.130000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD11 ' H32' ' A' ' 201' ' ' PLM . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.099999999999994 110.886 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 44' ' ' VAL . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 63.049999999999997 110.893 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 61.119999999999997 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 45.140000000000001 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 97' ' ' LEU . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 33.43 111.146 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG21 ' HG1' ' A' ' 201' ' ' PLM . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.138 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 73.140000000000001 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HG ' HD11 ' A' ' 71' ' ' LEU . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 52.229999999999997 110.945 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 6' ' ' ILE . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 110.89 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.72 HG21 HG22 ' A' ' 80' ' ' VAL . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 70.439999999999998 111.08 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 43.530000000000001 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.926 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.583 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 73' ' ' ILE . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 72.430000000000007 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.688 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 110.929 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 44.420000000000002 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.769 HD13 ' HC2' ' A' ' 202' ' ' PLM . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 62.299999999999997 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 62.130000000000003 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.096 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 53.030000000000001 110.906 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 64.450000000000003 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.819 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 62.450000000000003 110.981 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.108 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 102' ' ' ALA . 17.7 mt -54.76 -31.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 111.106 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -52.05 -58.86 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 110.768 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.34 -170.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.833 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -75.81 -71.48 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.837 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -176.37 -68.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 63.420000000000002 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 163.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.817 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.209999999999994 110.837 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.819 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.769 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' H3 ' ' CB ' ' A' ' 5' ' ' THR . 3.0 ttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.308 . . . . 61.530000000000001 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 65.3 179.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 70.219999999999999 110.875 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.461 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.767 HG21 ' CG ' ' A' ' 70' ' ' MET . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.121 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 10' ' ' ILE . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.139 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.825 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 51.25 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 53.119999999999997 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 65.519999999999996 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD12 ' A' ' 46' ' ' LEU . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.109999999999999 111.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 56' ' ' PHE . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE1' HD22 ' A' ' 46' ' ' LEU . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 62' ' ' THR . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD11 ' HE2' ' A' ' 70' ' ' MET . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 65.019999999999996 110.893 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 53.340000000000003 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 53.130000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 60.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 54' ' ' GLY . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.81 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 49' ' ' LEU . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.099999999999994 110.87 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 63.049999999999997 110.928 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 43' ' ' ILE . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 61.119999999999997 112.519 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 28' ' ' VAL . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.956 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 45.140000000000001 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 98' ' ' ALA . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 33.43 111.074 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.139 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 201' ' ' PLM . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 111.146 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.748 HG22 ' HA ' ' A' ' 89' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 73.140000000000001 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.905 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' A' ' 65' ' ' VAL . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.855 ' HE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.574 HD23 HD11 ' A' ' 6' ' ' ILE . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 110.869 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.623 HD12 ' H72' ' A' ' 202' ' ' PLM . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 70.439999999999998 111.149 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.682 ' CB ' HG23 ' A' ' 6' ' ' ILE . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 43.530000000000001 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.962 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 78' ' ' LEU . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.634 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.955 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 44.420000000000002 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.748 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD21 ' CG ' ' A' ' 202' ' ' PLM . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.299999999999997 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 53.030000000000001 110.951 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.145 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.818 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.734 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 64.239999999999995 111.046 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 102' ' ' ALA . 80.4 mt -79.55 -35.45 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 111.154 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -169.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.863 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 101.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.239999999999995 110.828 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.47 37.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 110.835 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -53.8 155.07 3.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 63.420000000000002 110.846 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -175.15 40.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 63.25 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.843 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.609 ' CG ' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.623 ' H72' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 61.530000000000001 110.852 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.512 ' CA ' HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -172.98 179.06 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 70.219999999999999 110.813 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 10' ' ' ILE . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.102 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' HG22 ' A' ' 14' ' ' VAL . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB3' HG11 ' A' ' 51' ' ' VAL . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 65.129999999999995 111.161 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 51.25 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 53.119999999999997 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.11 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.732 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 65.019999999999996 110.935 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' N ' HD23 ' A' ' 31' ' ' LEU . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 67' ' ' LEU . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 72.219999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 53.340000000000003 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 53.130000000000003 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.613 HD11 ' C1 ' ' A' ' 201' ' ' PLM . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.049999999999997 110.85 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 61.119999999999997 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 45.140000000000001 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 33.43 111.09 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 64.239999999999995 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 201' ' ' PLM . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.149 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 ' SD ' ' A' ' 70' ' ' MET . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 73.140000000000001 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG21 ' A' ' 33' ' ' ILE . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.862 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.732 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 68' ' ' GLU . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.965 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.658 HD13 HG22 ' A' ' 80' ' ' VAL . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.163 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 43.530000000000001 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.598 ' O ' HD22 ' A' ' 78' ' ' LEU . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.133 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.961 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 HG22 ' ND1' ' A' ' 107' ' ' HIS . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 73' ' ' ILE . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 72.430000000000007 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.615 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 72.409999999999997 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 44.420000000000002 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.615 HD12 ' CD2' ' A' ' 84' ' ' LEU . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.915 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.299999999999997 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 62.130000000000003 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 111.077 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 53.030000000000001 110.882 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 64.450000000000003 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.628 HD11 ' H71' ' A' ' 201' ' ' PLM . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.904 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.239999999999995 111.101 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.98 -52.47 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.17 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 52.22 -169.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 110.905 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' ND1' HG22 ' A' ' 79' ' ' THR . 2.9 t60 -79.92 -49.98 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 74.239999999999995 110.898 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.03 157.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 110.846 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -123.39 179.11 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 63.420000000000002 110.888 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -116.92 -63.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.25 110.914 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 71.209999999999994 110.836 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.638 ' H91' HG23 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.684 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.356 . . . . 61.530000000000001 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -118.75 -172.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 70.219999999999999 110.83 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.827 HD11 HD23 ' A' ' 71' ' ' LEU . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.068 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 10' ' ' ILE . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 70.25 111.133 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.409999999999997 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 14' ' ' VAL . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 10' ' ' ILE . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 111.153 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 51.25 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 53.119999999999997 110.858 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.409 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 65.519999999999996 110.909 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.109999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 53.310000000000002 110.969 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.785 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB3' HG23 ' A' ' 62' ' ' THR . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 65.019999999999996 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.438 HD21 HG23 ' A' ' 62' ' ' THR . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 67' ' ' LEU . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.077 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 53.340000000000003 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 53.130000000000003 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 60.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.599 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.099999999999994 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 44' ' ' VAL . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 63.049999999999997 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 61.119999999999997 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 45.140000000000001 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 30' ' ' GLN . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 33.43 111.153 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.438 HG23 HD21 ' A' ' 32' ' ' ASN . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.156 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 201' ' ' PLM . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 89' ' ' ILE . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.595 HD12 HG21 ' A' ' 33' ' ' ILE . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.862 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.764 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.767 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.827 HD23 HD11 ' A' ' 6' ' ' ILE . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.897 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.439999999999998 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.530000000000001 110.868 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 64.409999999999997 110.971 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 72.430000000000007 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.723 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.933 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 44.420000000000002 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.791 ' HA ' HG22 ' A' ' 65' ' ' VAL . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.109999999999999 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.015 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 62.299999999999997 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 62.130000000000003 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 1.015 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.09 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 71.109999999999999 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CB ' HG21 ' A' ' 61' ' ' VAL . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 53.030000000000001 110.94 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.658 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 64.450000000000003 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.686 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.943 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 64.239999999999995 111.152 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 101' ' ' LEU . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 102' ' ' ALA . 96.0 mt -75.23 -27.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.010000000000005 111.105 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -74.24 74.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.848 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -165.26 -68.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.874 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.05 176.82 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.837 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -135.38 -174.12 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.420000000000002 110.883 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -169.82 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 63.25 110.932 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 71.209999999999994 110.824 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PLM . . . . . 0.781 ' HG3' HG11 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PLM . . . . . 0.671 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.95 0.405 . . . . 70.219999999999999 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.773 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 111.131 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 10' ' ' ILE . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 70.25 111.128 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 14' ' ' VAL . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 10' ' ' ILE . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.134 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 51.25 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 65.319999999999993 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 53.119999999999997 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 65.519999999999996 110.9 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.073 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 53.310000000000002 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 32' ' ' ASN . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 65.019999999999996 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.594 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.113 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 53.340000000000003 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 53.130000000000003 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 60.43 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.837 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' ' 11' ' ' LYS . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.482 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.049999999999997 110.905 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 61.119999999999997 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 45.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 97' ' ' LEU . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 33.43 111.122 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.239999999999995 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.121 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 33' ' ' ILE . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.773 HD23 HD11 ' A' ' 6' ' ' ILE . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 80' ' ' VAL . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 43.530000000000001 110.852 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.409999999999997 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.904 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 78' ' ' LEU . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 73' ' ' ILE . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 72.430000000000007 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.742 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.654 HD23 HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.944 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.654 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 62.130000000000003 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 53.030000000000001 110.903 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.439999999999998 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 110.913 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 64.239999999999995 111.093 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 102' ' ' ALA . 18.0 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.163 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.838 0.351 . . . . 70.219999999999999 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG11 ' OE2' ' A' ' 40' ' ' GLU . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.61 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.096 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.677 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 70.25 111.121 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 63.409999999999997 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 14' ' ' VAL . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.748 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.128 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 51.25 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 65.319999999999993 111.084 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 53.119999999999997 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 71.129999999999995 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 46' ' ' LEU . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.158 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 53.310000000000002 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 32' ' ' ASN . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 65.019999999999996 110.937 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 31' ' ' LEU . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.171 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 53.340000000000003 110.959 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 53.130000000000003 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.726 ' OE2' HG11 ' A' ' 3' ' ' VAL . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 60.43 110.955 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.42 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.099999999999994 110.922 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.049999999999997 110.896 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 61.119999999999997 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 45.140000000000001 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 97' ' ' LEU . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 33.43 111.102 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' CG1' HG23 ' A' ' 89' ' ' ILE . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 73.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 34' ' ' LYS . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 52.229999999999997 110.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 6' ' ' ILE . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 73.329999999999998 110.927 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.618 HD13 HG22 ' A' ' 80' ' ' VAL . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 111.112 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 43.530000000000001 110.824 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 105' ' ' ILE . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.61 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.928 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 44.420000000000002 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 84' ' ' LEU . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.466 HD13 ' HB1' ' A' ' 95' ' ' ALA . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.240000000000002 110.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 53.030000000000001 110.955 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.503 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.450000000000003 110.912 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 64.239999999999995 111.12 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 80' ' ' VAL . 82.2 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 111.111 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.895 0.379 . . . . 70.219999999999999 110.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 71' ' ' LEU . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.068 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 10' ' ' ILE . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 70.25 111.098 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 14' ' ' VAL . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 10' ' ' ILE . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 65.129999999999995 111.149 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 51.25 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 65.319999999999993 111.144 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 53.119999999999997 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 65.519999999999996 110.855 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.587 ' CG2' HD12 ' A' ' 46' ' ' LEU . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.148 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 26' ' ' LEU . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.310000000000002 110.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CE1' HD22 ' A' ' 46' ' ' LEU . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 7' ' ' ILE . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 65.019999999999996 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.516 HD22 HG23 ' A' ' 64' ' ' THR . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.634 HG21 HD12 ' A' ' 67' ' ' LEU . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.142 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 53.340000000000003 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 53.130000000000003 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.836 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.099999999999994 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 61.119999999999997 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 45.140000000000001 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 98' ' ' ALA . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 33.43 111.117 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 64.239999999999995 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG13 ' CG2' ' A' ' 89' ' ' ILE . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.109 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG23 ' A' ' 89' ' ' ILE . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 73.140000000000001 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 33' ' ' ILE . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 52.229999999999997 110.936 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 71' ' ' LEU . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.403 ' CE ' HD11 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.885 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 80' ' ' VAL . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 111.135 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 43.530000000000001 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' CD1' ' A' ' 105' ' ' ILE . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 72.430000000000007 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.963 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 65' ' ' VAL . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.414 HD13 ' HB1' ' A' ' 95' ' ' ALA . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 62.299999999999997 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 111.044 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 71.109999999999999 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.668 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.894 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.615 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 64.450000000000003 111.146 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 62.450000000000003 110.926 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 64.239999999999995 111.151 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.721 ' CD1' HG21 ' A' ' 80' ' ' VAL . 52.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.168 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.048 HD11 HD23 ' A' ' 71' ' ' LEU . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.151 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 10' ' ' ILE . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 70.25 111.09 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 63.409999999999997 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 14' ' ' VAL . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.825 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 10' ' ' ILE . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 51.25 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 53.119999999999997 110.911 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 65.519999999999996 110.92 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 111.115 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.566 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.933 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.751 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 32' ' ' ASN . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 65.019999999999996 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 111.188 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 60.43 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.751 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 110.872 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.049999999999997 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 61.119999999999997 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 45.140000000000001 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG11 ' HB2' ' A' ' 98' ' ' ALA . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 33.43 111.185 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.144 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 73.140000000000001 112.51 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 33' ' ' ILE . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.895 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' HB2' HG22 ' A' ' 65' ' ' VAL . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.773 ' HG2' HG21 ' A' ' 6' ' ' ILE . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.865 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 70.439999999999998 111.119 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.729 ' CB ' HG23 ' A' ' 6' ' ' ILE . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 43.530000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' THR . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 71.409999999999997 111.164 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.913 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 78' ' ' LEU . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.906 HG22 HD13 ' A' ' 73' ' ' ILE . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 72.430000000000007 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.754 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.883 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 44.420000000000002 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 84' ' ' LEU . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' HB1' ' A' ' 95' ' ' ALA . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 62.299999999999997 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 62.130000000000003 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.621 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 63.240000000000002 111.038 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 71.109999999999999 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 53.030000000000001 110.953 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.627 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 64.450000000000003 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.651 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 62.450000000000003 110.891 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 111.049 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.841 HD13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.010000000000005 111.103 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.922 0.392 . . . . 70.219999999999999 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' CG2' HD11 ' A' ' 67' ' ' LEU . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' A' ' 70' ' ' MET . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.162 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.401 HD13 HD12 ' A' ' 10' ' ' ILE . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 70.25 111.178 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 63.409999999999997 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 14' ' ' VAL . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.81 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 10' ' ' ILE . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 111.127 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 51.25 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 53.119999999999997 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 65.519999999999996 110.92 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 71.129999999999995 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.09 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 53.310000000000002 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.764 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.775 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.019999999999996 110.902 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.45 ' HB2' HG23 ' A' ' 64' ' ' THR . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.741 HG21 HD12 ' A' ' 67' ' ' LEU . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.46 ' OE1' HG21 ' A' ' 3' ' ' VAL . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.826 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' C ' HG12 ' A' ' 14' ' ' VAL . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.013 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.81 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 63.049999999999997 110.92 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 61.119999999999997 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 72.319999999999993 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 45.140000000000001 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 33.43 111.114 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 64.239999999999995 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 111.163 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 69' ' ' ASP . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 73.140000000000001 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 33' ' ' ILE . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 52.229999999999997 110.909 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.808 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.775 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 68' ' ' GLU . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.931 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 70.439999999999998 111.134 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 43.530000000000001 110.892 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.924 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.542 ' O ' HD23 ' A' ' 78' ' ' LEU . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 73' ' ' ILE . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 44.420000000000002 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' A' ' 84' ' ' LEU . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 62.299999999999997 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 62.130000000000003 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 63.240000000000002 111.022 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 53.030000000000001 110.862 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 64.450000000000003 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 62.450000000000003 110.925 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.069 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 ' CG2' ' A' ' 80' ' ' VAL . 85.5 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.010000000000005 111.124 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.642 ' O ' HG22 ' A' ' 5' ' ' THR . 2.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 70.219999999999999 110.92 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CD ' ' A' ' 40' ' ' GLU . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.7 HG23 HD13 ' A' ' 6' ' ' ILE . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 HG23 ' A' ' 5' ' ' THR . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 73.349999999999994 111.14 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.63 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.25 111.163 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 14' ' ' VAL . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' HG21 ' A' ' 51' ' ' VAL . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 10' ' ' ILE . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 111.135 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 51.25 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 65.319999999999993 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 53.119999999999997 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.883 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.109999999999999 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.310000000000002 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE1' HD22 ' A' ' 46' ' ' LEU . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.019999999999996 110.878 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.527 HD21 HG22 ' A' ' 62' ' ' THR . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.72 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 111.152 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 53.340000000000003 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 53.130000000000003 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' CD ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 60.43 110.833 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.099999999999994 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 44' ' ' VAL . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 63.049999999999997 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 61.119999999999997 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' LEU . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 33.43 111.162 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.527 HG22 HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 64.239999999999995 111.156 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.052 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.762 HG22 ' HA ' ' A' ' 89' ' ' ILE . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 73.140000000000001 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 52.229999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 71' ' ' LEU . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' OD2' HG13 ' A' ' 65' ' ' VAL . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.677 ' HE1' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 68' ' ' GLU . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.18 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.65 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 43.530000000000001 110.865 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 71.409999999999997 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.879 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.125 HG21 HD13 ' A' ' 105' ' ' ILE . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 89' ' ' ILE . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 72.409999999999997 110.889 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.762 ' HA ' HG22 ' A' ' 65' ' ' VAL . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.481 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.855 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 90' ' ' GLU . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 62.299999999999997 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 62.130000000000003 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 53.030000000000001 110.896 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 104' ' ' VAL . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 110.881 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.534 HD11 ' CE1' ' A' ' 29' ' ' PHE . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.919 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 64.239999999999995 111.153 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 100' ' ' LYS . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.125 HD13 HG21 ' A' ' 80' ' ' VAL . 80.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.010000000000005 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.933 0.397 . . . . 70.219999999999999 110.842 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.692 HD11 HD23 ' A' ' 71' ' ' LEU . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 111.144 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.073 HD13 HD12 ' A' ' 10' ' ' ILE . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.047 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.073 HD12 HD13 ' A' ' 7' ' ' ILE . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 65.129999999999995 111.122 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 51.25 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 65.319999999999993 111.194 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 65.519999999999996 110.874 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.144 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 46' ' ' LEU . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.428 ' CD2' HD11 ' A' ' 7' ' ' ILE . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 65.019999999999996 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.095 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 53.340000000000003 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' OE2' ' A' ' 40' ' ' GLU . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' OE2' HG21 ' A' ' 35' ' ' THR . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 60.43 110.918 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.786 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.496 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.099999999999994 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 44' ' ' VAL . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 63.049999999999997 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 61.119999999999997 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 45.140000000000001 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 98' ' ' ALA . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 33.43 111.103 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 ' CG2' ' A' ' 89' ' ' ILE . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.143 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 69' ' ' ASP . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 73.140000000000001 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.96 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HB2' HG22 ' A' ' 65' ' ' VAL . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 6' ' ' ILE . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.953 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD13 HG22 ' A' ' 80' ' ' VAL . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 111.074 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.523 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 43.530000000000001 110.904 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 64.409999999999997 110.917 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 73' ' ' ILE . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 72.430000000000007 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 88' ' ' LYS . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.941 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.109999999999999 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 44.420000000000002 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.4 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 95' ' ' ALA . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 62.299999999999997 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 63.240000000000002 111.105 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 53.030000000000001 110.886 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 110.916 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 62.450000000000003 110.929 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.583 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 64.239999999999995 111.122 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 100' ' ' LYS . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 80' ' ' VAL . 93.4 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.010000000000005 111.132 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.445 ' N ' ' HG1' ' A' ' 5' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.96 0.41 . . . . 70.219999999999999 110.863 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 2' ' ' SER . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 74' ' ' SER . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 111.124 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 10' ' ' ILE . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 70.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.409999999999997 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 65.129999999999995 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 51.25 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 65.319999999999993 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 53.119999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 65.519999999999996 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.923 HG23 HD12 ' A' ' 46' ' ' LEU . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 53.310000000000002 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.789 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.644 HD11 HG13 ' A' ' 33' ' ' ILE . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 111.118 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 53.130000000000003 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.923 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.099999999999994 110.875 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 63.049999999999997 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 61.119999999999997 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 45.140000000000001 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 98' ' ' ALA . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 33.43 111.17 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 111.177 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.813 HG22 ' HA ' ' A' ' 89' ' ' ILE . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.506 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 52.229999999999997 110.985 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 68' ' ' GLU . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 110.939 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 43.530000000000001 110.902 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' THR . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.207 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 64.409999999999997 110.992 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.58 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 105' ' ' ILE . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 72.430000000000007 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.685 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.109999999999999 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 44.420000000000002 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.813 ' HA ' HG22 ' A' ' 65' ' ' VAL . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.423 HD13 ' HB1' ' A' ' 95' ' ' ALA . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 62.299999999999997 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 62.130000000000003 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.101 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.109999999999999 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 53.030000000000001 110.878 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.123 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 62.450000000000003 110.921 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.77 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 111.148 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 102' ' ' ALA . 64.6 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.888 0.375 . . . . 70.219999999999999 110.895 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 70' ' ' MET . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 111.088 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.808 ' HA ' HD12 ' A' ' 10' ' ' ILE . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 70.25 111.099 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 7' ' ' ILE . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 111.181 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 51.25 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 53.119999999999997 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 65.519999999999996 110.872 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 111.175 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 25' ' ' VAL . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 53.310000000000002 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.808 ' HB2' HG23 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' ASN . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 65.019999999999996 110.911 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.658 ' N ' HD12 ' A' ' 31' ' ' LEU . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.143 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 53.130000000000003 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.475 HD13 ' HA ' ' A' ' 46' ' ' LEU . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.901 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 44' ' ' VAL . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 63.049999999999997 110.967 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 61.119999999999997 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 45.140000000000001 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 97' ' ' LEU . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 33.43 111.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.146 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' CG1' HG23 ' A' ' 89' ' ' ILE . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 73.140000000000001 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.659 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 52.229999999999997 110.895 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.732 ' HG2' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 6' ' ' ILE . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 73.329999999999998 110.953 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 77' ' ' THR . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD13 HG22 ' A' ' 80' ' ' VAL . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.128 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.672 ' CB ' HG23 ' A' ' 6' ' ' ILE . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 43.530000000000001 110.913 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 71.409999999999997 111.194 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 73' ' ' ILE . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.93 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 84' ' ' LEU . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 62.299999999999997 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 62.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 63.240000000000002 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.109999999999999 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.768 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 53.030000000000001 110.977 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.450000000000003 111.206 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.450000000000003 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.134 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 101' ' ' LEU . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 102' ' ' ALA . 84.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.091 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.58 ' HA ' HD21 ' A' ' 71' ' ' LEU . 1.5 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.918 0.389 . . . . 70.219999999999999 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG21 ' OE2' ' A' ' 40' ' ' GLU . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 10' ' ' ILE . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 70.25 111.082 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 14' ' ' VAL . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HB3' HG11 ' A' ' 51' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 51.25 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 53.119999999999997 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.739 HG23 HD12 ' A' ' 46' ' ' LEU . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.194 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 53.310000000000002 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 56' ' ' PHE . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.553 ' HB3' HG23 ' A' ' 62' ' ' THR . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.663 HD11 ' CE ' ' A' ' 70' ' ' MET . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 65.019999999999996 110.897 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.543 ' N ' HD23 ' A' ' 31' ' ' LEU . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.647 ' CG2' HD12 ' A' ' 67' ' ' LEU . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 111.112 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 HD13 ' A' ' 67' ' ' LEU . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 53.130000000000003 111.102 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.47 ' OE2' HG21 ' A' ' 3' ' ' VAL . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 60.43 110.872 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 48' ' ' GLN . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.099999999999994 110.928 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 61.119999999999997 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 28' ' ' VAL . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.85 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 45.140000000000001 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 33.43 111.149 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.14 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.183 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 89' ' ' ILE . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 73.140000000000001 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 33' ' ' ILE . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 52.229999999999997 110.978 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.777 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.663 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 68' ' ' GLU . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.942 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 71.409999999999997 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.909 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.432 ' O ' HD23 ' A' ' 78' ' ' LEU . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 110.844 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.109999999999999 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 44.420000000000002 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 65' ' ' VAL . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.109999999999999 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.682 HD13 ' HB1' ' A' ' 95' ' ' ALA . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 62.130000000000003 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.096 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.981 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 62.450000000000003 110.909 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.572 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 64.239999999999995 111.094 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 102' ' ' ALA . 69.9 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.092 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.916 0.389 . . . . 70.219999999999999 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.486 HG11 ' OE2' ' A' ' 40' ' ' GLU . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 70' ' ' MET . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.107 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 10' ' ' ILE . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 70.25 111.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 7' ' ' ILE . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.834 ' HB3' HG11 ' A' ' 51' ' ' VAL . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 10' ' ' ILE . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 51.25 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 53.119999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.916 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.129999999999995 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 23' ' ' ARG . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.659 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.749 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.696 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 65.019999999999996 110.92 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 111.087 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.909 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 53.130000000000003 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' OE2' HG11 ' A' ' 3' ' ' VAL . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 56' ' ' PHE . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.714 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 63.049999999999997 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 61.119999999999997 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.866 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 45.140000000000001 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.43 111.158 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.122 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.117 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 69' ' ' ASP . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 52.229999999999997 110.986 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' HG22 ' A' ' 65' ' ' VAL . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 HD11 ' A' ' 6' ' ' ILE . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 110.913 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.195 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.621 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 43.530000000000001 110.862 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 64.409999999999997 110.907 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 105' ' ' ILE . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 78' ' ' LEU . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.948 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 44.420000000000002 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.555 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 95' ' ' ALA . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' CB ' HG22 ' A' ' 61' ' ' VAL . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 62.130000000000003 110.863 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.07 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.583 ' HB3' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 53.030000000000001 110.91 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 62.450000000000003 110.897 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 111.104 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 80' ' ' VAL . 65.9 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 111.112 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 HD23 ' A' ' 71' ' ' LEU . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 73.349999999999994 111.186 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.577 HD11 HD23 ' A' ' 31' ' ' LEU . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 70.25 111.11 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 63.409999999999997 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.82 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HB3' HG11 ' A' ' 51' ' ' VAL . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' NH2' HG12 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 10' ' ' ILE . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 65.129999999999995 111.094 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 51.25 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 49' ' ' LEU . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.154 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 53.119999999999997 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.834 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 23' ' ' ARG . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.128 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' O ' HD11 ' A' ' 46' ' ' LEU . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.846 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 7' ' ' ILE . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 65.019999999999996 110.886 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.147 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 53.340000000000003 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 53.130000000000003 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 60.43 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.427 ' HG ' HG21 ' A' ' 17' ' ' VAL . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.935 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 61.119999999999997 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 45.140000000000001 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 98' ' ' ALA . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 33.43 111.092 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.239999999999995 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG13 ' CG2' ' A' ' 89' ' ' ILE . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.329999999999998 111.138 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 89' ' ' ILE . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 73.140000000000001 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 33' ' ' ILE . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 52.229999999999997 110.865 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 70.439999999999998 111.175 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.761 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 43.530000000000001 110.81 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.907 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 78' ' ' LEU . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 72.430000000000007 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 44.420000000000002 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.836 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.784 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 62.299999999999997 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 62.130000000000003 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.784 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.065 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 71.109999999999999 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 53.030000000000001 110.885 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 64.450000000000003 111.084 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.856 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 62.450000000000003 110.909 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 64.239999999999995 111.095 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 100' ' ' LYS . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.127 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.936 0.398 . . . . 70.219999999999999 110.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' ILE . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.75 HD11 HD23 ' A' ' 71' ' ' LEU . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 111.154 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.844 HD13 HD12 ' A' ' 10' ' ' ILE . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.25 111.204 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 63.409999999999997 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HD13 ' A' ' 7' ' ' ILE . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.75 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 10' ' ' ILE . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.129999999999995 111.163 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 51.25 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 65.319999999999993 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 53.119999999999997 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.797 HG23 HD12 ' A' ' 46' ' ' LEU . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 111.154 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 53.310000000000002 110.87 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 33' ' ' ILE . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.926 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.63 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 31' ' ' LEU . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.192 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 53.130000000000003 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 60.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.406 ' C ' HG12 ' A' ' 14' ' ' VAL . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 110.913 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.049999999999997 110.913 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 61.119999999999997 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 45.140000000000001 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 97' ' ' LEU . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.158 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.412 HG13 ' CG2' ' A' ' 89' ' ' ILE . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 69' ' ' ASP . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 33' ' ' ILE . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 52.229999999999997 110.882 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.698 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.75 HD23 HD11 ' A' ' 6' ' ' ILE . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.901 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 70.439999999999998 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 78' ' ' LEU . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.09 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 64.409999999999997 110.966 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 105' ' ' ILE . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.409999999999997 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.109999999999999 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 95' ' ' ALA . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 62.299999999999997 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 62.130000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 63.240000000000002 111.105 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.109999999999999 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 53.030000000000001 110.953 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 110.898 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 80' ' ' VAL . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 111.094 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 80' ' ' VAL . 66.4 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 111.166 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.721 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.919 0.39 . . . . 70.219999999999999 110.852 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.557 HG21 ' OE1' ' A' ' 40' ' ' GLU . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.457 HG21 ' SD ' ' A' ' 70' ' ' MET . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.2 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 70.25 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 63.409999999999997 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.723 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.12 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 51.25 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.519999999999996 110.885 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.109999999999999 111.187 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 53.310000000000002 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 46' ' ' LEU . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 33' ' ' ILE . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 65.019999999999996 110.879 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.587 ' N ' HD12 ' A' ' 31' ' ' LEU . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 HD21 ' A' ' 31' ' ' LEU . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 53.130000000000003 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' OE1' HG21 ' A' ' 3' ' ' VAL . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.851 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' C ' HG12 ' A' ' 14' ' ' VAL . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 110.95 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.049999999999997 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 61.119999999999997 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 72.319999999999993 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 45.140000000000001 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 97' ' ' LEU . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 33.43 111.179 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.111 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 33' ' ' ILE . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 52.229999999999997 110.925 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 71' ' ' LEU . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 65' ' ' VAL . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 6' ' ' ILE . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 2' ' ' SER . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.834 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 43.530000000000001 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.904 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.898 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.420000000000002 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.41 HD12 ' CD2' ' A' ' 84' ' ' LEU . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.109999999999999 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 95' ' ' ALA . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 62.299999999999997 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 62.130000000000003 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.747 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.030000000000001 110.969 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.697 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 62.450000000000003 110.895 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 64.239999999999995 111.082 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 111.121 179.907 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 110.892 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.634 HD11 HD23 ' A' ' 71' ' ' LEU . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 73.349999999999994 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.02 HD13 HD12 ' A' ' 10' ' ' ILE . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.25 111.117 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.02 HD12 HD13 ' A' ' 7' ' ' ILE . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.158 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 51.25 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 65.319999999999993 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 53.119999999999997 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 65.519999999999996 110.906 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.109999999999999 111.121 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 53.310000000000002 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.413 ' CD2' HD11 ' A' ' 7' ' ' ILE . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 65.019999999999996 110.902 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.676 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 60.43 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.877 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 44' ' ' VAL . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 61.119999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 45.140000000000001 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 98' ' ' ALA . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 33.43 111.105 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 111.12 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 73.140000000000001 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.676 HD12 HG21 ' A' ' 33' ' ' ILE . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 52.229999999999997 110.956 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 6' ' ' ILE . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 78' ' ' LEU . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 111.128 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.462 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 43.530000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 71.409999999999997 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 110.91 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 72.430000000000007 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.893 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 44.420000000000002 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 84' ' ' LEU . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 95' ' ' ALA . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 62.130000000000003 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 63.240000000000002 111.07 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 71.109999999999999 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.539 ' CB ' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.038 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.747 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 64.450000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 62.450000000000003 110.801 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 64.239999999999995 111.129 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 102' ' ' ALA . 23.5 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.8 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.867 0.365 . . . . 70.219999999999999 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 111.137 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.568 HD13 HD12 ' A' ' 10' ' ' ILE . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.083 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 14' ' ' VAL . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 51.25 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 53.119999999999997 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 65.519999999999996 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.129999999999995 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.792 HG23 HD12 ' A' ' 46' ' ' LEU . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.167 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 53.310000000000002 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 46' ' ' LEU . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 33' ' ' ILE . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 65.019999999999996 110.912 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 67' ' ' LEU . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 111.148 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 53.130000000000003 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 60.43 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.792 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.099999999999994 110.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 63.049999999999997 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 61.119999999999997 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 45.140000000000001 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 98' ' ' ALA . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.039 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.429 HG13 ' CG2' ' A' ' 89' ' ' ILE . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.071 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 69' ' ' ASP . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 73.140000000000001 112.543 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 52.229999999999997 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 65' ' ' VAL . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 68' ' ' GLU . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.962 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 80' ' ' VAL . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 111.133 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' THR . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 75' ' ' GLY . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 111.174 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 64.409999999999997 110.883 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 78' ' ' LEU . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 73' ' ' ILE . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.430000000000007 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 110.904 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.429 ' CG2' HG13 ' A' ' 63' ' ' VAL . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.66 HD13 ' CB ' ' A' ' 95' ' ' ALA . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 62.299999999999997 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 62.130000000000003 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.109999999999999 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.733 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 53.030000000000001 110.947 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.450000000000003 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 72.439999999999998 110.937 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.909 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 111.077 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' LYS . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 102' ' ' ALA . 72.3 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.095 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.914 0.388 . . . . 70.219999999999999 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 71' ' ' LEU . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 111.095 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 10' ' ' ILE . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 70.25 111.117 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 63.409999999999997 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 7' ' ' ILE . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 51.25 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 65.319999999999993 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 53.119999999999997 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 46' ' ' LEU . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.095 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 53.310000000000002 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.463 ' CD2' HD11 ' A' ' 33' ' ' ILE . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 65.019999999999996 110.918 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 53.340000000000003 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 53.130000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.099999999999994 110.886 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 44' ' ' VAL . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 63.049999999999997 110.893 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 61.119999999999997 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 45.140000000000001 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 97' ' ' LEU . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 33.43 111.146 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.138 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 73.140000000000001 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HG ' HD11 ' A' ' 71' ' ' LEU . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 52.229999999999997 110.945 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 6' ' ' ILE . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 110.89 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.72 HG21 HG22 ' A' ' 80' ' ' VAL . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 70.439999999999998 111.08 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 43.530000000000001 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.926 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.583 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 73' ' ' ILE . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 72.430000000000007 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.688 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 110.929 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 44.420000000000002 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 62.299999999999997 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 62.130000000000003 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.096 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 53.030000000000001 110.906 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 64.450000000000003 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 62.450000000000003 110.981 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.108 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 102' ' ' ALA . 17.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 111.106 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.854 0.359 . . . . 70.219999999999999 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.767 HG21 ' CG ' ' A' ' 70' ' ' MET . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.121 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 10' ' ' ILE . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.139 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.825 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 51.25 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 53.119999999999997 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 65.519999999999996 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD12 ' A' ' 46' ' ' LEU . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.109999999999999 111.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 56' ' ' PHE . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE1' HD22 ' A' ' 46' ' ' LEU . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 62' ' ' THR . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.719 HD11 ' CE ' ' A' ' 70' ' ' MET . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 65.019999999999996 110.893 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 53.340000000000003 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 53.130000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 60.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 54' ' ' GLY . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.81 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 49' ' ' LEU . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.099999999999994 110.87 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 63.049999999999997 110.928 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 43' ' ' ILE . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 61.119999999999997 112.519 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 28' ' ' VAL . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.956 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 45.140000000000001 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 98' ' ' ALA . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 33.43 111.074 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.139 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 111.146 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.748 HG22 ' HA ' ' A' ' 89' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 73.140000000000001 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.905 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' A' ' 65' ' ' VAL . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.767 ' CG ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.574 HD23 HD11 ' A' ' 6' ' ' ILE . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 110.869 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 70.439999999999998 111.149 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.682 ' CB ' HG23 ' A' ' 6' ' ' ILE . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 43.530000000000001 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.962 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 78' ' ' LEU . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.634 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.955 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 44.420000000000002 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.748 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.299999999999997 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 53.030000000000001 110.951 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.145 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.818 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.734 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 64.239999999999995 111.046 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 102' ' ' ALA . 80.4 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 111.154 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.512 ' CA ' HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 110.813 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 10' ' ' ILE . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.102 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' HG22 ' A' ' 14' ' ' VAL . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB3' HG11 ' A' ' 51' ' ' VAL . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 65.129999999999995 111.161 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 51.25 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 53.119999999999997 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.11 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.732 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 65.019999999999996 110.935 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' N ' HD23 ' A' ' 31' ' ' LEU . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 67' ' ' LEU . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 72.219999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 53.340000000000003 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 53.130000000000003 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.049999999999997 110.85 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 61.119999999999997 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 45.140000000000001 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 33.43 111.09 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 64.239999999999995 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.149 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 ' SD ' ' A' ' 70' ' ' MET . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 73.140000000000001 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG21 ' A' ' 33' ' ' ILE . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.862 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.732 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 68' ' ' GLU . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.965 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.658 HD13 HG22 ' A' ' 80' ' ' VAL . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.163 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 43.530000000000001 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.598 ' O ' HD22 ' A' ' 78' ' ' LEU . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.133 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.961 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 73' ' ' ILE . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 72.430000000000007 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.615 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 72.409999999999997 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 44.420000000000002 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.615 HD12 ' CD2' ' A' ' 84' ' ' LEU . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.915 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.299999999999997 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 62.130000000000003 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 111.077 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 53.030000000000001 110.882 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 64.450000000000003 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.904 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.239999999999995 111.101 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.17 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.949 0.404 . . . . 70.219999999999999 110.83 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.827 HD11 HD23 ' A' ' 71' ' ' LEU . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.068 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 10' ' ' ILE . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 70.25 111.133 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.409999999999997 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 14' ' ' VAL . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 10' ' ' ILE . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 111.153 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 51.25 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 53.119999999999997 110.858 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 65.519999999999996 110.909 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.109999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 53.310000000000002 110.969 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.785 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB3' HG23 ' A' ' 62' ' ' THR . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 65.019999999999996 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.438 HD21 HG23 ' A' ' 62' ' ' THR . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 67' ' ' LEU . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.077 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 53.340000000000003 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 53.130000000000003 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 60.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.599 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.099999999999994 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 44' ' ' VAL . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 63.049999999999997 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 61.119999999999997 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 45.140000000000001 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 30' ' ' GLN . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 33.43 111.153 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.438 HG23 HD21 ' A' ' 32' ' ' ASN . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.156 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 31' ' ' LEU . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 89' ' ' ILE . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.595 HD12 HG21 ' A' ' 33' ' ' ILE . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.862 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.764 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.767 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.827 HD23 HD11 ' A' ' 6' ' ' ILE . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.897 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.439999999999998 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.530000000000001 110.868 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 64.409999999999997 110.971 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 72.430000000000007 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.723 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.933 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 44.420000000000002 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.791 ' HA ' HG22 ' A' ' 65' ' ' VAL . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.109999999999999 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.015 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 62.299999999999997 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 62.130000000000003 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 1.015 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.09 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 71.109999999999999 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CB ' HG21 ' A' ' 61' ' ' VAL . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 53.030000000000001 110.94 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.658 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 64.450000000000003 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.686 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.943 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 64.239999999999995 111.152 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 101' ' ' LEU . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 102' ' ' ALA . 96.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.010000000000005 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 tpp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.81 0.338 . . . . 61.530000000000001 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -103.98 -168.11 1.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 70.219999999999999 110.805 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -49.62 -28.75 3.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 74.430000000000007 111.119 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -64.84 -41.35 95.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.898 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -69.84 -29.15 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 74.040000000000006 111.168 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.773 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -72.53 -49.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 111.131 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 10' ' ' ILE . 47.8 mm -70.88 -33.48 52.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 70.25 111.128 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.8 -32.75 45.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 75.25 110.923 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -32.48 58.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.872 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.788 ' O ' HG22 ' A' ' 14' ' ' VAL . 50.4 mt -73.86 -56.77 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 74.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.606 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.47 -33.48 9.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 75.219999999999999 110.905 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.94 -39.23 51.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 55.240000000000002 111.122 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -69.97 -50.61 40.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 75.409999999999997 110.843 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 10' ' ' ILE . 2.6 m -51.16 -45.66 31.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.134 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.87 4.0 77.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.747 . . . . 73.25 112.48 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.19 1.66 10.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 51.25 111.098 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -51.97 136.56 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 65.319999999999993 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 8.5 m-20 -103.73 144.95 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.611 0.72 . . . . 53.119999999999997 110.878 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -9.76 26.89 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.71 2.273 . . . . 65.120000000000005 112.336 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.73 -34.16 52.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 110.895 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.58 -91.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.779 -0.724 . . . . 62.509999999999998 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.9 Cg_endo -69.76 -168.04 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.67 2.247 . . . . 62.450000000000003 112.365 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -147.29 166.94 25.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 65.519999999999996 110.9 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -47.04 104.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.911 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.3 m -113.92 173.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 111.073 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.46 142.52 27.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 53.310000000000002 110.95 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.51 -172.62 23.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 74.5 112.454 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -148.73 150.83 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 72.430000000000007 111.114 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.837 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.2 m-85 -123.92 139.62 53.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.878 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -113.19 93.35 4.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.667 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 3.3 tp -83.82 129.88 34.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 65.019999999999996 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.6 m-80 -126.13 109.38 12.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.839 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.594 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -97.56 132.41 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 72.219999999999999 111.113 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -72.13 151.87 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 53.340000000000003 110.934 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -145.34 172.95 12.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.142 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.12 -13.97 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 70.239999999999995 111.09 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.91 6.76 14.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 74.340000000000003 110.873 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 142.95 -130.42 4.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.783 -0.722 . . . . 44.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.6 143.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 53.130000000000003 111.137 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.98 125.83 47.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 60.43 110.888 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -90.9 152.14 20.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 75.519999999999996 110.875 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -152.79 147.01 25.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.95 117.84 55.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.43 . . . . 73.120000000000005 111.119 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.478 HG21 ' HD1' ' A' ' 201' ' ' PLM . 1.5 t -115.57 104.73 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.144 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.88 150.52 24.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.835 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.837 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.26 -13.58 12.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.409999999999997 110.928 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -65.09 -49.68 69.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.896 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -112.27 -0.46 15.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 72.310000000000002 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 4.3 mm? 60.93 75.32 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.975 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 -179.16 6.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.948 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.606 HG11 ' HB3' ' A' ' 11' ' ' LYS . 3.5 p -148.07 144.57 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 111.115 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.41 168.18 20.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.856 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.482 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -95.2 162.4 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.049999999999997 110.905 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.65 -155.42 33.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 61.119999999999997 112.536 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.44 147.0 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.896 0.379 . . . . 63.32 111.075 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -79.63 159.77 26.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.89 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.96 -29.54 60.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 45.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.43 84.33 0.22 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.72 0.771 . . . . 74.329999999999998 110.879 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 144.3 53.32 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.707 2.271 . . . . 73.319999999999993 112.314 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -16.23 62.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.851 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG21 ' HB3' ' A' ' 97' ' ' LEU . 77.3 t -150.93 145.39 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 33.43 111.122 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.49 115.11 22.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 64.239999999999995 111.115 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG21 ' HG1' ' A' ' 201' ' ' PLM . 44.5 t -101.43 131.77 48.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.121 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.48 107.86 12.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.15 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.3 p -133.55 148.63 30.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.098 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.53 161.19 30.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.474 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 33' ' ' ILE . 7.2 tp -51.96 -62.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.933 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.2 mt-10 -51.52 -40.45 59.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 110.906 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 79.8 m-20 -60.24 -47.79 84.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.888 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -52.83 58.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 74.019999999999996 110.919 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.773 HD23 HD11 ' A' ' 6' ' ' ILE . 7.9 mt -51.55 -34.87 38.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.931 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.88 -44.95 95.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 111.102 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 80' ' ' VAL . 8.5 mt -74.39 -62.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.58 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.54 -25.34 37.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 43.530000000000001 110.852 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.88 -1.55 67.92 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.792 -0.718 . . . . 72.549999999999997 112.491 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.4 mttt 64.12 13.63 7.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.939 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -92.51 -36.78 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 71.409999999999997 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.742 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -126.32 164.99 19.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 64.409999999999997 110.904 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.548 ' N ' HD23 ' A' ' 78' ' ' LEU . 22.1 p -114.58 148.85 37.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.178 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.847 HG22 HD13 ' A' ' 73' ' ' ILE . 80.1 t -53.31 -36.61 26.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 72.019999999999996 111.147 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.91 -51.57 44.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.72 -0.752 . . . . 72.430000000000007 112.453 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.742 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -57.27 -57.29 13.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 72.209999999999994 110.88 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.04 -34.95 66.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.058 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.654 HD23 HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -53.63 -51.79 61.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 72.409999999999997 110.944 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -46.96 77.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 73.109999999999999 110.857 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -57.07 -24.93 57.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.863 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.78 32.76 9.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 44.420000000000002 112.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.654 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.8 -34.0 57.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.881 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD13 ' HA1' ' A' ' 202' ' ' PLM . 17.5 mt -106.47 127.13 62.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.146 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.56 149.15 21.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' A' ' 202' ' ' PLM . 48.6 mt -112.46 122.93 49.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 71.230000000000004 110.923 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.37 111.01 8.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 110.895 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.02 -89.43 0.51 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 72.140000000000001 112.479 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.87 99.57 5.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 62.130000000000003 110.871 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.73 -22.63 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 111.138 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.04 -53.45 20.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 110.835 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.742 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.53 -40.18 68.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 53.030000000000001 110.903 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.571 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.3 -51.4 13.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.1 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.6 69.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.093 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -52.71 -41.48 63.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.439999999999998 110.891 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.0 OUTLIER -62.98 -50.54 70.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 110.913 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.541 ' HB2' ' HD2' ' A' ' 202' ' ' PLM . . . -49.77 -30.38 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 64.239999999999995 111.093 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -53.81 -38.82 64.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.925 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -77.22 -20.33 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.131 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 102' ' ' ALA . 18.0 mt -82.07 -46.81 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.163 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -67.35 90.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.865 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.9 -170.2 3.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.863 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -59.84 150.51 28.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.871 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -69.68 -175.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 63.420000000000002 110.868 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 62.81 67.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 71.209999999999994 110.859 -179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.667 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.541 ' H71' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.753 0.311 . . . . 61.530000000000001 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m 64.29 171.13 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 70.219999999999999 110.843 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.726 HG11 ' OE2' ' A' ' 40' ' ' GLU . 71.7 t -48.01 -42.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.111 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -48.18 -36.49 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 73.400000000000006 110.885 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.4 m -82.17 -33.33 29.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 74.040000000000006 111.136 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.61 HD11 HD23 ' A' ' 71' ' ' LEU . 6.7 mm -68.33 -55.05 17.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.096 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.677 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.4 mm -63.02 -36.76 77.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 70.25 111.121 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -51.8 -39.5 58.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.903 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -32.92 65.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 63.409999999999997 110.923 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.812 ' O ' HG23 ' A' ' 14' ' ' VAL . 34.3 mt -66.43 -57.38 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 74.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.748 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -50.33 -46.81 55.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.939 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.57 72.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 55.240000000000002 111.117 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -72.6 -42.45 64.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.409999999999997 110.841 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.3 t -51.34 -49.3 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 65.129999999999995 111.128 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.12 9.49 69.45 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.513 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.83 -3.84 14.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 51.25 111.053 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.5 t -50.85 136.74 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 65.319999999999993 111.084 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.46 142.25 24.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 53.119999999999997 110.873 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -15.17 37.22 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.402 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -38.17 81.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.2 -90.8 1.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.712 -0.756 . . . . 62.509999999999998 112.466 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.8 Cg_endo -69.77 168.4 21.67 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 62.450000000000003 112.37 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.13 165.49 15.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.883 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -63.91 101.5 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 71.129999999999995 110.923 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.794 HG23 HD12 ' A' ' 46' ' ' LEU . 27.6 m -98.76 174.15 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.158 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.98 140.18 52.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 53.310000000000002 110.927 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 139.77 -178.83 19.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 74.5 112.504 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.42 145.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.042 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.767 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.3 m-85 -112.83 145.47 40.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 74.319999999999993 110.86 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 70.7 tp60 -124.53 94.61 4.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 73.099999999999994 110.947 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 2.2 tp -83.86 130.99 34.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 65.019999999999996 110.937 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.657 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.2 m-80 -126.26 110.39 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 74.200000000000003 110.848 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 31' ' ' LEU . 4.6 mp -97.91 134.39 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 111.171 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -69.24 153.69 43.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 53.340000000000003 110.959 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.1 p -145.45 172.28 13.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.74 -15.78 58.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.167 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.84 9.68 15.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.88 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.28 -128.17 3.76 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.708 -0.758 . . . . 44.130000000000003 112.44 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -144.27 143.87 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.785 0.326 . . . . 53.130000000000003 111.156 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.726 ' OE2' HG11 ' A' ' 3' ' ' VAL . 6.7 pt-20 -103.11 124.08 47.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 60.43 110.955 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -86.18 154.89 21.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.966 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.42 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 88.3 m95 -152.37 139.25 19.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 73.049999999999997 110.984 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.44 116.12 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.158 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.97 102.27 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 75.109999999999999 111.132 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 154.62 28.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 64.120000000000005 110.866 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -113.41 -12.66 12.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.911 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -50.9 45.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.409999999999997 110.887 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -109.04 -0.19 19.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.957 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.6 mm? 59.08 79.48 0.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 75.099999999999994 110.922 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -144.39 174.11 11.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 110.909 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.03 140.44 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 74.540000000000006 111.172 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -145.48 168.45 20.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 62.439999999999998 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -91.26 162.13 14.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 63.049999999999997 110.896 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.73 -159.75 30.74 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 61.119999999999997 112.465 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.96 146.3 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 63.32 111.12 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -79.9 163.33 24.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.34 70.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 45.140000000000001 111.075 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -178.81 82.55 0.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.67 0.747 . . . . 74.329999999999998 110.854 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 138.86 38.65 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.69 2.26 . . . . 73.319999999999993 112.319 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.76 -20.8 62.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.85 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 97' ' ' LEU . 87.6 t -147.95 149.86 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 33.43 111.102 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.96 106.54 10.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 64.239999999999995 111.186 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -92.29 125.88 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.27 108.53 14.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.118 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' CG1' HG23 ' A' ' 89' ' ' ILE . 13.9 m -127.17 168.89 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.141 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 167.48 12.98 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.793 -0.718 . . . . 73.140000000000001 112.459 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 34' ' ' LYS . 2.0 tp -55.25 -61.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.77 0.319 . . . . 52.229999999999997 110.883 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -51.23 -46.98 62.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 72.129999999999995 110.859 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -54.62 -49.42 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.837 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.515 ' HE2' ' C8 ' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -63.63 -56.41 16.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 6' ' ' ILE . 6.1 mt -51.4 -32.03 24.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 73.329999999999998 110.927 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.32 -43.56 98.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 111.069 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.637 HD12 ' H71' ' A' ' 202' ' ' PLM . 8.4 mt -74.72 -62.33 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 111.112 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.454 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.78 -27.31 50.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 43.530000000000001 110.824 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.01 -2.83 73.08 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 72.549999999999997 112.458 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 pttt 67.01 8.24 5.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 72.219999999999999 110.928 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.4 m -81.67 -38.34 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 111.116 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.89 170.03 15.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 64.409999999999997 110.917 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.1 p -121.63 154.03 37.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.696 HG21 HG21 ' A' ' 105' ' ' ILE . 88.7 t -51.28 -38.43 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.019999999999996 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.91 -52.77 46.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.771 -0.728 . . . . 72.430000000000007 112.516 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -44.34 94.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 72.209999999999994 110.919 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -34.76 75.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.61 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.08 -51.86 68.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.274 -0.421 . . . . 72.409999999999997 110.928 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.06 -47.02 72.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.945 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.97 -29.77 70.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 73.049999999999997 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.5 36.96 5.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 44.420000000000002 112.522 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -76.8 -33.44 58.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.707 0.289 . . . . 75.340000000000003 110.88 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.613 HD13 ' HA1' ' A' ' 202' ' ' PLM . 9.2 mt -97.36 127.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 73.310000000000002 111.159 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.84 148.08 22.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.871 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.498 HD21 ' CG ' ' A' ' 202' ' ' PLM . 54.5 mt -114.35 123.01 48.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 71.230000000000004 110.931 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.51 111.1 8.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.821 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.73 -89.02 0.49 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 72.140000000000001 112.565 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.03 97.1 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.801 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.466 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.8 -29.73 69.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.240000000000002 110.994 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.74 -49.38 76.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.7 -47.83 83.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 53.030000000000001 110.955 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.74 -46.27 82.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.15 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -52.08 -30.66 26.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 64.450000000000003 111.06 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -69.1 -34.45 75.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.439999999999998 110.931 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.781 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.9 mt -60.71 -53.5 56.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 62.450000000000003 110.912 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.3 -29.84 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 64.239999999999995 111.12 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -57.47 -46.6 83.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 71.400000000000006 110.85 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -76.0 -20.5 15.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.119 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 80' ' ' VAL . 82.2 mt -73.7 -35.12 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.010000000000005 111.111 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.88 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.809 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 52.12 -170.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.798 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.93 -170.4 2.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.219999999999999 110.84 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -58.09 150.71 20.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.831 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.41 178.78 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.25 110.879 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.7 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.773 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.781 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.637 ' H71' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 61.530000000000001 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -111.2 -169.38 1.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 70.219999999999999 110.898 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -48.29 -28.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 74.430000000000007 111.175 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.45 -45.12 92.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 73.400000000000006 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -68.33 -22.65 64.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.040000000000006 111.14 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 71' ' ' LEU . 6.0 mm -78.14 -45.7 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.068 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.715 HD13 HD12 ' A' ' 10' ' ' ILE . 41.3 mm -75.14 -26.74 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 70.25 111.098 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.83 -34.34 27.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 75.25 110.902 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -78.34 -41.65 32.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 14' ' ' VAL . 20.4 mt -58.79 -56.73 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -56.61 -37.57 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.884 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.65 98.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 55.240000000000002 111.044 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -73.55 -39.36 64.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.95 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 10' ' ' ILE . 64.0 t -50.87 -50.66 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 65.129999999999995 111.149 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.56 13.02 61.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.476 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.88 -1.11 11.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 51.25 111.129 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.406 HG22 ' H51' ' A' ' 201' ' ' PLM . 41.2 t -51.11 135.97 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 65.319999999999993 111.144 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.3 m-20 -103.31 144.45 28.67 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 53.119999999999997 110.846 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -9.9 27.23 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 65.120000000000005 112.339 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.65 -33.98 53.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 64.430000000000007 110.899 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.32 -91.65 0.75 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 62.509999999999998 112.514 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.81 -168.33 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.659 2.24 . . . . 62.450000000000003 112.339 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -147.09 166.32 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.294 -0.412 . . . . 65.519999999999996 110.855 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -49.41 102.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 110.842 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.587 ' CG2' HD12 ' A' ' 46' ' ' LEU . 17.2 m -109.59 173.03 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 111.148 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 26' ' ' LEU . 1.2 pt? -138.09 134.01 34.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.310000000000002 110.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 144.06 -172.37 25.24 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 74.5 112.547 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.46 154.55 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 72.430000000000007 111.117 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.836 ' CE1' HD22 ' A' ' 46' ' ' LEU . 26.1 m-85 -122.63 140.6 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.319999999999993 110.875 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 62.6 tp60 -118.35 93.49 4.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.912 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 5.1 tp -79.67 129.77 34.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.477 . . . . 65.019999999999996 110.929 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.516 HD22 HG23 ' A' ' 64' ' ' THR . 7.0 m-20 -125.3 141.39 52.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.86 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.634 HG21 HD12 ' A' ' 67' ' ' LEU . 4.9 mp -130.97 121.59 50.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.142 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.3 148.45 51.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 53.340000000000003 110.889 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.8 p -145.19 174.43 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 111.203 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.47 -16.11 57.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 70.239999999999995 111.103 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.95 12.42 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 110.896 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.69 -131.54 5.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.804 -0.712 . . . . 44.130000000000003 112.52 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -145.45 141.14 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.691 0.281 . . . . 53.130000000000003 111.137 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -95.36 115.91 28.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 60.43 110.896 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -86.81 153.16 21.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.954 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 92.7 m95 -151.95 140.81 21.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -113.47 120.08 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.134 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -127.8 103.18 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.14 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.61 154.15 25.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.208 -0.451 . . . . 64.120000000000005 110.896 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.836 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -111.5 -14.04 13.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 72.409999999999997 110.913 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -66.48 -50.5 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.291 -0.413 . . . . 73.409999999999997 110.944 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -112.02 -1.76 15.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.951 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 59.59 81.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 75.099999999999994 110.906 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 178.77 7.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 73.120000000000005 110.891 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.763 HG22 HG12 ' A' ' 44' ' ' VAL . 21.2 t -147.05 146.31 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 74.540000000000006 111.164 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.12 167.39 30.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 62.439999999999998 110.881 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.8 161.62 14.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.887 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.58 -157.84 36.65 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.765 -0.731 . . . . 61.119999999999997 112.434 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.7 146.37 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 63.32 111.18 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -77.03 162.52 27.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.837 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.67 -34.3 62.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 45.140000000000001 111.077 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.17 83.16 0.23 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 110.883 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.59 68.62 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.655 2.237 . . . . 73.319999999999993 112.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.65 -17.63 60.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.883 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.615 HG11 ' HB2' ' A' ' 98' ' ' ALA . 86.6 t -148.69 147.26 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 33.43 111.117 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.4 115.82 22.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 64.239999999999995 111.156 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG21 ' HG1' ' A' ' 201' ' ' PLM . 40.2 t -101.22 129.72 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.278 -0.419 . . . . 74.329999999999998 111.109 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.516 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -123.06 108.1 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 111.159 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG23 ' A' ' 89' ' ' ILE . 3.2 m -124.31 170.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 111.143 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.98 160.02 21.51 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 73.140000000000001 112.551 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 33' ' ' ILE . 7.1 tp -54.46 -61.59 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.72 0.295 . . . . 52.229999999999997 110.936 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' HD21 ' A' ' 71' ' ' LEU . 15.2 mt-10 -61.41 -40.65 95.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.864 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.02 -45.43 83.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.200000000000003 110.871 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.454 ' HE3' ' H81' ' A' ' 202' ' ' PLM . 0.0 OUTLIER -62.51 -64.92 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 74.019999999999996 110.901 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -53.13 -32.56 48.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 73.329999999999998 110.885 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.68 -31.49 57.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.166 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.728 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 11.1 mt -86.63 -59.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 111.135 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -24.08 28.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 43.530000000000001 110.883 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.89 -1.89 60.18 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.695 -0.764 . . . . 72.549999999999997 112.483 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 70.63 6.58 5.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.906 0.384 . . . . 72.219999999999999 110.96 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 p -84.56 -38.67 19.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 71.409999999999997 111.191 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.95 169.37 14.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.934 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 79.9 p -122.98 148.9 44.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 73.109999999999999 111.141 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' CD1' ' A' ' 105' ' ' ILE . 93.3 t -51.24 -39.94 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 72.019999999999996 111.15 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.34 -40.15 95.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.796 -0.716 . . . . 72.430000000000007 112.45 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.47 -37.54 74.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 72.209999999999994 110.851 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.18 -37.76 72.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.117 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -53.51 -51.59 62.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.963 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -46.95 66.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 110.861 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -71.49 -21.64 61.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 73.049999999999997 110.869 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.84 44.54 6.34 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.468 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 7.9 mmpt? -77.23 -33.34 56.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.737 0.303 . . . . 75.340000000000003 110.855 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.544 HG23 HG13 ' A' ' 65' ' ' VAL . 3.1 mt -99.72 135.82 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 73.310000000000002 111.118 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 148.21 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.888 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.487 HD21 ' CG ' ' A' ' 202' ' ' PLM . 62.2 mt -112.39 123.38 50.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.906 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.23 111.14 6.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 62.299999999999997 110.852 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.81 -90.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 72.140000000000001 112.385 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.64 94.75 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.907 0.384 . . . . 62.130000000000003 110.846 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -59.15 -27.05 65.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 111.044 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -61.71 -54.19 45.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 71.109999999999999 110.837 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.668 HD23 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.98 -51.27 66.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.894 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.615 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -61.51 -47.46 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 111.09 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -55.14 -30.87 60.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 64.450000000000003 111.146 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -69.91 -33.37 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.897 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.681 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.9 mt -62.89 -56.22 19.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 62.450000000000003 110.926 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.34 -30.15 11.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 64.239999999999995 111.151 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.63 -44.51 77.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.85 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.687 HG11 ' H52' ' A' ' 201' ' ' PLM . 2.6 p -69.05 -20.03 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 111.162 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.721 ' CD1' HG21 ' A' ' 80' ' ' VAL . 52.9 mt -76.61 -40.88 33.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.010000000000005 111.168 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -78.65 61.46 2.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 72.239999999999995 110.826 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -156.85 -50.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.848 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.32 148.96 30.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 72.219999999999999 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -162.06 103.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 110.881 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -105.03 104.01 13.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 63.25 110.854 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.91 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.751 ' HD2' HD13 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.728 ' C8 ' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.2 mtp . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.759 0.314 . . . . 61.530000000000001 110.901 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 t -144.48 -169.44 3.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 70.219999999999999 110.862 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.3 p -49.89 -30.75 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 74.430000000000007 111.097 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -61.02 -37.37 82.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.973 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -78.1 -34.55 50.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 111.178 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.048 HD11 HD23 ' A' ' 71' ' ' LEU . 6.1 mm -66.54 -55.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.151 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 10' ' ' ILE . 37.8 mm -60.94 -36.84 74.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 70.25 111.09 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -51.26 -38.51 53.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 75.25 110.867 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -31.77 57.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 63.409999999999997 110.91 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 14' ' ' VAL . 36.4 mt -68.28 -59.34 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.155 -0.475 . . . . 74.0 111.058 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.825 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.79 -38.21 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 75.219999999999999 110.901 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -50.4 73.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 55.240000000000002 111.13 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -36.6 75.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 10' ' ' ILE . 86.5 t -49.84 -48.49 21.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 65.129999999999995 111.155 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.91 13.45 61.11 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.732 -0.747 . . . . 73.25 112.492 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.15 4.97 9.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 51.25 111.112 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 t -51.08 138.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -103.92 143.16 26.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.572 0.701 . . . . 53.119999999999997 110.911 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -14.95 36.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 65.120000000000005 112.345 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.61 -38.21 80.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 64.430000000000007 110.841 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.57 -90.89 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.484 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 154.37 68.0 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 62.450000000000003 112.355 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.566 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -114.91 166.91 11.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 65.519999999999996 110.92 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -47.46 105.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.7 m -111.08 173.44 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 111.115 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.566 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -140.89 150.24 42.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.933 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 126.73 -171.31 18.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 74.5 112.534 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.53 151.99 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 72.430000000000007 111.13 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.751 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.0 m-85 -121.7 147.06 46.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 110.936 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -123.36 94.24 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.909 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 4.3 tp -82.84 130.56 35.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 65.019999999999996 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.1 m-20 -124.93 135.65 53.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.919 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -123.81 128.74 74.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 111.188 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -66.78 150.59 48.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 53.340000000000003 110.875 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 p -145.45 175.51 10.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 74.329999999999998 111.142 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.82 -15.85 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.096 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.3 t -116.22 11.45 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.801 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 138.85 -129.23 4.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 44.130000000000003 112.488 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.89 141.19 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.174 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -95.94 123.49 39.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 60.43 110.873 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -92.19 144.5 25.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 75.519999999999996 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -143.65 137.13 28.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.894 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -106.11 119.51 55.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 111.117 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.751 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -123.58 102.66 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 75.109999999999999 111.132 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.12 25.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.120000000000005 110.902 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -112.59 -12.2 13.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.94 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -68.27 -50.58 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 73.409999999999997 110.849 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -111.98 0.38 16.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.838 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.621 HD11 ' C1 ' ' A' ' 201' ' ' PLM . 3.8 mm? 58.69 76.96 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.099999999999994 110.872 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.1 ptmt -139.04 176.1 8.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.120000000000005 110.913 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.3 140.53 19.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 74.540000000000006 111.133 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -145.8 167.74 22.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 62.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.8 156.5 16.96 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.049999999999997 110.91 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.49 -158.14 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.728 -0.749 . . . . 61.119999999999997 112.524 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.69 146.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 63.32 111.104 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -78.62 161.3 27.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.82 -32.06 65.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 45.140000000000001 111.106 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.8 t -178.33 82.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.7 0.762 . . . . 74.329999999999998 110.827 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 140.2 42.06 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.653 2.236 . . . . 73.319999999999993 112.393 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -60.85 -20.88 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.808 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG11 ' HB2' ' A' ' 98' ' ' ALA . 75.4 t -150.6 144.88 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 33.43 111.185 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.24 114.57 22.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.084 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.69 HG21 ' HG1' ' A' ' 201' ' ' PLM . 45.6 t -97.27 130.87 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.144 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.69 108.45 13.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 73.530000000000001 111.174 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 69' ' ' ASP . 11.9 p -130.78 155.01 41.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.132 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -91.86 159.8 25.9 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.809 -0.71 . . . . 73.140000000000001 112.51 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 33' ' ' ILE . 8.1 tp -51.84 -62.01 1.9 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.793 0.33 . . . . 52.229999999999997 110.895 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.36 -44.03 79.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 72.129999999999995 110.847 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' HB2' HG22 ' A' ' 65' ' ' VAL . 13.6 m-20 -55.86 -49.19 74.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 71.200000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.773 ' HG2' HG21 ' A' ' 6' ' ' ILE . 5.6 ttm -65.12 -53.21 48.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.856 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -54.54 -38.18 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 73.329999999999998 110.865 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.91 -33.04 61.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 111.053 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.906 HD13 HG22 ' A' ' 80' ' ' VAL . 9.3 mt -85.28 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 70.439999999999998 111.119 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.729 ' CB ' HG23 ' A' ' 6' ' ' ILE . 29.8 t -54.7 -22.19 13.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 43.530000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.67 ' O ' HG23 ' A' ' 77' ' ' THR . . . -83.29 12.84 48.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.683 -0.77 . . . . 72.549999999999997 112.422 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 12.5 ptmt 47.65 31.02 1.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.874 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.3 p -106.5 -35.76 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 71.409999999999997 111.164 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.6 OUTLIER -129.45 166.25 19.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 64.409999999999997 110.913 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' HD23 ' A' ' 78' ' ' LEU . 20.5 p -110.71 148.91 31.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 111.107 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.906 HG22 HD13 ' A' ' 73' ' ' ILE . 60.6 t -56.46 -36.4 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.019999999999996 111.105 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.46 -48.22 55.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.811 -0.709 . . . . 72.430000000000007 112.448 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.754 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -58.48 -56.91 16.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.898 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.78 -38.82 73.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 111.084 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.98 -52.15 59.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.883 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -47.27 81.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.834 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.63 -39.27 73.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 73.049999999999997 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.75 32.06 3.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.756 -0.735 . . . . 44.420000000000002 112.46 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.637 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.5 mmtt -76.78 -33.88 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.774 0.321 . . . . 75.340000000000003 110.911 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.823 HD13 ' HC2' ' A' ' 202' ' ' PLM . 10.6 mt -104.85 123.79 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.136 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.66 149.47 21.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 110.832 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.621 HD13 ' HB1' ' A' ' 95' ' ' ALA . 46.9 mt -113.47 122.65 47.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 71.230000000000004 110.871 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.46 111.45 11.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 62.299999999999997 110.893 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 113.84 -90.05 0.53 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.855 -0.688 . . . . 72.140000000000001 112.545 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.42 96.51 4.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.842 0.353 . . . . 62.130000000000003 110.806 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.621 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -56.28 -31.42 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 63.240000000000002 111.038 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -47.77 84.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 71.109999999999999 110.898 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.533 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.8 mt -58.56 -49.08 78.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 53.030000000000001 110.953 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.627 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.13 -47.74 78.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.340000000000003 111.115 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.71 -33.68 56.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 64.450000000000003 111.077 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -63.86 -28.21 69.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.439999999999998 110.892 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.651 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.4 mt -72.42 -55.23 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 62.450000000000003 110.891 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.597 ' HB2' ' HD2' ' A' ' 202' ' ' PLM . . . -50.5 -31.97 16.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 64.239999999999995 111.049 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -31.1 62.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 71.400000000000006 110.875 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.5 p -79.71 -19.73 12.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.099999999999994 111.098 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.841 HD13 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -54.26 -24.38 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.010000000000005 111.103 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.496 ' O ' HG23 ' A' ' 105' ' ' ILE . 0.0 OUTLIER 63.53 -169.54 0.19 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 72.239999999999995 110.88 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -53.15 -58.4 7.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.816 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -148.03 -49.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.219999999999999 110.839 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -171.84 137.82 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.904 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 69.35 -75.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 63.25 110.86 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 71.209999999999994 110.825 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.756 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.823 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 61.530000000000001 110.865 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.29 -169.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 70.219999999999999 110.858 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' CG2' HD11 ' A' ' 67' ' ' LEU . 85.6 t -49.24 -43.04 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 111.136 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.65 -33.66 23.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.893 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.8 m -81.17 -34.56 32.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.168 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' A' ' 70' ' ' MET . 7.1 mm -69.73 -51.71 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 73.349999999999994 111.162 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 HD13 HD12 ' A' ' 10' ' ' ILE . 46.1 mm -66.0 -35.25 74.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 70.25 111.178 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -51.45 -36.6 44.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -32.48 58.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 63.409999999999997 110.821 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.774 ' O ' HG23 ' A' ' 14' ' ' VAL . 45.5 mt -71.42 -57.29 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.27 -0.423 . . . . 74.0 111.113 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.81 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.15 -37.8 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.869 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.1 83.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 55.240000000000002 111.112 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -76.63 -40.47 49.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.95 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 10' ' ' ILE . 25.1 t -50.56 -50.65 21.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 65.129999999999995 111.127 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.14 13.04 60.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 73.25 112.499 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.55 -1.03 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.827 0.346 . . . . 51.25 111.143 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -50.91 138.59 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.109 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -103.47 144.65 29.08 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 53.119999999999997 110.89 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.66 -10.1 27.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.633 2.222 . . . . 65.120000000000005 112.415 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.9 -34.71 57.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 110.936 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.0 -91.24 0.66 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.482 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.7 Cg_endo -69.7 -168.75 0.29 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.402 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.7 166.44 27.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 65.519999999999996 110.92 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -48.58 103.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 71.129999999999995 110.886 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.1 m -112.33 173.53 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 111.09 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.37 140.61 39.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.108 -0.496 . . . . 53.310000000000002 110.953 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 137.83 -175.55 21.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.729 -0.748 . . . . 74.5 112.529 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.89 152.77 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 72.430000000000007 111.141 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.764 ' HB2' HG23 ' A' ' 44' ' ' VAL . 23.6 m-85 -120.05 144.68 47.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.937 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -122.86 100.48 6.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.924 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.775 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -83.65 126.71 33.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 65.019999999999996 110.902 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.45 ' HB2' HG23 ' A' ' 64' ' ' THR . 4.9 m-80 -126.07 107.98 10.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 110.891 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.741 HG21 HD12 ' A' ' 67' ' ' LEU . 3.6 mp -109.44 138.28 37.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 111.12 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.0 153.48 41.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.863 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.0 p -143.91 177.82 8.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.161 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.01 -16.54 58.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 70.239999999999995 111.155 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.35 18.02 15.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.340000000000003 110.839 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 131.29 -124.97 4.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 44.130000000000003 112.479 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -141.67 139.17 31.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 53.130000000000003 111.15 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.46 ' OE1' HG21 ' A' ' 3' ' ' VAL . 13.5 pt-20 -98.18 127.49 44.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.826 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -97.03 153.94 17.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.86 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 85.2 m95 -151.97 141.1 21.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.049999999999997 110.928 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.58 119.17 59.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.78 102.44 10.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -84.17 151.06 25.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.859 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -108.2 -14.9 14.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.939 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -65.06 -49.42 70.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 110.93 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -111.38 -3.81 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 72.310000000000002 110.948 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.63 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 3.9 mm? 60.99 79.98 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.013 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 178.45 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.120000000000005 110.893 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.81 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.95 141.26 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 111.163 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -146.16 168.5 20.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 62.439999999999998 110.885 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.55 161.87 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 63.049999999999997 110.92 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.66 -158.9 35.93 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.732 -0.747 . . . . 61.119999999999997 112.434 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.88 145.21 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 63.32 111.196 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -75.25 162.92 28.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 72.319999999999993 110.888 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.66 70.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 45.140000000000001 111.129 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.04 83.57 0.23 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 74.329999999999998 110.861 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 149.08 67.0 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.702 2.268 . . . . 73.319999999999993 112.382 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.27 -17.01 60.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.822 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.2 t -150.39 148.12 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.425 . . . . 33.43 111.114 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 110.2 17.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 64.239999999999995 111.127 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' ' HG3' ' A' ' 201' ' ' PLM . 80.2 t -97.62 125.18 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.329999999999998 111.163 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -121.84 119.62 32.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.530000000000001 111.129 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 69' ' ' ASP . 8.2 p -146.38 124.5 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 72.430000000000007 111.119 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.87 168.21 2.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.655 -0.783 . . . . 73.140000000000001 112.502 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.741 HD12 HG21 ' A' ' 33' ' ' ILE . 4.3 tp -64.75 -61.5 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.748 0.309 . . . . 52.229999999999997 110.909 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.808 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.0 mt-10 -49.81 -32.96 15.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 110.893 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 65' ' ' VAL . 86.9 m-20 -62.96 -49.01 76.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.435 . . . . 71.200000000000003 110.89 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.775 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.31 -47.39 79.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.019999999999996 110.845 -179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 68' ' ' GLU . 14.3 mt -51.62 -38.57 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.931 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -62.15 -47.83 82.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 72.120000000000005 111.074 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 80' ' ' VAL . 9.4 mt -68.16 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 70.439999999999998 111.134 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.68 -28.02 53.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 43.530000000000001 110.892 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.06 -2.55 72.41 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 72.549999999999997 112.479 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 67.76 7.93 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.1 m -87.19 -37.22 17.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.089 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -122.87 169.72 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.924 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.542 ' O ' HD23 ' A' ' 78' ' ' LEU . 76.6 p -127.72 149.48 50.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 73.109999999999999 111.199 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.585 HG22 HD13 ' A' ' 73' ' ' ILE . 89.0 t -50.99 -39.6 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 111.131 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -38.27 94.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.56 -42.56 78.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.759 0.314 . . . . 72.209999999999994 110.855 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.02 -34.96 71.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.119 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.51 -51.68 68.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.8 -47.23 67.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.905 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.6 -35.44 78.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 73.049999999999997 110.957 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.51 38.54 3.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 44.420000000000002 112.464 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 9.0 mmpt? -77.29 -33.3 55.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD13 ' HC2' ' A' ' 202' ' ' PLM . 35.2 mt -96.65 128.62 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.143 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 149.57 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.901 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -116.65 122.68 45.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 110.932 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.75 112.23 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 62.299999999999997 110.81 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.87 -94.24 0.74 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.22 94.07 4.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.764 0.316 . . . . 62.130000000000003 110.897 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -61.95 -25.61 67.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 63.240000000000002 111.022 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -50.02 66.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 71.109999999999999 110.875 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.32 -48.14 81.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 53.030000000000001 110.862 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.73 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.72 -47.33 72.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 111.057 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.36 -42.03 61.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 64.450000000000003 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -55.8 -42.09 75.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 72.439999999999998 110.903 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 ' H62' ' A' ' 201' ' ' PLM . 1.5 mt -54.61 -47.51 73.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 62.450000000000003 110.925 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.612 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -49.51 -40.11 36.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 64.239999999999995 111.069 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -52.78 -33.05 46.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.879 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG21 ' H41' ' A' ' 201' ' ' PLM . 3.5 t -78.6 -28.88 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 111.131 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.504 HG21 ' CG2' ' A' ' 80' ' ' VAL . 85.5 mt -79.41 -37.13 18.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 74.010000000000005 111.124 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -53.56 103.02 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 110.865 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -98.47 37.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.239999999999995 110.788 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.69 166.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 72.219999999999999 110.854 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -96.18 27.26 3.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 63.420000000000002 110.859 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 -170.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.797 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.209999999999994 110.854 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.846 ' H62' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.612 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.812 0.339 . . . . 61.530000000000001 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.642 ' O ' HG22 ' A' ' 5' ' ' THR . 2.9 t -120.72 -178.51 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 70.219999999999999 110.92 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CD ' ' A' ' 40' ' ' GLU . 62.5 t -47.56 -28.68 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 74.430000000000007 111.136 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -56.76 -42.36 79.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 73.400000000000006 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.7 HG23 HD13 ' A' ' 6' ' ' ILE . 3.9 t -78.1 -20.36 52.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 74.040000000000006 111.105 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 HG23 ' A' ' 5' ' ' THR . 6.9 mm -80.68 -51.93 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 73.349999999999994 111.14 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.63 ' HA ' HD12 ' A' ' 10' ' ' ILE . 29.7 mm -70.13 -27.77 33.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.479 . . . . 70.25 111.163 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.75 -40.27 79.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.911 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.57 -32.9 62.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 63.409999999999997 110.948 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.779 ' O ' HG23 ' A' ' 14' ' ' VAL . 43.9 mt -65.91 -56.79 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.0 111.09 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HB3' HG21 ' A' ' 51' ' ' VAL . 13.4 ptmt -53.98 -41.67 68.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 75.219999999999999 110.906 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.8 -45.9 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 55.240000000000002 111.132 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -73.76 -40.41 63.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 75.409999999999997 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 10' ' ' ILE . 66.0 t -49.14 -53.18 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 111.135 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.02 8.33 70.79 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.45 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.56 3.23 11.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.805 0.336 . . . . 51.25 111.117 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.3 t -50.67 140.14 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 65.319999999999993 111.123 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.6 m-20 -103.44 144.58 28.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.596 0.712 . . . . 53.119999999999997 110.846 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -10.39 28.44 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.722 2.281 . . . . 65.120000000000005 112.342 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.32 -34.91 59.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.430000000000007 110.834 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.87 -91.74 0.71 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.807 -0.711 . . . . 62.509999999999998 112.455 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.8 -166.19 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 62.450000000000003 112.325 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.6 mmt-85 -147.26 166.94 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.883 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -47.87 103.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 110.889 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.1 m -108.19 173.27 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.294 -0.412 . . . . 72.109999999999999 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.89 136.51 27.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.310000000000002 110.971 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.64 -169.39 24.37 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.692 -0.766 . . . . 74.5 112.433 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.06 151.6 15.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.925 0.393 . . . . 72.430000000000007 111.168 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.833 ' CE1' HD22 ' A' ' 46' ' ' LEU . 27.7 m-85 -118.4 146.6 44.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 110.908 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 42' ' ' TRP . 72.3 tp60 -125.09 101.18 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD21 ' HE3' ' A' ' 70' ' ' MET . 0.4 OUTLIER -84.23 125.45 32.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.019999999999996 110.878 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.527 HD21 HG22 ' A' ' 62' ' ' THR . 4.6 m-80 -125.76 109.2 12.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.200000000000003 110.894 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.72 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -107.59 135.38 46.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 111.152 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.21 153.46 42.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 53.340000000000003 110.889 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 p -143.57 176.44 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.149 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.27 -16.18 58.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 70.239999999999995 111.097 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.1 14.19 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.896 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 136.05 -126.53 3.9 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 44.130000000000003 112.538 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -144.3 138.73 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.809 0.338 . . . . 53.130000000000003 111.094 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' CD ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -98.52 124.82 43.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 60.43 110.833 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -92.47 156.15 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.519999999999996 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' H ' ' NE2' ' A' ' 30' ' ' GLN . 95.9 m95 -152.94 142.75 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 73.049999999999997 110.951 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.34 117.48 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 73.120000000000005 111.072 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -124.14 103.05 12.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.125 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.32 154.48 21.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.814 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -114.64 -12.44 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 111.0 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -50.34 52.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.906 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.76 -1.26 16.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 72.310000000000002 110.882 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.2 79.85 0.21 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 75.099999999999994 110.946 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.44 179.1 7.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 110.875 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.795 HG22 HG12 ' A' ' 44' ' ' VAL . 57.9 t -147.6 146.13 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 111.081 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.62 167.16 28.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 62.439999999999998 110.833 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.49 161.65 14.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 63.049999999999997 110.886 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.93 -157.63 34.08 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 61.119999999999997 112.434 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.07 136.01 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.32 111.159 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -65.12 162.22 17.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.885 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.37 -30.99 65.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.12 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.49 82.81 0.22 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 110.873 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 145.78 58.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.704 2.269 . . . . 73.319999999999993 112.318 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.46 -15.29 61.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.843 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 97' ' ' LEU . 83.8 t -150.9 145.76 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 33.43 111.162 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.527 HG22 HD21 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -125.23 104.63 8.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 64.239999999999995 111.156 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.652 HG21 ' HG1' ' A' ' 201' ' ' PLM . 42.5 t -88.68 130.01 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.052 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.58 107.78 12.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 73.530000000000001 111.115 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.762 HG22 ' HA ' ' A' ' 89' ' ' ILE . 52.3 t -134.55 131.24 54.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 72.430000000000007 111.124 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 166.59 3.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 73.140000000000001 112.468 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -65.39 -61.31 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.788 0.328 . . . . 52.229999999999997 110.93 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.786 ' HA ' HD12 ' A' ' 71' ' ' LEU . 22.8 mt-10 -48.45 -44.22 35.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 72.129999999999995 110.86 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' OD2' HG13 ' A' ' 65' ' ' VAL . 65.7 t0 -52.77 -53.83 42.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.854 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.632 ' HE3' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -61.06 -42.85 99.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.851 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 68' ' ' GLU . 75.5 mt -51.67 -43.93 62.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.53 89.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 72.120000000000005 111.096 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.54 HG21 ' H81' ' A' ' 202' ' ' PLM . 8.5 mt -71.55 -63.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.18 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.65 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -57.35 -22.65 43.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 43.530000000000001 110.865 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.17 -1.17 68.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.798 -0.715 . . . . 72.549999999999997 112.462 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 pttt 70.42 6.89 6.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.929 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.2 p -86.16 -36.72 19.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 71.409999999999997 111.113 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER -121.92 169.24 11.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.879 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -121.89 148.79 44.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 111.139 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.125 HG21 HD13 ' A' ' 105' ' ' ILE . 53.6 t -50.82 -51.51 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.019999999999996 111.127 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -38.09 50.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.454 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.74 -47.93 70.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 72.209999999999994 110.888 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 89' ' ' ILE . . . -58.64 -47.14 85.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 111.059 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.809 ' CD2' ' HG3' ' A' ' 202' ' ' PLM . 1.6 tm? -54.89 -49.99 69.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.44 . . . . 72.409999999999997 110.889 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.62 -47.04 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.91 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -61.15 -40.28 93.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.899 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.86 40.08 3.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 44.420000000000002 112.548 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -100.05 -18.84 16.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 110.979 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.784 HD13 ' HC2' ' A' ' 202' ' ' PLM . 9.1 mt -92.74 119.96 41.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 73.310000000000002 111.128 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.481 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -92.8 145.12 24.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.855 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 90' ' ' GLU . 10.8 mt -133.69 122.78 23.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.861 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.21 110.79 19.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 62.299999999999997 110.821 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.16 -84.5 0.31 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.433 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.97 96.92 3.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.812 0.339 . . . . 62.130000000000003 110.933 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.8 -32.87 33.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.240000000000002 111.081 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.06 -48.42 81.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.828 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.7 mt -55.61 -48.19 75.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 53.030000000000001 110.896 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.67 -32.25 70.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 111.133 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.57 76.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 64.450000000000003 111.089 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' O ' HG23 ' A' ' 104' ' ' VAL . 10.2 tttt -52.46 -37.68 57.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 110.881 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.534 HD11 ' CE1' ' A' ' 29' ' ' PHE . 4.4 mt -54.84 -54.85 37.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 62.450000000000003 110.919 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.59 -44.78 47.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 64.239999999999995 111.153 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -52.88 -34.94 57.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 71.400000000000006 110.931 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.711 HG11 ' H32' ' A' ' 201' ' ' PLM . 2.9 t -77.53 -40.8 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.099999999999994 111.154 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.125 HD13 HG21 ' A' ' 80' ' ' VAL . 80.5 mt -52.04 -33.8 16.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 74.010000000000005 111.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 102.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 110.821 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.6 -169.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.772 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -62.08 159.44 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 110.893 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -108.33 -176.94 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 63.420000000000002 110.891 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -162.51 141.26 8.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 63.25 110.856 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 71.209999999999994 110.91 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.711 ' H32' HG11 ' A' ' 104' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.809 ' HG3' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.862 0.363 . . . . 61.530000000000001 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 m -104.49 -170.78 1.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 70.219999999999999 110.842 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.19 -28.96 5.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.145 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -60.74 -36.33 78.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.943 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -81.19 -28.6 34.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 74.040000000000006 111.108 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.692 HD11 HD23 ' A' ' 71' ' ' LEU . 7.4 mm -74.8 -46.51 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 111.144 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.073 HD13 HD12 ' A' ' 10' ' ' ILE . 36.4 mm -76.26 -26.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.047 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.21 -48.59 54.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.884 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.11 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.813 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.073 HD12 HD13 ' A' ' 7' ' ' ILE . 84.4 mt -54.99 -56.56 10.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 74.0 111.176 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -63.94 -37.05 85.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.945 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.03 -42.76 77.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 55.240000000000002 111.071 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -75.35 -38.85 59.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.861 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 96.8 t -49.26 -50.06 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 65.129999999999995 111.122 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.2 10.57 68.31 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.08 3.55 9.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.876 0.37 . . . . 51.25 111.12 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' H51' ' A' ' 201' ' ' PLM . 31.5 t -51.23 140.54 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 65.319999999999993 111.194 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 6.8 m-20 -103.04 145.39 30.48 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.863 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -10.18 27.93 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.653 2.235 . . . . 65.120000000000005 112.362 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -34.98 58.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 64.430000000000007 110.918 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -81.83 -91.46 0.57 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 62.509999999999998 112.464 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.7 -166.38 0.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.707 2.271 . . . . 62.450000000000003 112.339 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -149.65 168.23 24.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 65.519999999999996 110.874 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.5 ptmt -45.44 112.44 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.915 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 11.9 m -120.96 173.84 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.144 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 46' ' ' LEU . 2.5 pt? -145.26 145.78 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 53.310000000000002 110.904 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 128.84 -169.66 20.23 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.758 -0.734 . . . . 74.5 112.508 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.75 153.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 111.212 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -121.12 143.41 49.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.871 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -122.48 94.8 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 110.915 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 13.7 tp -84.43 130.91 34.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 65.019999999999996 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.28 109.19 12.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.4 mp -92.44 126.84 44.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.095 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' CB ' ' HA2' ' A' ' 66' ' ' GLY . 7.9 ttmm -74.01 149.03 41.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 53.340000000000003 110.91 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.455 HG21 ' OE2' ' A' ' 40' ' ' GLU . 2.1 p -143.48 172.01 13.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 74.329999999999998 111.104 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.27 59.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.127 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.64 5.87 14.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.887 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.35 -133.99 5.32 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.513 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.23 139.09 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.109 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' OE2' HG21 ' A' ' 35' ' ' THR . 3.6 mm-40 -96.3 118.96 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 60.43 110.918 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.68 149.04 25.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 75.519999999999996 110.977 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -152.01 144.59 24.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.291 -0.413 . . . . 73.049999999999997 110.938 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.78 123.82 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 73.120000000000005 111.136 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.786 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.08 102.91 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.28 145.05 28.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 64.120000000000005 110.883 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.496 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -102.12 -11.39 18.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.972 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -71.29 -48.61 49.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.409999999999997 110.859 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -110.41 -4.37 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 110.928 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 59.5 62.21 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 75.099999999999994 110.888 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 ptmt -122.63 -179.63 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.904 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG22 HG12 ' A' ' 44' ' ' VAL . 90.7 t -146.5 145.78 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.078 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -154.31 168.36 26.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 62.439999999999998 110.831 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.32 161.57 13.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 63.049999999999997 110.925 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 -153.14 28.72 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.783 -0.722 . . . . 61.119999999999997 112.503 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.8 147.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -79.38 162.23 25.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.9 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.99 -34.59 60.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 45.140000000000001 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.08 83.91 0.23 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.672 0.748 . . . . 74.329999999999998 110.843 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 142.0 46.9 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.699 2.266 . . . . 73.319999999999993 112.354 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -18.92 65.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.409999999999997 110.881 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 98' ' ' ALA . 95.1 t -147.6 150.77 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 33.43 111.103 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.63 105.13 8.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 111.163 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.743 HG21 ' HG1' ' A' ' 201' ' ' PLM . 36.2 t -86.97 131.9 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 74.329999999999998 111.143 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.15 109.01 14.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.156 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 69' ' ' ASP . 9.5 p -136.77 150.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.16 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA2' ' CB ' ' A' ' 34' ' ' LYS . . . -96.44 164.51 23.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 73.140000000000001 112.545 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -54.24 -62.0 1.94 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.96 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -50.03 -34.0 20.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 110.871 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HB2' HG22 ' A' ' 65' ' ' VAL . 38.0 m-20 -70.07 -44.73 68.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.873 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.36 -51.98 31.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.874 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.692 HD23 HD11 ' A' ' 6' ' ' ILE . 10.7 mt -52.78 -37.43 59.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.953 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.29 -34.93 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.120000000000005 111.073 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 10.5 mt -85.24 -60.08 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 70.439999999999998 111.074 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.523 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -54.81 -25.57 29.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 43.530000000000001 110.904 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.6 -1.14 60.76 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.724 -0.75 . . . . 72.549999999999997 112.427 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 mttp 66.24 12.37 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 72.219999999999999 110.933 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.8 p -88.44 -38.51 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 111.128 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -129.39 169.33 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 64.409999999999997 110.917 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.561 ' O ' HD23 ' A' ' 78' ' ' LEU . 81.1 p -116.3 156.18 27.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 73.109999999999999 111.124 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 73' ' ' ILE . 92.6 t -59.32 -40.36 81.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 111.143 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.72 -41.58 93.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.789 -0.72 . . . . 72.430000000000007 112.518 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.57 -47.12 70.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 110.823 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' ' HG3' ' A' ' 88' ' ' LYS . . . -57.47 -44.56 84.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.420000000000002 111.121 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.463 HD21 ' HG3' ' A' ' 202' ' ' PLM . 0.2 OUTLIER -53.0 -51.49 61.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.941 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -28.85 24.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 73.109999999999999 110.825 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -87.58 -28.07 22.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 73.049999999999997 110.896 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.69 44.93 3.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.785 -0.721 . . . . 44.420000000000002 112.487 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -81.38 -33.14 32.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.871 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.44 HD13 ' HC2' ' A' ' 202' ' ' PLM . 2.3 mt -105.65 131.56 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 73.310000000000002 111.104 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.71 149.46 21.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 110.873 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.569 HD22 ' HA ' ' A' ' 95' ' ' ALA . 10.9 mt -108.92 122.75 47.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.912 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.14 110.96 9.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 62.299999999999997 110.809 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.63 -72.88 0.21 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.492 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.39 102.99 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 62.130000000000003 110.875 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -69.98 -27.76 64.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 63.240000000000002 111.105 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -66.04 -52.86 45.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.109999999999999 110.874 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -54.58 -47.28 73.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 53.030000000000001 110.886 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.85 -36.82 75.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 74.340000000000003 111.141 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -46.03 90.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.168 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -52.82 -38.57 61.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 110.916 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.729 HD21 ' H61' ' A' ' 201' ' ' PLM . 1.6 mt -55.02 -48.61 73.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 62.450000000000003 110.929 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.618 ' HB2' ' HE2' ' A' ' 202' ' ' PLM . . . -49.33 -52.88 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 64.239999999999995 111.122 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.33 -30.04 26.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 71.400000000000006 110.907 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 100' ' ' LYS . 7.9 t -79.92 -31.96 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.099999999999994 111.084 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 80' ' ' VAL . 93.4 mt -58.74 -30.94 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 74.010000000000005 111.132 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 179.48 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.239999999999995 110.864 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.46 104.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 74.239999999999995 110.855 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -59.29 -176.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 72.219999999999999 110.865 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -169.46 -170.02 1.01 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 63.420000000000002 110.928 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 69.36 -75.8 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 63.25 110.871 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 71.209999999999994 110.883 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.771 ' H72' HG22 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.679 ' C8 ' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.751 0.31 . . . . 61.530000000000001 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -169.22 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 70.219999999999999 110.863 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.5 t -48.85 -48.29 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.147 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.12 -36.63 41.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 73.400000000000006 110.912 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -71.61 -34.75 70.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 74' ' ' SER . 7.4 mm -68.61 -53.22 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 111.124 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 10' ' ' ILE . 50.9 mm -65.24 -33.36 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 70.25 111.16 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.16 -31.81 21.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.25 110.953 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -75.36 -39.61 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 63.409999999999997 110.822 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.822 ' O ' HG22 ' A' ' 14' ' ' VAL . 27.4 mt -66.86 -58.05 7.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.447 . . . . 74.0 111.079 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -48.66 -32.72 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.219999999999999 110.907 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.09 -53.45 12.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 55.240000000000002 111.15 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -53.56 56.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 75.409999999999997 110.875 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.8 m -51.72 -45.35 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 65.129999999999995 111.133 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.28 -7.04 66.7 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.817 -0.706 . . . . 73.25 112.436 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.78 -15.92 18.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.832 0.348 . . . . 51.25 111.13 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 22' ' ' PRO . 25.2 t -50.67 121.44 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 65.319999999999993 111.137 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -105.11 144.11 28.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.718 . . . . 53.119999999999997 110.853 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -18.15 37.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.7 2.267 . . . . 65.120000000000005 112.355 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.39 -36.74 81.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.897 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.47 -87.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.514 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HG2' HG13 ' A' ' 17' ' ' VAL . 53.7 Cg_endo -69.69 120.57 7.35 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.631 2.221 . . . . 62.450000000000003 112.408 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.9 166.02 22.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 65.519999999999996 110.833 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -91.72 94.84 9.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 71.129999999999995 110.921 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.923 HG23 HD12 ' A' ' 46' ' ' LEU . 21.1 m -77.73 176.04 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 72.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.91 131.94 56.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 53.310000000000002 110.982 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.99 178.91 26.26 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 74.5 112.512 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.86 153.3 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.379 . . . . 72.430000000000007 111.128 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.789 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.1 m-85 -123.67 144.68 49.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 110.886 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.2 tp60 -119.67 93.69 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 110.936 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.644 HD11 HG13 ' A' ' 33' ' ' ILE . 1.4 tp -83.57 129.29 34.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 65.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.1 m-80 -125.98 109.88 12.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 110.821 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -97.91 134.39 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 72.219999999999999 111.118 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 3.8 mttp -72.3 153.11 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 53.340000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -145.13 173.3 12.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 111.127 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.16 -14.49 59.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 111.052 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.9 7.21 14.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.867 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.2 -128.93 3.55 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 44.130000000000003 112.497 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.14 140.63 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 53.130000000000003 111.167 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -98.03 124.48 42.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.856 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -88.68 150.48 22.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 75.519999999999996 110.911 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.79 143.55 22.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 110.871 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mp -115.99 121.03 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.163 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.619 HG21 ' HE1' ' A' ' 201' ' ' PLM . 1.6 t -119.28 104.55 15.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 75.109999999999999 111.1 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.31 152.07 23.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 64.120000000000005 110.821 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.923 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.1 -12.73 13.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.917 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.69 -50.46 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 73.409999999999997 110.872 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -109.52 -0.37 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 72.310000000000002 110.915 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.4 mm? 58.43 72.33 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.099999999999994 110.875 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ptmt -139.23 179.4 6.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 73.120000000000005 110.925 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.6 p -147.23 141.15 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.540000000000006 111.154 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -141.76 168.28 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 62.439999999999998 110.912 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.63 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 63.049999999999997 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.3 -156.75 24.37 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.73 -0.748 . . . . 61.119999999999997 112.518 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -118.5 147.0 22.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.836 0.351 . . . . 63.32 111.136 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -80.95 160.03 24.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 110.885 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.65 -32.88 53.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 45.140000000000001 111.158 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.45 84.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.671 0.748 . . . . 74.329999999999998 110.863 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 141.31 44.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.656 2.238 . . . . 73.319999999999993 112.314 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.27 -15.64 63.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.879 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 98' ' ' ALA . 96.2 t -149.66 150.17 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 33.43 111.17 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.22 113.85 19.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 64.239999999999995 111.147 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.727 HG21 ' HG1' ' A' ' 201' ' ' PLM . 85.5 t -98.51 126.98 51.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.432 . . . . 74.329999999999998 111.177 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.09 108.32 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 73.530000000000001 111.101 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.813 HG22 ' HA ' ' A' ' 89' ' ' ILE . 20.3 t -134.97 157.69 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.187 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -92.69 165.39 28.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.506 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -58.08 -62.02 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.826 0.346 . . . . 52.229999999999997 110.985 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.648 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.5 mt-10 -51.11 -33.06 24.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.959 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB2' HG12 ' A' ' 65' ' ' VAL . 76.1 m-20 -67.57 -45.89 74.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 71.200000000000003 110.841 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -50.04 67.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.85 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 68' ' ' GLU . 10.8 mt -51.17 -34.31 30.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 73.329999999999998 110.939 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.86 92.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 72.120000000000005 111.114 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.76 -63.36 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 111.19 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -60.07 -18.73 48.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 43.530000000000001 110.902 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 77' ' ' THR . . . -86.27 13.65 56.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.74 -0.743 . . . . 72.549999999999997 112.504 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 47.52 30.53 1.69 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.907 0.384 . . . . 72.219999999999999 110.919 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 75' ' ' GLY . 44.9 p -106.12 -35.4 7.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 111.207 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -126.1 169.2 13.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 64.409999999999997 110.992 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.58 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -117.38 148.56 41.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 73.109999999999999 111.202 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG21 HD13 ' A' ' 105' ' ' ILE . 85.5 t -55.82 -44.64 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 111.088 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.12 -32.62 71.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 72.430000000000007 112.501 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.91 -44.04 33.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.321 . . . . 72.209999999999994 110.896 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -68.4 -34.53 76.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.14 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.685 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.45 -51.87 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -60.87 -46.84 89.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 73.109999999999999 110.914 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -57.06 -38.55 73.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 73.049999999999997 110.849 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.0 29.08 4.73 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 44.420000000000002 112.491 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.501 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 15.8 mmtt -76.68 -34.0 58.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.726 0.298 . . . . 75.340000000000003 110.838 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.813 ' HA ' HG22 ' A' ' 65' ' ' VAL . 5.8 mt -106.95 126.06 62.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.421 . . . . 73.310000000000002 111.138 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.61 146.57 23.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 110.863 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 202' ' ' PLM . 14.2 mt -111.94 122.9 49.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 71.230000000000004 110.932 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.2 t -135.99 154.01 51.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 62.299999999999997 110.837 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.88 -82.12 0.42 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 72.140000000000001 112.499 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.61 94.36 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 62.130000000000003 110.879 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.423 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -62.96 -30.56 71.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 63.240000000000002 111.101 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -60.19 -45.36 93.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 71.109999999999999 110.935 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.1 mt -62.13 -47.2 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 53.030000000000001 110.878 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.544 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -64.5 -49.76 70.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.093 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -49.38 -39.92 34.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.123 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -42.66 87.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.829 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.802 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.8 mt -54.74 -53.37 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 62.450000000000003 110.921 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.77 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.95 -40.51 43.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 64.239999999999995 111.148 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.2 -34.66 70.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 71.400000000000006 110.898 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -78.19 -40.57 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.111 -0.495 . . . . 74.099999999999994 111.14 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 102' ' ' ALA . 64.6 mt -52.81 -31.33 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.010000000000005 111.135 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.5 m170 -52.75 102.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 110.869 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -175.86 -177.39 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.86 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -107.54 136.52 47.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 110.818 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.29 166.86 21.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.91 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -96.87 -34.96 11.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 63.25 110.867 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 71.209999999999994 110.787 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.802 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.593 ' HA1' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 61.530000000000001 110.841 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 t -149.44 -169.22 3.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 70.219999999999999 110.895 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.0 t -48.64 -42.15 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 74.430000000000007 111.161 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -51.04 -34.67 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.400000000000006 110.879 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.98 -34.75 32.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 74.040000000000006 111.183 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.732 HG21 ' HG2' ' A' ' 70' ' ' MET . 6.4 mm -69.84 -55.52 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 111.088 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.808 ' HA ' HD12 ' A' ' 10' ' ' ILE . 37.7 mm -61.09 -30.01 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 70.25 111.099 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -58.73 -34.48 71.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.857 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.04 -32.44 59.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.094 -0.503 . . . . 63.409999999999997 110.843 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 7' ' ' ILE . 36.4 mt -68.49 -57.5 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -53.76 -34.08 57.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.963 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.26 -36.77 63.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 55.240000000000002 111.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -52.08 16.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 75.409999999999997 110.809 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.7 m -51.9 -47.11 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 111.181 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.19 -0.34 70.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.829 -0.701 . . . . 73.25 112.467 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.1 3.91 12.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.917 0.389 . . . . 51.25 111.148 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -49.69 138.83 4.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.131 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 2.2 m-20 -103.47 144.91 29.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.552 0.692 . . . . 53.119999999999997 110.9 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -9.56 26.42 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.779 2.319 . . . . 65.120000000000005 112.276 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -33.99 49.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 64.430000000000007 110.934 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.28 -91.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 62.509999999999998 112.515 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.73 -168.38 0.27 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.673 2.249 . . . . 62.450000000000003 112.351 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -148.28 166.16 28.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 65.519999999999996 110.872 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -46.84 111.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 23' ' ' ARG . 17.4 m -118.51 171.63 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 111.175 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD12 ' C ' ' A' ' 25' ' ' VAL . 5.4 mp -140.86 128.36 21.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 53.310000000000002 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.25 -173.83 28.13 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 74.5 112.537 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.47 155.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 72.430000000000007 111.188 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.808 ' HB2' HG23 ' A' ' 44' ' ' VAL . 24.2 m-85 -121.98 141.74 51.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -122.85 94.24 4.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 73.099999999999994 110.848 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' ASN . 1.6 tp -81.41 130.2 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 65.019999999999996 110.911 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.658 ' N ' HD12 ' A' ' 31' ' ' LEU . 13.1 m-80 -126.48 109.13 11.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 110.9 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.659 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.7 mp -96.25 131.9 41.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.143 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 145.0 31.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 110.904 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.44 163.78 35.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 74.329999999999998 111.205 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.99 -13.97 50.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 70.239999999999995 111.073 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.98 19.44 19.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 119.92 -128.49 7.56 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.69 -0.767 . . . . 44.130000000000003 112.453 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -144.3 138.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.737 0.303 . . . . 53.130000000000003 111.157 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -97.77 118.55 34.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.875 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.58 151.24 23.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.921 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -152.23 147.35 26.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.295 -0.411 . . . . 73.049999999999997 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.93 121.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.120000000000005 111.183 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -128.98 103.71 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 75.109999999999999 111.155 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -84.66 148.6 26.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 64.120000000000005 110.849 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.786 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -102.49 -17.4 15.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.874 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -64.88 -48.09 75.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.911 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -111.29 -4.41 14.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 72.310000000000002 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 2.9 mm? 58.87 60.19 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.901 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -120.41 -179.81 4.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 73.120000000000005 110.915 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.755 HG22 HG12 ' A' ' 44' ' ' VAL . 21.8 t -146.24 147.45 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 111.179 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.32 167.89 28.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.846 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.97 161.4 14.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 63.049999999999997 110.967 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.43 -154.62 33.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.74 . . . . 61.119999999999997 112.504 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.6 147.15 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -78.73 162.69 25.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.34 -31.45 65.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 45.140000000000001 111.048 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.65 83.09 0.24 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.66 0.743 . . . . 74.329999999999998 110.856 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 141.25 44.4 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.608 2.205 . . . . 73.319999999999993 112.396 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -60.8 -22.36 64.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.927 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 97' ' ' LEU . 90.7 t -150.59 146.39 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 33.43 111.119 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.33 106.13 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 64.239999999999995 111.165 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.732 HG21 ' HG1' ' A' ' 201' ' ' PLM . 36.9 t -91.28 127.78 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 74.329999999999998 111.146 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.5 107.67 12.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 111.076 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' CG1' HG23 ' A' ' 89' ' ' ILE . 8.2 m -125.58 169.37 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.430000000000007 111.1 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.32 164.53 18.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.763 -0.732 . . . . 73.140000000000001 112.517 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.659 HD12 ' CG2' ' A' ' 33' ' ' ILE . 3.9 tp -58.92 -55.01 40.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 52.229999999999997 110.895 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -54.86 -45.82 74.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.918 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.31 -52.29 59.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.851 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.732 ' HG2' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -54.5 -55.1 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.95 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.466 HD23 HD11 ' A' ' 6' ' ' ILE . 6.8 mt -59.59 -31.63 69.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.458 . . . . 73.329999999999998 110.953 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 77' ' ' THR . . . -61.74 -51.02 70.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 111.072 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.586 HD12 ' H72' ' A' ' 202' ' ' PLM . 10.0 mt -72.1 -62.79 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.439999999999998 111.128 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.672 ' CB ' HG23 ' A' ' 6' ' ' ILE . 34.8 t -55.49 -22.31 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 43.530000000000001 110.913 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.73 -1.87 63.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 72.549999999999997 112.497 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 mttt 66.2 11.8 8.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 72.219999999999999 110.87 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 72' ' ' ALA . 14.8 t -100.41 -26.99 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 71.409999999999997 111.194 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.15 169.45 14.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.449 . . . . 64.409999999999997 110.943 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.6 p -127.66 153.29 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.199 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.54 HG22 HD13 ' A' ' 73' ' ' ILE . 86.8 t -54.9 -42.51 63.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 72.019999999999996 111.06 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.21 -34.63 80.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.495 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.94 -47.93 73.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 110.945 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.6 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.51 -35.2 70.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.154 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.76 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.95 -51.95 59.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.93 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -47.15 73.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.889 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -69.15 -20.92 64.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 73.049999999999997 110.907 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.48 47.59 6.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 44.420000000000002 112.453 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.2 mmpt? -87.12 -33.06 19.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.693 0.283 . . . . 75.340000000000003 110.894 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' CD2' ' A' ' 84' ' ' LEU . 15.1 mt -90.38 123.73 42.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 73.310000000000002 111.14 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.55 147.11 26.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.922 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 pp -137.96 138.23 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 110.897 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.91 110.52 9.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 62.299999999999997 110.834 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.86 -85.19 0.3 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.701 -0.761 . . . . 72.140000000000001 112.48 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.05 99.0 5.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.784 0.326 . . . . 62.130000000000003 110.916 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.05 -22.13 48.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 63.240000000000002 111.134 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -51.82 38.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.109999999999999 110.891 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.768 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.55 -41.77 70.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 53.030000000000001 110.977 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.536 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -74.99 -50.91 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 74.340000000000003 111.071 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -49.19 -42.73 41.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.450000000000003 111.206 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -53.12 -40.41 64.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 72.439999999999998 110.898 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.1 mp -64.34 -55.44 21.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 62.450000000000003 110.921 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' HB2' ' HF1' ' A' ' 202' ' ' PLM . . . -48.36 -29.17 3.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.134 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -44.84 39.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 110.911 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.553 HG11 ' H52' ' A' ' 201' ' ' PLM . 0.9 OUTLIER -69.33 -19.92 23.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.145 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 102' ' ' ALA . 84.0 mt -70.54 -29.62 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 111.091 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -54.14 171.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.867 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.07 114.38 1.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.875 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -139.68 -64.38 0.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 72.219999999999999 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.11 -175.36 2.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 63.420000000000002 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -120.03 27.84 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.895 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.864 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.732 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.664 ' HC2' HG21 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mmt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.759 0.314 . . . . 61.530000000000001 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.58 ' HA ' HD21 ' A' ' 71' ' ' LEU . 1.5 m 62.07 177.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.907 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG21 ' OE2' ' A' ' 40' ' ' GLU . 96.4 t -52.49 -28.93 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 111.101 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -51.32 -55.33 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 73.400000000000006 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.8 m -63.05 -49.41 74.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 111.178 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -50.36 -55.59 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' HA ' HD12 ' A' ' 10' ' ' ILE . 43.3 mm -66.46 -47.21 84.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 70.25 111.082 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -51.32 -37.21 46.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 75.25 110.903 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -36.29 76.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 110.903 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 14' ' ' VAL . 44.6 mt -70.07 -56.35 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 74.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.648 ' HB3' HG11 ' A' ' 51' ' ' VAL . 18.5 ptpt -48.56 -34.62 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 75.219999999999999 110.916 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.99 -41.65 61.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 55.240000000000002 111.151 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.0 tpp85 -68.31 -52.08 37.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.828 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.1 m -51.64 -47.02 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.137 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.28 -2.53 67.52 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.693 -0.765 . . . . 73.25 112.494 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.8 -2.67 15.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.786 0.327 . . . . 51.25 111.098 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -50.54 126.57 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 111.116 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 m-20 -104.29 143.76 27.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 53.119999999999997 110.848 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -11.98 32.05 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 65.120000000000005 112.349 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.58 -36.27 65.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.430000000000007 110.949 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.88 -90.94 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 62.509999999999998 112.502 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.455 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.9 Cg_endo -69.77 -166.75 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.231 . . . . 62.450000000000003 112.352 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -139.58 162.53 34.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.813 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -68.99 99.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.951 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.739 HG23 HD12 ' A' ' 46' ' ' LEU . 17.3 m -100.5 174.17 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 111.194 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -127.7 133.79 49.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 53.310000000000002 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.5 -178.68 24.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 74.5 112.477 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 56' ' ' PHE . 2.4 t -142.8 155.18 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 72.430000000000007 111.177 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.5 m-85 -122.4 137.26 54.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.878 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.553 ' HB3' HG23 ' A' ' 62' ' ' THR . 44.6 tp60 -110.72 98.62 7.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 110.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.72 HD11 ' HE2' ' A' ' 70' ' ' MET . 1.1 tt -78.79 127.45 32.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 65.019999999999996 110.897 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.543 ' N ' HD23 ' A' ' 31' ' ' LEU . 17.9 m-80 -127.82 107.64 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 110.959 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.647 ' CG2' HD12 ' A' ' 67' ' ' LEU . 3.5 mp -102.35 124.27 56.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 111.112 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 147.63 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.902 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.409 HG22 HD13 ' A' ' 67' ' ' LEU . 5.6 p -145.73 172.92 12.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 111.192 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.56 -14.63 59.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 70.239999999999995 111.118 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.0 9.26 14.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.816 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 141.42 -134.6 6.37 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.683 -0.77 . . . . 44.130000000000003 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 33' ' ' ILE . 9.1 p -143.71 137.32 24.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.766 0.317 . . . . 53.130000000000003 111.102 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.47 ' OE2' HG21 ' A' ' 3' ' ' VAL . 16.5 mt-10 -84.11 132.92 34.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 60.43 110.872 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -106.98 141.86 37.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.519999999999996 110.902 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 88.4 m95 -152.06 146.66 25.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 mt -116.01 119.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 73.120000000000005 111.129 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -122.47 102.1 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 75.109999999999999 111.098 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.54 155.19 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 64.120000000000005 110.949 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -112.89 -13.95 13.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.232 -0.44 . . . . 72.409999999999997 110.948 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -66.83 -50.73 61.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.905 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' C ' HD22 ' A' ' 49' ' ' LEU . 37.5 mt-30 -109.39 -2.27 17.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.310000000000002 110.96 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 48' ' ' GLN . 1.6 mm? 60.65 66.68 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 75.099999999999994 110.928 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -130.99 177.42 7.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.9 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.648 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -147.51 140.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.540000000000006 111.118 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -143.81 168.74 19.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 62.439999999999998 110.824 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.04 155.55 16.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 63.049999999999997 110.872 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.21 -155.71 22.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.818 -0.706 . . . . 61.119999999999997 112.563 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.79 147.36 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 63.32 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 28' ' ' VAL . 18.2 t80 -80.46 155.43 27.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.85 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.89 -33.44 50.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 45.140000000000001 111.097 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.08 85.0 0.21 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.845 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 159.76 52.17 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.642 2.228 . . . . 73.319999999999993 112.355 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -80.8 -21.3 41.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.845 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.1 t -149.4 148.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.249 -0.432 . . . . 33.43 111.149 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' HB3' ' A' ' 30' ' ' GLN . 0.2 OUTLIER -121.47 111.26 17.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.14 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.749 HG21 ' HG1' ' A' ' 201' ' ' PLM . 71.3 t -91.41 127.94 43.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.183 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.2 108.51 13.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 73.530000000000001 111.178 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG13 HG23 ' A' ' 89' ' ' ILE . 2.2 m -129.91 168.03 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 111.157 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.93 164.73 26.43 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 73.140000000000001 112.534 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 33' ' ' ILE . 5.7 tp -59.81 -61.86 2.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.814 0.34 . . . . 52.229999999999997 110.978 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.777 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.9 mt-10 -60.49 -33.64 72.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 72.129999999999995 110.939 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -53.04 -54.72 31.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 71.200000000000003 110.874 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.72 ' HE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.27 -43.0 87.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.861 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 68' ' ' GLU . 45.4 mt -51.64 -42.45 62.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.942 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.29 -37.99 79.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.06 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.0 mt -72.8 -63.74 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.439999999999998 111.105 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.78 -26.66 36.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.923 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -83.69 16.36 31.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 72.549999999999997 112.443 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 3.0 ptmt 47.0 30.96 1.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.6 m -102.67 -32.71 9.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 71.409999999999997 111.107 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -134.39 169.28 17.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.909 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 111' ' ' HIS . 47.6 p -122.78 148.7 45.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.12 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.11 -38.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.019999999999996 111.145 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.24 -43.05 93.7 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.45 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.65 -47.58 62.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.863 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -60.87 -34.87 75.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 74.420000000000002 111.067 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -57.65 -51.88 67.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 110.844 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -47.22 75.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.259 -0.428 . . . . 73.109999999999999 110.922 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.63 -22.09 66.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 73.049999999999997 110.907 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.79 37.52 11.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 44.420000000000002 112.483 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.8 mmpt? -76.95 -33.38 57.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 75.340000000000003 110.931 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.572 HD13 ' HC2' ' A' ' 202' ' ' PLM . 13.2 mt -97.55 126.28 50.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.186 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 149.06 22.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.109999999999999 110.905 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.682 HD13 ' HB1' ' A' ' 95' ' ' ALA . 33.5 mt -119.3 122.71 42.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 71.230000000000004 110.916 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.27 110.97 12.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 62.299999999999997 110.817 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.46 -84.76 0.37 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.865 -0.683 . . . . 72.140000000000001 112.562 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.5 98.22 4.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.781 0.324 . . . . 62.130000000000003 110.861 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -58.67 -27.25 64.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.096 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -51.81 59.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.897 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.588 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.7 mt -55.24 -48.36 74.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 53.030000000000001 110.981 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -69.75 -30.69 68.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.108 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.18 80.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.142 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -53.18 -34.51 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 72.439999999999998 110.908 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.576 HD21 ' HA1' ' A' ' 201' ' ' PLM . 1.5 mt -55.89 -54.42 44.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 62.450000000000003 110.909 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -49.73 -29.82 8.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 64.239999999999995 111.094 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.56 -47.06 85.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 71.400000000000006 110.889 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -70.57 -20.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 111.128 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 102' ' ' ALA . 69.9 mt -73.07 -30.78 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 111.092 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -79.95 58.51 2.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 72.239999999999995 110.883 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.89 157.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.875 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t60 60.83 99.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 72.219999999999999 110.894 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 59.7 97.3 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 63.420000000000002 110.837 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -65.68 176.71 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 79' ' ' THR . 22.0 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.431 . . . . 71.209999999999994 110.936 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.749 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.708 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.766 0.317 . . . . 61.530000000000001 110.933 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t -110.87 -169.67 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 110.88 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG11 ' OE2' ' A' ' 40' ' ' GLU . 3.7 p -50.65 -29.43 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.08 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -61.94 -35.53 78.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.400000000000006 110.865 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -27.46 41.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 111.141 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' HB3' ' A' ' 70' ' ' MET . 5.3 mm -77.28 -51.26 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.107 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 10' ' ' ILE . 36.7 mm -69.15 -26.92 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 70.25 111.091 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.36 -44.11 68.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.865 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -70.6 -37.69 73.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.802 HD12 HD13 ' A' ' 7' ' ' ILE . 51.4 mt -56.87 -57.28 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.834 ' HB3' HG11 ' A' ' 51' ' ' VAL . 2.5 ptpt -55.95 -46.0 78.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.875 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.99 -37.38 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 55.240000000000002 111.103 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -78.98 -37.96 38.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 75.409999999999997 110.884 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 10' ' ' ILE . 98.8 t -51.5 -46.23 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.83 11.95 65.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 73.25 112.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.9 2.38 11.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 51.25 111.085 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -51.06 139.5 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 111.125 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.15 143.09 25.97 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.558 0.695 . . . . 53.119999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -14.87 36.43 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.661 2.24 . . . . 65.120000000000005 112.355 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.22 -38.53 82.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 110.904 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.55 -90.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.749 . . . . 62.509999999999998 112.509 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 54.1 Cg_endo -69.8 158.17 57.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 62.450000000000003 112.358 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -116.12 166.35 12.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 65.519999999999996 110.916 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -49.73 104.22 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.129999999999995 110.869 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 23' ' ' ARG . 33.5 m -112.44 173.31 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 72.109999999999999 111.116 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.659 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -137.73 161.62 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 53.310000000000002 110.888 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 120.17 -168.7 13.82 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.683 -0.77 . . . . 74.5 112.494 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.05 154.05 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 72.430000000000007 111.12 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.749 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.9 m-85 -120.89 143.47 48.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.881 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 62' ' ' THR . 44.2 tp60 -117.69 95.04 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 73.099999999999994 110.931 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD11 ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -84.12 127.17 33.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 65.019999999999996 110.92 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.94 126.93 49.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.871 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.588 ' CG2' HD12 ' A' ' 67' ' ' LEU . 5.2 mp -123.32 135.07 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 111.087 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' O ' HD13 ' A' ' 67' ' ' LEU . 1.5 mttp -66.69 154.08 41.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.909 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.0 p -145.48 178.41 8.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.102 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.07 -18.32 55.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 70.239999999999995 111.074 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.86 20.21 14.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 74.340000000000003 110.865 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 129.75 -124.86 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.76 . . . . 44.130000000000003 112.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.76 143.65 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 53.130000000000003 111.127 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' OE2' HG11 ' A' ' 3' ' ' VAL . 10.6 pt-20 -104.46 122.01 44.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.89 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -86.84 155.36 20.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 110.895 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.415 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 83.6 m95 -148.08 137.56 22.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG23 ' HB2' ' A' ' 56' ' ' PHE . 2.8 mp -107.06 110.93 33.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.120000000000005 111.147 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -118.24 103.02 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 75.109999999999999 111.146 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.81 154.07 24.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 64.120000000000005 110.829 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.714 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.02 -15.16 13.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.865 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -50.39 66.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 73.409999999999997 110.902 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -111.62 -0.39 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 110.936 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' HG12 ' A' ' 14' ' ' VAL . 3.3 mm? 60.01 82.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.915 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 175.89 10.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.83 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.834 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.4 p -148.84 141.7 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.540000000000006 111.166 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.75 167.82 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 62.439999999999998 110.854 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.66 152.15 20.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 63.049999999999997 110.931 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.33 -168.5 31.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 61.119999999999997 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 142.54 22.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.825 0.345 . . . . 63.32 111.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' A' ' 43' ' ' ILE . 20.0 t80 -75.1 161.0 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.866 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.51 -34.18 61.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 45.140000000000001 111.098 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.87 85.16 0.24 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.655 0.74 . . . . 74.329999999999998 110.915 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 160.39 49.87 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.319999999999993 112.305 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.17 -20.1 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.6 t -147.02 148.8 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.43 111.158 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -121.9 108.27 13.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.122 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 HG21 ' HG1' ' A' ' 201' ' ' PLM . 21.4 t -93.96 131.48 40.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.117 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.1 108.52 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.530000000000001 111.168 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 69' ' ' ASP . 14.0 p -136.64 130.92 47.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 72.430000000000007 111.144 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.47 176.24 48.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.527 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CG2' ' A' ' 33' ' ' ILE . 2.7 tp -65.43 -61.79 1.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 52.229999999999997 110.986 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -49.48 -32.82 12.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.914 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' HB2' HG22 ' A' ' 65' ' ' VAL . 32.5 m-20 -68.74 -46.4 68.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.912 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.855 ' HE1' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -69.27 -48.85 60.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.019999999999996 110.892 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD23 HD11 ' A' ' 6' ' ' ILE . 7.3 mt -56.24 -35.61 67.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 73.329999999999998 110.913 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.12 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 111.104 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.698 HD12 ' C8 ' ' A' ' 202' ' ' PLM . 9.4 mt -75.96 -61.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.195 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.621 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -55.0 -24.33 23.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.118 -0.492 . . . . 43.530000000000001 110.862 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.34 -1.6 65.17 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 72.549999999999997 112.468 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 69.37 7.32 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 72.219999999999999 110.913 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -87.17 -37.04 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.104 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.704 HD22 ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -126.54 169.87 12.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 64.409999999999997 110.907 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.548 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -123.85 148.73 46.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.2 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 105' ' ' ILE . 74.0 t -52.12 -48.87 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 72.019999999999996 111.171 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.87 -33.38 60.11 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.741 -0.742 . . . . 72.430000000000007 112.426 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.09 -54.94 5.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 72.209999999999994 110.881 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HB2' HD22 ' A' ' 78' ' ' LEU . . . -56.85 -44.42 82.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.12 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 ' HG3' ' A' ' 202' ' ' PLM . 1.6 tm? -52.79 -52.07 58.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.948 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.09 -36.91 66.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.877 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -70.26 -34.53 72.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.049999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 107.08 33.84 3.12 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.741 -0.742 . . . . 44.420000000000002 112.47 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' HG3' ' HB1' ' A' ' 83' ' ' ALA . 8.7 mmpt? -76.98 -32.97 57.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.911 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' HC2' ' A' ' 202' ' ' PLM . 3.0 mt -106.04 132.42 53.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 73.310000000000002 111.161 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 149.26 21.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 73.109999999999999 110.852 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 95' ' ' ALA . 14.7 mt -111.71 124.35 52.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.506 . . . . 71.230000000000004 110.935 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.18 111.4 7.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.838 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.61 -70.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.751 . . . . 72.140000000000001 112.478 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' CB ' HG22 ' A' ' 61' ' ' VAL . 1.1 t0 -143.87 106.23 4.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.756 0.312 . . . . 62.130000000000003 110.863 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.543 ' HA ' HD22 ' A' ' 91' ' ' LEU . . . -73.47 -28.96 62.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 63.240000000000002 111.07 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -66.18 -51.42 57.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' HB3' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -54.58 -47.07 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 53.030000000000001 110.91 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.643 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.23 -35.5 71.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 111.053 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.42 98.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 111.108 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -52.22 -43.4 64.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 110.945 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -54.83 -53.47 54.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 62.450000000000003 110.897 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.609 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -48.4 -29.32 3.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 64.239999999999995 111.104 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -68.47 -47.21 67.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 71.400000000000006 110.896 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -64.96 -20.14 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.14 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.623 HD13 HG21 ' A' ' 80' ' ' VAL . 65.9 mt -68.92 -30.14 45.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 111.112 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -52.09 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.808 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 52.05 -169.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.874 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 57.2 m-70 -67.45 -169.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.219999999999999 110.91 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -52.0 111.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 63.420000000000002 110.904 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -169.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 63.25 110.888 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.849 179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.828 ' HG3' ' HG ' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.718 ' HG3' HD21 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' HG2' HG21 ' A' ' 5' ' ' THR . 1.9 mpp? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.783 0.325 . . . . 61.530000000000001 110.853 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 63.28 -175.28 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 70.219999999999999 110.863 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.1 -34.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -50.29 -38.61 42.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 73.400000000000006 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.575 HG21 ' HG2' ' A' ' 1' ' ' MET . 94.8 m -82.2 -28.27 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 74.040000000000006 111.157 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.788 HD11 HD23 ' A' ' 71' ' ' LEU . 5.6 mm -75.29 -56.31 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 73.349999999999994 111.186 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.577 HD11 HD23 ' A' ' 31' ' ' LEU . 36.0 mm -61.88 -27.39 42.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 70.25 111.11 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.63 -36.96 74.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.876 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -70.32 -34.53 72.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 63.409999999999997 110.875 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.82 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.5 mt -70.68 -56.49 10.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 74.0 111.129 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.803 ' HB3' HG11 ' A' ' 51' ' ' VAL . 19.4 ptpt -47.23 -34.9 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.482 . . . . 75.219999999999999 110.928 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.05 38.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 55.240000000000002 111.134 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' HD2' ' C8 ' ' A' ' 201' ' ' PLM . 0.0 OUTLIER -63.21 -53.11 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 75.409999999999997 110.811 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 10' ' ' ILE . 5.7 m -51.19 -45.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 65.129999999999995 111.094 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.54 1.1 73.45 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 73.25 112.485 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.53 1.56 12.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 51.25 111.122 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 49' ' ' LEU . 25.2 t -50.56 133.4 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 65.319999999999993 111.154 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -103.54 146.11 31.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.528 0.68 . . . . 53.119999999999997 110.841 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -10.33 28.35 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.735 2.29 . . . . 65.120000000000005 112.297 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.19 -34.55 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.43 . . . . 64.430000000000007 110.884 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.33 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 62.509999999999998 112.526 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.5 Cg_endo -69.75 -166.98 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.669 2.246 . . . . 62.450000000000003 112.326 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.69 166.57 27.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 65.519999999999996 110.834 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -48.52 103.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 71.129999999999995 110.936 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 23' ' ' ARG . 14.4 m -107.43 173.44 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 111.128 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' O ' HD11 ' A' ' 46' ' ' LEU . 1.1 mp -140.82 138.87 34.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.846 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 133.42 -175.27 20.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.694 -0.765 . . . . 74.5 112.463 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.8 153.71 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.8 0.333 . . . . 72.430000000000007 111.235 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.736 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.3 m-85 -119.72 147.83 44.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 74.319999999999993 110.857 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.3 tp60 -124.78 98.43 5.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.099999999999994 110.872 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 17.9 tp -88.44 130.03 35.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 65.019999999999996 110.886 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -126.75 110.6 13.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.893 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.621 HG21 HD12 ' A' ' 67' ' ' LEU . 4.5 mp -99.47 132.95 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.147 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 66' ' ' GLY . 10.9 mtpt -72.12 153.31 41.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 53.340000000000003 110.969 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 p -144.49 174.17 11.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 111.154 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.33 -14.78 59.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 70.239999999999995 111.06 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -115.74 7.4 14.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.866 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.29 -128.25 3.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.716 -0.754 . . . . 44.130000000000003 112.49 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.92 140.63 25.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.787 0.327 . . . . 53.130000000000003 111.125 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -98.49 123.87 42.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 60.43 110.898 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -89.03 151.42 22.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.926 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -152.35 140.53 20.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 73.049999999999997 110.957 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.38 120.26 61.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.120000000000005 111.128 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.29 102.86 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 111.157 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.43 147.76 27.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 64.120000000000005 110.877 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -103.32 -14.43 16.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.917 -179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -66.37 -49.73 65.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.929 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -111.48 -3.17 15.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.913 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.617 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 3.4 mm? 58.84 67.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.099999999999994 110.935 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.87 -178.18 4.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.120000000000005 110.924 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.06 141.84 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 74.540000000000006 111.143 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.82 167.66 23.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 62.439999999999998 110.852 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.78 150.2 20.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.941 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.72 -156.82 21.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.755 -0.736 . . . . 61.119999999999997 112.504 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 p -121.41 147.55 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.89 0.376 . . . . 63.32 111.115 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -80.27 155.34 27.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.842 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.59 -31.78 26.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 45.140000000000001 111.088 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.61 84.1 0.24 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.687 0.756 . . . . 74.329999999999998 110.89 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.47 40.24 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.682 2.255 . . . . 73.319999999999993 112.326 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -60.9 -20.4 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.84 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 98' ' ' ALA . 90.1 t -150.19 150.3 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 33.43 111.092 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.24 111.77 16.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 64.239999999999995 111.134 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.625 HG21 ' HG1' ' A' ' 201' ' ' PLM . 60.2 t -97.81 129.55 47.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.435 . . . . 74.329999999999998 111.138 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.93 107.57 13.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.156 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 89' ' ' ILE . 50.8 t -132.03 155.58 41.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.113 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -93.66 163.26 25.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 73.140000000000001 112.517 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.621 HD12 HG21 ' A' ' 33' ' ' ILE . 5.9 tp -54.41 -62.21 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.772 0.32 . . . . 52.229999999999997 110.865 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.9 mt-10 -51.9 -32.94 34.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.834 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 71.200000000000003 110.852 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -50.85 45.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.898 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.788 HD23 HD11 ' A' ' 6' ' ' ILE . 6.6 mt -52.89 -35.66 58.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 110.954 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.63 77.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.125 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' H92' ' A' ' 202' ' ' PLM . 7.5 mt -79.14 -62.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 70.439999999999998 111.175 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.761 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.84 -22.46 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 43.530000000000001 110.81 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.24 -4.06 67.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.828 -0.701 . . . . 72.549999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 66.11 8.32 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 72.219999999999999 110.877 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.3 t -91.13 -34.88 14.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.246 -0.433 . . . . 71.409999999999997 111.179 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 79' ' ' THR . 0.7 OUTLIER -121.74 169.12 11.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.907 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HD23 ' A' ' 78' ' ' LEU . 82.7 p -126.89 151.03 48.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 111.08 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.6 t -51.38 -39.58 22.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -59.36 -42.12 97.28 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 72.430000000000007 112.516 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -43.22 73.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 72.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -66.65 -35.82 81.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 74.420000000000002 111.137 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -51.71 65.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.978 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -54.12 -47.06 72.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.827 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -68.45 -25.53 65.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 73.049999999999997 110.943 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.28 40.68 6.02 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.75 -0.738 . . . . 44.420000000000002 112.505 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.579 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 13.7 mmtt -76.72 -33.07 58.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 110.847 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.836 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.0 mt -103.39 133.79 46.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 73.310000000000002 111.19 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.42 149.05 21.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.914 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.784 HD13 ' HB1' ' A' ' 95' ' ' ALA . 43.0 mt -114.47 122.87 47.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 71.230000000000004 110.912 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.2 t -134.61 148.71 50.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 62.299999999999997 110.901 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.86 -79.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.521 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.5 94.32 3.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.353 . . . . 62.130000000000003 110.842 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.784 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -63.68 -25.52 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.065 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.83 -51.14 61.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 71.109999999999999 110.892 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.475 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.4 mt -55.5 -46.98 76.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 53.030000000000001 110.885 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.726 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.92 -31.06 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 111.085 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.455 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -61.65 -45.11 95.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 64.450000000000003 111.084 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 104' ' ' VAL . 25.0 tttm -54.33 -41.45 69.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.856 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.744 HD11 ' H71' ' A' ' 201' ' ' PLM . 0.7 OUTLIER -54.45 -44.64 72.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 62.450000000000003 110.909 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB2' ' CF ' ' A' ' 202' ' ' PLM . . . -51.52 -53.64 35.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 64.239999999999995 111.095 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -30.17 62.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.861 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 100' ' ' LYS . 13.2 t -79.34 -29.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 111.165 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.435 HD13 ' H82' ' A' ' 202' ' ' PLM . 24.2 mt -76.19 -27.52 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.127 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -54.56 172.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.872 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -55.92 176.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.793 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.1 t60 60.74 34.95 19.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 72.219999999999999 110.841 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.7 122.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 63.420000000000002 110.879 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -129.47 -42.92 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 63.25 110.841 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 71.209999999999994 110.863 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.744 ' H71' HD11 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.743 ' CD ' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HA ' HG21 ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.801 0.334 . . . . 61.530000000000001 110.886 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -101.77 -169.98 1.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 70.219999999999999 110.861 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 33' ' ' ILE . 73.8 t -47.84 -39.2 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.168 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -52.31 -37.99 57.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 73.400000000000006 110.899 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 1' ' ' MET . 30.7 p -81.18 -22.12 39.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 74.040000000000006 111.12 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.75 HD11 HD23 ' A' ' 71' ' ' LEU . 10.2 mm -79.77 -43.36 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.349999999999994 111.154 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.844 HD13 HD12 ' A' ' 10' ' ' ILE . 27.8 mm -75.36 -25.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.25 111.204 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -51.25 -37.59 47.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.924 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.91 -35.76 50.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 63.409999999999997 110.834 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.844 HD12 HD13 ' A' ' 7' ' ' ILE . 66.0 mt -64.07 -57.86 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 74.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.75 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -53.43 -38.62 63.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 110.922 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.43 -33.5 75.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.16 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -79.17 -42.17 26.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 10' ' ' ILE . 21.8 t -51.2 -47.49 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.129999999999995 111.163 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.64 11.18 67.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 73.25 112.525 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.81 -6.06 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 51.25 111.064 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.4 t -51.26 138.76 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 65.319999999999993 111.089 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 35.1 m-20 -103.83 142.63 24.99 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.556 0.694 . . . . 53.119999999999997 110.908 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -10.78 29.3 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.694 2.262 . . . . 65.120000000000005 112.345 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.45 -35.2 60.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 110.851 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.38 -91.6 0.92 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.817 -0.706 . . . . 62.509999999999998 112.506 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.6 Cg_endo -69.73 -165.97 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.767 2.311 . . . . 62.450000000000003 112.342 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.78 165.75 27.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.9 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -67.07 100.8 0.79 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 110.894 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.797 HG23 HD12 ' A' ' 46' ' ' LEU . 35.9 m -103.46 174.75 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 111.154 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -125.47 136.33 53.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 53.310000000000002 110.87 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.47 -177.97 26.36 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 74.5 112.43 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.78 153.27 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 72.430000000000007 111.176 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.798 ' CE2' HD22 ' A' ' 46' ' ' LEU . 25.0 m-85 -124.94 141.01 52.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.792 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.73 93.34 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 73.099999999999994 110.868 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.828 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 1.3 tp -82.23 130.62 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 65.019999999999996 110.926 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.63 ' N ' HD12 ' A' ' 31' ' ' LEU . 9.0 m-80 -126.73 109.87 12.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 74.200000000000003 110.939 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 HD21 ' A' ' 31' ' ' LEU . 4.8 mp -97.25 131.94 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 111.192 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.98 151.64 41.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 110.883 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -145.16 172.89 12.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.168 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.09 -13.66 59.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 70.239999999999995 111.091 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.71 5.55 14.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.874 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -130.7 4.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.684 -0.77 . . . . 44.130000000000003 112.442 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 p -143.34 141.28 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.835 0.35 . . . . 53.130000000000003 111.172 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -98.73 123.0 42.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.177 -0.465 . . . . 60.43 110.878 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -88.61 152.68 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 75.519999999999996 110.866 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -152.58 150.14 29.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.931 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.85 114.52 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.202 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.514 HG21 ' HD1' ' A' ' 201' ' ' PLM . 1.6 t -115.04 105.76 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.206 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.32 152.28 22.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 64.120000000000005 110.914 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.18 -11.33 12.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.452 . . . . 72.409999999999997 110.879 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 26' ' ' LEU . 17.4 mttt -68.43 -50.08 55.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.409999999999997 110.884 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -111.55 1.54 16.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 72.310000000000002 110.897 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.713 HD11 ' H32' ' A' ' 201' ' ' PLM . 4.4 mm? 59.13 74.1 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 75.099999999999994 110.913 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -141.87 176.46 8.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.877 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.5 p -147.6 141.28 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 111.109 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -141.79 168.72 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.439999999999998 110.887 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -92.81 162.02 14.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.049999999999997 110.913 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 -160.07 36.38 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 61.119999999999997 112.474 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.85 146.73 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 63.32 111.114 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -79.93 156.66 27.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 110.89 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.57 -34.26 36.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 45.140000000000001 111.093 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t -178.65 82.65 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.691 0.757 . . . . 74.329999999999998 110.81 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 141.66 45.67 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.636 2.224 . . . . 73.319999999999993 112.314 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -19.68 63.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 74.409999999999997 110.868 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 97' ' ' LEU . 74.8 t -149.27 146.54 17.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.158 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.21 106.72 11.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.113 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG21 ' HG1' ' A' ' 201' ' ' PLM . 37.8 t -87.16 131.21 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 74.329999999999998 111.099 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.25 107.51 12.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.491 . . . . 73.530000000000001 111.069 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 69' ' ' ASP . 13.8 p -134.63 144.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 72.430000000000007 111.093 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.68 167.22 44.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.719 -0.753 . . . . 73.140000000000001 112.489 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 33' ' ' ILE . 7.2 tp -58.99 -61.87 2.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 52.229999999999997 110.882 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 71' ' ' LEU . 7.2 mt-10 -49.46 -32.88 12.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.129999999999995 110.893 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.7 m-20 -68.73 -46.31 69.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.48 . . . . 71.200000000000003 110.89 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.698 ' HB3' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -69.44 -48.99 59.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.847 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.75 HD23 HD11 ' A' ' 6' ' ' ILE . 5.6 mt -53.32 -39.2 63.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.901 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -57.12 -40.6 77.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 72.120000000000005 111.075 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.2 mt -73.93 -60.14 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.276 -0.42 . . . . 70.439999999999998 111.138 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.542 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -54.25 -26.48 29.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 43.530000000000001 110.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -89.71 20.17 36.85 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.549999999999997 112.425 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.3 OUTLIER 46.37 32.84 1.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.898 0.38 . . . . 72.219999999999999 110.911 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.613 ' O ' HD22 ' A' ' 78' ' ' LEU . 5.3 m -102.61 -28.03 12.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 111.09 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.77 170.09 16.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 64.409999999999997 110.966 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 70.1 p -126.57 151.3 48.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.115 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 105' ' ' ILE . 87.2 t -50.73 -41.66 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 72.019999999999996 111.086 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.45 -40.61 94.55 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.528 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.29 -43.86 63.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 72.209999999999994 110.833 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -64.59 -34.75 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 74.420000000000002 111.12 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.23 -51.86 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 72.409999999999997 110.936 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.07 -47.3 68.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 73.109999999999999 110.908 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.4 -24.35 64.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 73.049999999999997 110.902 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.01 6.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.0 mmtt -76.75 -31.07 56.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 75.340000000000003 110.925 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.585 HD13 ' CD ' ' A' ' 202' ' ' PLM . 2.9 mt -107.2 131.4 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 111.09 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 149.56 21.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.859 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 95' ' ' ALA . 44.4 mt -109.39 122.64 47.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.94 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 110.78 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 62.299999999999997 110.857 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.09 -79.51 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.791 -0.718 . . . . 72.140000000000001 112.497 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.86 99.16 3.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.837 0.351 . . . . 62.130000000000003 110.874 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 91' ' ' LEU . . . -60.11 -29.84 68.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 63.240000000000002 111.105 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -61.42 -54.1 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 71.109999999999999 110.9 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.761 HD12 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.83 -38.75 67.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 53.030000000000001 110.953 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -71.4 -51.21 25.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.340000000000003 111.046 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.98 -35.42 64.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 111.06 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.4 tttp -62.05 -27.76 69.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 72.439999999999998 110.85 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.65 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.4 mt -72.07 -54.82 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 62.450000000000003 110.898 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 80' ' ' VAL . . . -50.27 -30.96 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 111.094 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -32.48 67.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.917 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 101' ' ' LEU . 1.4 p -80.02 -20.46 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 111.136 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 80' ' ' VAL . 66.4 mt -87.27 -30.3 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 74.010000000000005 111.166 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -51.74 103.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.482 . . . . 72.239999999999995 110.87 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -178.44 -171.08 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 74.239999999999995 110.86 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -149.27 156.46 42.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 72.219999999999999 110.852 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.6 m170 57.48 77.16 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 63.420000000000002 110.864 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.75 147.64 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 63.25 110.805 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.867 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.828 ' HG3' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.585 ' CD ' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 61.530000000000001 110.867 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.721 ' HA ' HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -176.57 173.38 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 70.219999999999999 110.852 -179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.557 HG21 ' OE1' ' A' ' 40' ' ' GLU . 75.9 t -52.64 -28.66 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 74.430000000000007 111.158 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -53.75 -35.74 61.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 110.908 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.1 m -81.26 -53.61 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.040000000000006 111.146 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.457 HG21 ' SD ' ' A' ' 70' ' ' MET . 1.9 mp -49.45 -53.95 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.2 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mm -61.59 -50.84 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 70.25 111.161 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -51.78 -36.95 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.918 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.81 -32.22 57.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 63.409999999999997 110.863 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' HG23 ' A' ' 14' ' ' VAL . 53.4 mt -73.01 -56.87 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 74.0 111.107 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.723 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -48.37 -37.22 16.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.949 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.08 91.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 55.240000000000002 111.118 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -75.0 -39.76 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 110.904 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 10' ' ' ILE . 33.9 t -50.77 -47.89 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.12 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.02 12.38 64.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.504 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.23 2.83 9.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 51.25 111.082 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 t -51.68 139.4 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 111.166 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 27.3 m-20 -103.49 145.0 29.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.612 0.72 . . . . 53.119999999999997 110.848 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -9.51 26.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.68 2.253 . . . . 65.120000000000005 112.316 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.24 -33.67 49.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 110.916 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.63 -91.58 0.7 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.477 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.2 Cg_endo -69.75 -167.92 0.25 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.702 2.268 . . . . 62.450000000000003 112.32 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -148.43 167.83 24.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 65.519999999999996 110.885 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 mtmt -46.23 104.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 110.924 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' ARG . 12.4 m -114.18 173.64 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 72.109999999999999 111.187 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 pp -149.18 140.99 23.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 53.310000000000002 110.894 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.19 -171.2 24.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 74.5 112.487 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -148.39 150.65 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.165 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 46' ' ' LEU . 28.2 m-85 -123.5 142.03 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.319999999999993 110.849 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -115.28 95.34 5.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 33' ' ' ILE . 3.0 tp -81.44 128.11 33.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 65.019999999999996 110.879 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.587 ' N ' HD12 ' A' ' 31' ' ' LEU . 12.3 m-80 -126.5 114.32 17.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 110.887 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.687 HD11 HD21 ' A' ' 31' ' ' LEU . 3.5 mp -109.76 131.19 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 72.219999999999999 111.131 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 150.02 42.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 53.340000000000003 110.892 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -143.39 177.46 8.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 74.329999999999998 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.41 -15.2 58.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 70.239999999999995 111.116 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -115.86 16.81 16.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.867 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.65 -129.74 5.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 44.130000000000003 112.398 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.57 140.38 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.323 . . . . 53.130000000000003 111.181 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' OE1' HG21 ' A' ' 3' ' ' VAL . 8.5 pt-20 -101.15 122.85 44.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 60.43 110.851 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -86.25 155.65 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 75.519999999999996 110.936 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -152.92 143.66 22.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.914 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 125.25 73.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 111.125 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.43 104.08 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 111.128 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.9 151.67 24.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.871 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -114.79 -11.7 12.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.861 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -68.81 -49.79 55.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.846 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -111.5 -0.42 16.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.868 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD21 ' O2 ' ' A' ' 201' ' ' PLM . 4.5 mm? 60.25 81.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 110.95 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 179.53 7.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.876 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.3 143.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 74.540000000000006 111.145 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.19 168.23 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 62.439999999999998 110.854 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.61 162.66 13.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.049999999999997 110.887 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.64 -156.31 33.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.71 -0.757 . . . . 61.119999999999997 112.447 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.0 p -120.48 146.78 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 63.32 111.099 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -79.58 157.07 27.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 72.319999999999993 110.845 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.78 -32.03 29.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 45.140000000000001 111.076 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.37 84.48 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.611 0.72 . . . . 74.329999999999998 110.842 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 151.11 68.86 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.624 2.216 . . . . 73.319999999999993 112.371 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.03 -17.74 59.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.786 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 97' ' ' LEU . 89.8 t -150.55 146.27 16.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 33.43 111.179 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.7 108.47 15.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 64.239999999999995 111.167 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.475 HG21 ' HG1' ' A' ' 201' ' ' PLM . 39.1 t -90.43 130.52 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.111 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.6 108.14 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 111.134 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 14.6 p -135.25 131.7 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.145 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.51 166.35 48.82 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.748 -0.739 . . . . 73.140000000000001 112.515 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD12 HG21 ' A' ' 33' ' ' ILE . 5.7 tp -58.54 -62.33 1.93 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 52.229999999999997 110.925 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.621 ' HA ' HD12 ' A' ' 71' ' ' LEU . 16.3 mt-10 -51.54 -42.28 61.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 110.851 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' HG22 ' A' ' 65' ' ' VAL . 80.7 m-20 -52.89 -51.2 62.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.200000000000003 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.457 ' SD ' HG21 ' A' ' 6' ' ' ILE . 1.3 mtt -63.15 -52.43 62.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 110.897 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 ' HA ' ' A' ' 2' ' ' SER . 13.5 mt -50.95 -38.67 51.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 73.329999999999998 110.834 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.59 77.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.273 -0.422 . . . . 72.120000000000005 111.058 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.0 mt -71.73 -61.84 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 70.439999999999998 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.86 -30.91 58.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 43.530000000000001 110.91 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.5 -2.37 59.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.796 -0.716 . . . . 72.549999999999997 112.481 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 4.7 pttt 68.24 7.74 6.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.926 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 p -81.32 -39.48 25.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 111.108 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' THR . 0.3 OUTLIER -127.56 169.66 13.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 64.409999999999997 110.904 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . 21.7 p -129.04 152.79 48.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 73.109999999999999 111.136 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.517 HG13 ' HB1' ' A' ' 202' ' ' PLM . 97.4 t -50.38 -39.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 72.019999999999996 111.169 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.64 -51.11 46.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 72.430000000000007 112.405 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.89 -53.25 49.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.352 . . . . 72.209999999999994 110.892 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.3 -34.61 58.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 111.088 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -59.47 -51.83 68.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 72.409999999999997 110.898 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.99 84.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.899 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -56.62 -24.81 50.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 73.049999999999997 110.896 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.98 26.34 31.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 44.420000000000002 112.533 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -76.85 -33.81 57.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.62 HD13 ' HA1' ' A' ' 202' ' ' PLM . 8.6 mt -99.44 115.21 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 111.105 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -97.97 147.52 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.109999999999999 110.929 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 95' ' ' ALA . 1.8 pp -132.69 135.21 45.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.961 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.4 110.86 13.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 62.299999999999997 110.885 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.47 -84.39 0.32 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 72.140000000000001 112.535 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.07 101.02 4.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 62.130000000000003 110.894 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.492 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -54.24 -25.67 24.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.240000000000002 111.021 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -50.13 66.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 71.109999999999999 110.952 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.747 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -54.84 -40.36 69.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 53.030000000000001 110.969 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -75.16 -51.19 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.073 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.65 -41.57 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 111.105 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -54.3 -28.28 41.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.914 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.84 HD21 ' H62' ' A' ' 201' ' ' PLM . 1.3 mt -74.53 -52.39 12.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 62.450000000000003 110.895 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HB2' ' HD1' ' A' ' 202' ' ' PLM . . . -49.65 -30.31 8.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.1 -0.5 . . . . 64.239999999999995 111.082 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.11 -34.0 59.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 71.400000000000006 110.926 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.2 p -80.64 -20.41 11.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.178 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 53.9 mt -86.05 -39.85 13.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 111.121 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -51.87 122.07 7.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 110.891 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 m80 63.3 82.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.916 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.48 -169.9 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.845 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 33.5 m80 63.19 87.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.902 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -172.81 63.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 63.25 110.81 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 71.209999999999994 110.87 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.84 ' H62' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.62 ' HA1' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.785 0.326 . . . . 61.530000000000001 110.818 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 m -135.14 -169.48 2.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 70.219999999999999 110.892 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.0 t -48.17 -42.71 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.111 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -49.85 -35.09 21.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.13 -0.486 . . . . 73.400000000000006 110.842 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 m -81.51 -32.59 32.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 74.040000000000006 111.14 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.634 HD11 HD23 ' A' ' 71' ' ' LEU . 12.0 mm -71.42 -56.99 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 73.349999999999994 111.137 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.02 HD13 HD12 ' A' ' 10' ' ' ILE . 30.3 mm -61.08 -32.11 51.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.25 111.117 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.88 -38.84 57.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.241 -0.436 . . . . 75.25 110.847 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -32.58 58.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 63.409999999999997 110.903 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.02 HD12 HD13 ' A' ' 7' ' ' ILE . 56.9 mt -67.64 -58.39 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 74.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' HA ' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -52.06 -38.16 56.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.935 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.29 -33.71 75.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.099 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -79.45 -40.57 29.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.814 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 10' ' ' ILE . 28.2 t -50.46 -49.91 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 65.129999999999995 111.158 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.82 12.24 62.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.406 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -122.75 3.57 9.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.338 . . . . 51.25 111.081 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.5 t -51.14 139.68 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 65.319999999999993 111.145 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 29.1 m-20 -103.35 144.62 29.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.638 0.732 . . . . 53.119999999999997 110.812 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -9.52 26.31 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.628 2.219 . . . . 65.120000000000005 112.329 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.09 -33.77 50.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.897 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.39 -91.75 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.75 . . . . 62.509999999999998 112.422 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.3 Cg_endo -69.71 -168.06 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 62.450000000000003 112.362 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -148.66 167.58 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 65.519999999999996 110.906 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.01 111.31 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 110.892 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -121.25 173.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.109999999999999 111.121 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.85 132.31 20.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 53.310000000000002 110.959 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 142.82 -168.11 26.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.803 -0.713 . . . . 74.5 112.495 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -143.73 154.5 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 111.05 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.831 ' CE1' HD22 ' A' ' 46' ' ' LEU . 25.6 m-85 -121.63 141.88 50.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.961 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -119.64 94.18 4.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.899 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.665 HD22 ' CD ' ' A' ' 201' ' ' PLM . 9.6 tp -82.27 129.26 34.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 65.019999999999996 110.902 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' N ' HD12 ' A' ' 31' ' ' LEU . 7.2 m-20 -124.7 133.64 53.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 110.862 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.676 HG21 HD12 ' A' ' 67' ' ' LEU . 4.7 mp -126.89 131.84 70.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 111.147 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -67.53 152.61 45.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 53.340000000000003 110.924 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.54 176.96 9.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.201 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.5 -17.02 56.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 70.239999999999995 111.08 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.35 16.02 15.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.798 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.42 -127.44 4.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 44.130000000000003 112.489 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.7 p -143.21 140.2 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 53.130000000000003 111.103 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -94.93 127.89 41.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 60.43 110.855 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -99.2 144.8 27.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.867 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -143.18 145.35 32.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 73.049999999999997 110.86 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -114.53 119.04 60.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.107 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.99 103.35 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 75.109999999999999 111.129 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.98 153.75 24.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.120000000000005 110.857 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -112.77 -11.15 13.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.947 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -69.43 -50.72 43.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 110.884 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -112.21 -1.32 15.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.992 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.1 mm? 59.46 81.94 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.877 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -179.13 6.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 110.909 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 HG12 ' A' ' 44' ' ' VAL . 47.7 t -146.91 146.98 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 74.540000000000006 111.11 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.24 167.27 29.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.439999999999998 110.856 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 153.79 17.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 63.049999999999997 110.943 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.58 -154.24 23.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.811 -0.709 . . . . 61.119999999999997 112.472 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.88 147.41 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 63.32 111.126 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -77.95 159.63 28.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.869 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.32 -32.91 40.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 45.140000000000001 111.129 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.4 t -177.69 84.68 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 110.787 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 151.3 68.72 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.717 2.278 . . . . 73.319999999999993 112.311 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -70.36 -22.73 62.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.921 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 98' ' ' ALA . 72.1 t -150.32 145.79 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.146 -0.479 . . . . 33.43 111.105 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.53 108.93 15.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.132 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.578 HG21 ' HG1' ' A' ' 201' ' ' PLM . 45.9 t -88.84 129.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 111.12 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -122.63 108.55 13.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 73.530000000000001 111.148 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.9 p -138.91 125.01 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.185 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.77 165.44 14.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 73.140000000000001 112.503 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.676 HD12 HG21 ' A' ' 33' ' ' ILE . 6.2 tp -58.09 -61.37 2.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.825 0.345 . . . . 52.229999999999997 110.956 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -48.56 -47.61 39.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.158 -0.473 . . . . 72.129999999999995 110.94 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' HB2' HG22 ' A' ' 65' ' ' VAL . 73.1 m-20 -51.77 -51.9 52.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 71.200000000000003 110.906 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -57.76 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 74.019999999999996 110.879 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD23 HD11 ' A' ' 6' ' ' ILE . 6.4 mt -49.94 -35.87 25.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 73.329999999999998 110.912 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 78' ' ' LEU . . . -59.43 -51.09 71.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.072 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.604 HG21 ' H71' ' A' ' 202' ' ' PLM . 10.9 mt -71.93 -59.66 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 111.128 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.462 ' CB ' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.01 -22.28 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 43.530000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.43 -0.92 56.22 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.663 -0.779 . . . . 72.549999999999997 112.441 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 69.92 9.11 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 110.86 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.9 t -103.65 -27.9 12.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 71.409999999999997 111.174 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -119.23 169.6 9.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 64.409999999999997 110.91 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.558 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -130.87 159.29 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.678 HG13 ' HC2' ' A' ' 202' ' ' PLM . 46.0 t -56.35 -53.23 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.019999999999996 111.089 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -34.93 61.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.762 -0.733 . . . . 72.430000000000007 112.494 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.63 -50.62 72.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.864 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -71.58 -44.62 64.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 74.420000000000002 111.071 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.7 -49.65 64.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.893 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.71 -29.3 17.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.849 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -91.73 -27.6 17.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 73.049999999999997 110.908 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.19 43.92 3.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 44.420000000000002 112.45 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -80.6 -33.32 36.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.909 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.678 HD13 ' CC ' ' A' ' 202' ' ' PLM . 5.1 mt -96.77 129.22 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 111.134 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -93.26 149.4 21.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.87 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD13 ' CB ' ' A' ' 95' ' ' ALA . 14.0 mt -112.89 122.75 48.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.971 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.89 111.0 11.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 62.299999999999997 110.818 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.19 -84.61 0.37 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.677 -0.773 . . . . 72.140000000000001 112.472 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.66 96.53 3.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.899 0.381 . . . . 62.130000000000003 110.897 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.479 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -55.01 -29.72 57.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 63.240000000000002 111.07 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.26 -49.49 75.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 71.109999999999999 110.848 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.539 ' CB ' HG21 ' A' ' 61' ' ' VAL . 1.9 mt -58.61 -48.03 82.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 53.030000000000001 111.038 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.747 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -66.86 -35.72 80.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.141 -0.481 . . . . 74.340000000000003 111.05 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.05 88.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 64.450000000000003 111.133 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -57.55 -33.33 68.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.439999999999998 110.887 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.0 mt -57.97 -55.39 35.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.277 -0.419 . . . . 62.450000000000003 110.801 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB2' ' HD1' ' A' ' 202' ' ' PLM . . . -50.13 -30.69 11.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.415 . . . . 64.239999999999995 111.129 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -48.07 67.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.435 . . . . 71.400000000000006 110.923 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 101' ' ' LEU . 3.9 p -64.48 -19.96 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.135 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.55 HD13 ' C8 ' ' A' ' 202' ' ' PLM . 23.5 mt -79.04 -42.2 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.151 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -51.56 103.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 72.239999999999995 110.894 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -173.77 118.97 0.28 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 110.792 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 52.7 33.75 14.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 72.219999999999999 110.801 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.93 149.58 29.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 110.867 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -55.66 101.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 63.25 110.773 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 71.209999999999994 110.845 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.665 ' CD ' HD22 ' A' ' 31' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.732 ' HD1' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.55 ' HG3' HD22 ' A' ' 71' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.526 0.043 0 CA-C-O 120.793 0.33 . . . . 61.530000000000001 110.801 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.426 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.8 m -153.87 171.33 19.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 110.88 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -50.77 -27.96 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.186 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -57.04 -56.25 24.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 73.400000000000006 110.84 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 m -61.55 -17.88 56.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.040000000000006 111.208 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.8 mp -82.93 -46.94 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 111.137 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.568 HD13 HD12 ' A' ' 10' ' ' ILE . 45.5 mm -77.09 -30.68 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.25 111.083 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.45 -32.85 70.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -76.26 -31.97 58.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 63.409999999999997 110.856 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 14' ' ' VAL . 56.0 mt -70.63 -57.62 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.0 111.146 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.59 -33.3 32.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.219999999999999 110.905 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.78 56.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 55.240000000000002 111.194 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -78.73 -50.26 11.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.828 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.1 m -52.18 -42.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 65.129999999999995 111.109 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.08 0.73 82.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.711 -0.757 . . . . 73.25 112.456 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.47 -8.62 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.868 0.366 . . . . 51.25 111.106 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -50.96 129.2 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.171 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 75.3 m-20 -104.2 144.34 28.49 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.588 0.708 . . . . 53.119999999999997 110.867 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -11.56 31.09 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.644 2.23 . . . . 65.120000000000005 112.365 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -36.44 64.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.438 . . . . 64.430000000000007 110.901 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -87.83 -90.36 1.07 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 62.509999999999998 112.505 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 53.8 Cg_endo -69.76 -168.06 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.699 2.266 . . . . 62.450000000000003 112.335 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 mmt-85 -139.25 163.71 31.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 65.519999999999996 110.81 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -71.62 99.63 2.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 71.129999999999995 110.849 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.792 HG23 HD12 ' A' ' 46' ' ' LEU . 27.5 m -98.74 174.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 111.167 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -126.09 134.12 51.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 53.310000000000002 110.89 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.21 -179.62 25.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.471 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.0 t -145.93 154.8 12.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.914 0.388 . . . . 72.430000000000007 111.097 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE1' HD22 ' A' ' 46' ' ' LEU . 23.8 m-85 -124.84 140.2 53.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.872 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -113.93 93.69 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.866 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 33' ' ' ILE . 14.3 tp -82.42 128.63 34.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 65.019999999999996 110.912 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -127.16 108.35 10.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 110.856 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.68 HG21 HD12 ' A' ' 67' ' ' LEU . 4.3 mp -97.22 134.66 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 111.148 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -72.46 152.89 41.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 53.340000000000003 110.898 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -145.42 172.3 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -14.77 59.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 70.239999999999995 111.105 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -115.96 8.05 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.808 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.47 -130.94 4.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 44.130000000000003 112.455 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.44 139.23 26.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 53.130000000000003 111.181 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -97.45 125.3 42.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 60.43 110.891 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.8 152.68 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 75.519999999999996 110.903 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -151.85 150.21 29.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.877 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.01 114.62 44.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 73.120000000000005 111.116 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.43 104.62 17.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 111.123 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.08 151.3 23.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.486 . . . . 64.120000000000005 110.812 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.792 HD12 HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -112.52 -16.1 12.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.917 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -64.68 -49.67 70.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.959 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -110.79 -1.56 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 110.905 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mm? 59.29 73.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 75.099999999999994 110.951 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -178.32 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 73.120000000000005 110.949 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 t -145.48 148.41 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 74.540000000000006 111.119 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.87 167.43 25.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.102 -0.499 . . . . 62.439999999999998 110.839 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.86 156.54 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 63.049999999999997 110.909 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.96 -154.33 26.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.743 -0.742 . . . . 61.119999999999997 112.501 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.8 147.07 28.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 63.32 111.125 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -78.6 159.18 28.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.863 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.21 -31.34 42.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 45.140000000000001 111.073 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -177.98 84.38 0.23 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.651 0.738 . . . . 74.329999999999998 110.865 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 144.68 54.8 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.266 . . . . 73.319999999999993 112.371 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -17.78 64.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 110.863 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 98' ' ' ALA . 78.7 t -150.81 145.99 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 33.43 111.039 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 115.42 23.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.103 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.588 HG21 ' HG1' ' A' ' 201' ' ' PLM . 25.6 t -99.47 127.21 52.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.071 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 107.95 14.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 111.201 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 69' ' ' ASP . 7.1 p -133.83 157.63 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 111.107 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -93.64 163.53 26.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.782 -0.723 . . . . 73.140000000000001 112.543 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD12 HG21 ' A' ' 33' ' ' ILE . 6.6 tp -55.67 -62.42 1.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.693 0.282 . . . . 52.229999999999997 110.945 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 mt-10 -50.93 -42.09 59.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.905 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB2' HG22 ' A' ' 65' ' ' VAL . 60.2 m-20 -53.92 -51.65 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.848 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.7 mtp -68.81 -47.99 64.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 74.019999999999996 110.842 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.55 HD22 ' HG3' ' A' ' 1' ' ' MET . 13.3 mt -52.06 -37.79 54.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.962 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.564 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -60.47 -41.61 94.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 111.081 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 80' ' ' VAL . 7.4 mt -69.06 -64.29 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 111.133 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.0 t -54.97 -28.45 51.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.872 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' THR . . . -80.73 14.25 25.96 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 72.549999999999997 112.497 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' CG ' ' O ' ' A' ' 75' ' ' GLY . 0.6 OUTLIER 48.01 31.19 2.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.882 0.373 . . . . 72.219999999999999 110.923 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.63 HG23 ' O ' ' A' ' 75' ' ' GLY . 30.2 p -105.88 -33.36 7.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 111.174 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -130.91 169.28 15.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 64.409999999999997 110.883 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.494 ' O ' HD23 ' A' ' 78' ' ' LEU . 66.4 p -121.48 148.61 44.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 73.109999999999999 111.075 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.429 HG22 HD13 ' A' ' 73' ' ' ILE . 98.9 t -51.56 -41.17 26.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 72.019999999999996 111.111 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.81 -45.2 93.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 72.430000000000007 112.451 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -50.91 68.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 72.209999999999994 110.896 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -56.85 -34.69 68.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.420000000000002 111.055 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -51.64 67.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 72.409999999999997 110.904 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -47.15 66.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.891 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.049999999999997 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 44.84 6.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 44.420000000000002 112.523 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.4 mmtt -76.72 -32.9 58.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.747 0.308 . . . . 75.340000000000003 110.845 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.517 HD13 ' HC2' ' A' ' 202' ' ' PLM . 2.1 mt -105.87 130.64 57.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.077 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.99 149.39 21.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.903 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.66 HD13 ' CB ' ' A' ' 95' ' ' ALA . 59.4 mt -109.28 123.06 48.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.955 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.56 110.89 8.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 62.299999999999997 110.853 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.8 -83.02 0.31 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.140000000000001 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.2 98.46 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.782 0.325 . . . . 62.130000000000003 110.86 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.66 ' CB ' HD13 ' A' ' 91' ' ' LEU . . . -58.55 -23.7 58.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.131 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -67.54 -53.87 24.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.109999999999999 110.849 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.733 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.2 OUTLIER -54.63 -42.78 71.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 53.030000000000001 110.947 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.71 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -72.86 -42.66 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.099 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.68 -44.34 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.450000000000003 111.034 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -52.84 -39.6 62.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 72.439999999999998 110.937 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.492 HD23 ' H51' ' A' ' 201' ' ' PLM . 1.4 mt -54.77 -55.49 29.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.909 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.537 ' HB2' ' CD ' ' A' ' 202' ' ' PLM . . . -50.28 -41.86 51.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 64.239999999999995 111.077 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.85 -34.23 72.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 71.400000000000006 110.868 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 100' ' ' LYS . 3.0 t -77.34 -26.35 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.099999999999994 111.112 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 102' ' ' ALA . 72.3 mt -60.5 -29.28 44.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 74.010000000000005 111.095 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -61.87 95.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 72.239999999999995 110.82 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.36 -170.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 110.856 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -104.09 156.08 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 72.219999999999999 110.846 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -170.06 -170.11 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 63.420000000000002 110.875 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 68.9 t60 63.24 104.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 63.25 110.908 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 71.209999999999994 110.801 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.588 ' HG1' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.537 ' CD ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.761 0.315 . . . . 61.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -116.86 -170.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 110.891 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.09 -31.76 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.103 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -59.74 -48.5 81.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 73.400000000000006 110.871 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -21.07 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 111.12 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.778 HD11 HD23 ' A' ' 71' ' ' LEU . 20.7 mm -77.74 -49.22 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 111.095 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.787 HD13 HD12 ' A' ' 10' ' ' ILE . 31.7 mm -71.21 -32.26 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 70.25 111.117 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.7 -31.23 62.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.87 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.44 -33.0 58.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 63.409999999999997 110.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.787 HD12 HD13 ' A' ' 7' ' ' ILE . 55.3 mt -67.59 -56.75 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.164 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -53.06 -34.82 58.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.898 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.89 -36.31 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.076 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -74.35 -52.93 10.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 110.886 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.2 m -51.77 -47.0 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 65.129999999999995 111.126 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.57 -0.95 75.07 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.751 -0.737 . . . . 73.25 112.484 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.74 -5.18 15.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 51.25 111.077 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 t -50.24 137.24 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 65.319999999999993 111.155 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 32.5 m-20 -103.53 143.84 27.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.541 0.686 . . . . 53.119999999999997 110.903 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -11.52 31.06 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.705 2.27 . . . . 65.120000000000005 112.345 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.27 -35.89 63.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.430000000000007 110.935 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.46 -91.12 0.94 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.717 -0.754 . . . . 62.509999999999998 112.464 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.5 Cg_endo -69.73 -166.9 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.715 2.277 . . . . 62.450000000000003 112.385 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -142.26 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.875 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -66.87 100.16 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 71.129999999999995 110.862 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.77 HG23 HD12 ' A' ' 46' ' ' LEU . 30.6 m -101.42 173.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.109999999999999 111.095 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.88 138.6 53.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 53.310000000000002 110.919 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 142.59 -178.53 20.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.523 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.5 144.53 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 72.430000000000007 111.12 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.786 ' HB2' HG23 ' A' ' 44' ' ' VAL . 22.6 m-85 -112.25 144.8 41.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.854 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -122.46 95.16 4.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.099999999999994 110.901 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 201' ' ' PLM . 16.5 tp -84.14 132.36 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 65.019999999999996 110.918 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -125.55 109.77 13.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.895 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 ' CG2' HD12 ' A' ' 67' ' ' LEU . 4.3 mp -99.06 136.78 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 111.128 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -80.46 146.66 31.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 53.340000000000003 110.927 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.16 164.89 31.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 74.329999999999998 111.141 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.67 -13.62 44.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 70.239999999999995 111.129 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 23.58 13.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 74.340000000000003 110.907 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.24 -124.98 6.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 44.130000000000003 112.479 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -140.95 139.71 33.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 53.130000000000003 111.105 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -99.79 122.19 42.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.843 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -86.5 151.36 23.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.834 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -152.46 143.69 23.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 73.049999999999997 110.94 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.26 122.98 69.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 111.109 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.798 HG12 HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -127.84 103.4 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.159 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.26 154.69 27.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.9 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.77 HD12 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -112.72 -11.33 13.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 110.964 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -69.41 -51.06 40.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 110.876 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.69 -1.12 15.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.918 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD11 ' H32' ' A' ' 201' ' ' PLM . 4.2 mm? 59.61 80.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 75.099999999999994 110.886 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 -179.57 6.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 73.120000000000005 110.885 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.798 HG22 HG12 ' A' ' 44' ' ' VAL . 21.4 t -146.83 147.31 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 74.540000000000006 111.123 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.74 166.15 32.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 62.439999999999998 110.844 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -93.15 161.78 14.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 63.049999999999997 110.893 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.41 -156.14 33.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 61.119999999999997 112.459 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.35 144.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 63.32 111.121 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.08 152.82 36.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 72.319999999999993 110.859 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.09 -28.16 23.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 45.140000000000001 111.148 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 t -178.34 83.19 0.23 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.705 0.764 . . . . 74.329999999999998 110.893 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 144.08 52.83 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.657 2.238 . . . . 73.319999999999993 112.377 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -61.94 -24.86 67.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.846 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 97' ' ' LEU . 97.1 t -150.86 148.7 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 33.43 111.146 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.49 110.76 17.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.125 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG21 ' HG1' ' A' ' 201' ' ' PLM . 58.2 t -94.73 133.93 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.329999999999998 111.138 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -122.23 108.38 13.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 73.530000000000001 111.16 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 11.5 p -138.88 135.73 42.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 111.097 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 167.16 54.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 73.140000000000001 112.484 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' HG ' HD11 ' A' ' 71' ' ' LEU . 7.2 tp -54.64 -61.61 2.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.8 0.334 . . . . 52.229999999999997 110.945 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -49.2 -53.65 20.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 110.89 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -50.86 -50.44 56.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 71.200000000000003 110.836 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -58.83 6.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.019999999999996 110.796 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 HD11 ' A' ' 6' ' ' ILE . 6.3 mt -49.46 -35.33 19.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 73.329999999999998 110.89 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.83 -54.17 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.123 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.72 HG21 HG22 ' A' ' 80' ' ' VAL . 13.6 mt -71.66 -60.22 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 70.439999999999998 111.08 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -54.98 -32.26 61.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 43.530000000000001 110.83 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.43 -1.16 60.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.77 -0.729 . . . . 72.549999999999997 112.495 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm 66.75 11.45 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 72.219999999999999 110.939 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -83.68 -40.29 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -123.15 167.84 13.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 64.409999999999997 110.926 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.583 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -102.83 156.16 17.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 73.109999999999999 111.101 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 73' ' ' ILE . 83.8 t -66.94 -42.6 89.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 72.019999999999996 111.14 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.25 -39.16 58.08 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 72.430000000000007 112.477 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.688 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -61.56 -57.09 13.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.89 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.721 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -59.49 -34.89 73.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 111.086 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -51.81 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 110.929 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.59 -41.49 63.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 110.88 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -79.1 -18.58 53.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.049999999999997 110.871 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.87 45.33 7.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.732 -0.747 . . . . 44.420000000000002 112.459 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.721 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 8.3 mmpt? -79.02 -31.75 44.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.697 0.284 . . . . 75.340000000000003 110.893 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.769 HD13 ' HC2' ' A' ' 202' ' ' PLM . 4.4 mt -104.04 125.19 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 73.310000000000002 111.148 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -102.2 148.89 24.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.916 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 95' ' ' ALA . 1.6 pp -132.23 140.11 48.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 71.230000000000004 110.933 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.88 110.36 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 62.299999999999997 110.864 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.86 -82.89 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 72.140000000000001 112.519 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.82 106.12 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 62.130000000000003 110.802 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . . . -62.33 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.096 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -65.63 -44.72 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.254 -0.43 . . . . 71.109999999999999 110.841 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -59.96 -48.27 82.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 53.030000000000001 110.906 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.3 -40.32 74.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 111.124 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.35 88.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 64.450000000000003 111.045 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -52.71 -38.94 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.908 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.819 HD21 ' H71' ' A' ' 201' ' ' PLM . 1.5 mt -56.71 -50.83 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 62.450000000000003 110.981 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -49.15 -29.79 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 64.239999999999995 111.108 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -59.48 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.933 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.42 -24.3 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 74.099999999999994 111.151 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 102' ' ' ALA . 17.7 mt -54.76 -31.82 24.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.010000000000005 111.106 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -52.05 -58.86 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 110.768 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.34 -170.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.833 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -75.81 -71.48 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.837 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -176.37 -68.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 63.420000000000002 110.907 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.79 163.84 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 63.25 110.817 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.209999999999994 110.837 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.819 ' H71' HD21 ' A' ' 101' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.769 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' H3 ' ' CB ' ' A' ' 5' ' ' THR . 3.0 ttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.748 0.308 . . . . 61.530000000000001 110.86 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 65.3 179.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 70.219999999999999 110.875 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 33' ' ' ILE . 4.9 p -48.49 -30.92 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.097 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.61 -45.36 63.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 110.875 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.461 ' CB ' ' H3 ' ' A' ' 1' ' ' MET . 61.6 m -76.97 -33.6 57.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 74.040000000000006 111.154 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.767 HG21 ' CG ' ' A' ' 70' ' ' MET . 6.9 mm -63.91 -48.27 86.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 73.349999999999994 111.121 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 10' ' ' ILE . 34.2 mm -67.62 -28.04 40.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.25 111.139 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -35.46 73.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 75.25 110.888 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -71.32 -32.67 68.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 110.834 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.825 ' O ' HG22 ' A' ' 14' ' ' VAL . 36.0 mt -66.85 -57.03 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 74.0 111.12 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HB3' HG11 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -51.0 -36.15 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.961 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.7 62.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 55.240000000000002 111.089 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -79.09 -53.23 7.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.872 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 10' ' ' ILE . 1.4 m -52.34 -41.58 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 65.129999999999995 111.165 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.51 -1.16 81.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.699 -0.762 . . . . 73.25 112.48 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.14 -6.52 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 51.25 111.121 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -50.46 129.05 8.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 111.082 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m-20 -104.4 143.77 27.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.561 0.696 . . . . 53.119999999999997 110.886 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -11.62 31.3 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.749 2.3 . . . . 65.120000000000005 112.323 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.81 -36.44 64.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 64.430000000000007 110.93 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.05 -90.91 0.91 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.65 -0.786 . . . . 62.509999999999998 112.463 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.2 Cg_endo -69.75 -166.68 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.69 2.26 . . . . 62.450000000000003 112.328 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -140.93 164.11 31.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 65.519999999999996 110.846 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -68.66 99.99 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.921 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.747 HG23 HD12 ' A' ' 46' ' ' LEU . 18.0 m -100.89 174.36 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 72.109999999999999 111.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.32 130.88 50.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.085 -0.507 . . . . 53.310000000000002 110.98 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 149.37 178.58 24.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.666 -0.778 . . . . 74.5 112.405 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG21 ' CE1' ' A' ' 56' ' ' PHE . 2.0 t -144.72 153.8 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 72.430000000000007 111.162 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.81 ' CE1' HD22 ' A' ' 46' ' ' LEU . 24.7 m-85 -122.91 134.28 54.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.868 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.448 ' HB3' HG22 ' A' ' 62' ' ' THR . 0.4 OUTLIER -104.72 96.79 6.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 73.099999999999994 110.912 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.855 HD11 ' HE2' ' A' ' 70' ' ' MET . 1.1 tt -83.78 128.67 34.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 65.019999999999996 110.893 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' HD23 ' A' ' 31' ' ' LEU . 7.4 m-80 -127.53 108.64 10.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.891 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD12 ' A' ' 67' ' ' LEU . 4.6 mp -100.81 131.71 47.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 72.219999999999999 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 152.21 35.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 53.340000000000003 110.854 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -144.75 176.93 9.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.87 -14.13 59.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.029 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.93 13.96 16.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.340000000000003 110.832 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 134.73 -131.84 6.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.751 . . . . 44.130000000000003 112.503 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -142.21 137.75 29.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.744 0.307 . . . . 53.130000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -95.14 120.19 34.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 60.43 110.905 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -86.79 139.75 30.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 75.519999999999996 110.928 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 31' ' ' LEU . 94.1 m95 -144.65 153.79 42.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 73.049999999999997 110.949 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 54' ' ' GLY . 2.3 mp -128.89 126.15 64.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.115 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.802 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -124.4 102.73 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 75.109999999999999 111.178 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.83 156.15 27.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.871 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.81 HD22 ' CE1' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -115.71 -12.39 11.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.409999999999997 110.937 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -68.67 -50.48 50.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.932 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 49' ' ' LEU . 38.5 mt-30 -110.63 -1.05 16.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 72.310000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 49' ' ' LEU . 1.9 mm? 59.84 69.5 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 75.099999999999994 110.87 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -134.31 -179.73 5.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.88 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.7 p -147.08 141.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 111.129 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -143.75 168.87 18.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.244 -0.434 . . . . 62.439999999999998 110.787 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -96.54 162.47 13.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 63.049999999999997 110.928 -179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.436 ' C ' HD11 ' A' ' 43' ' ' ILE . . . 83.51 -155.5 32.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.79 -0.719 . . . . 61.119999999999997 112.519 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.17 146.56 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 63.32 111.096 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 28' ' ' VAL . 20.3 t80 -79.07 150.96 31.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.956 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.75 -32.85 14.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 45.140000000000001 111.172 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.31 82.99 0.23 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.61 0.719 . . . . 74.329999999999998 110.843 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 150.9 68.71 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.685 2.257 . . . . 73.319999999999993 112.346 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -70.96 -23.43 62.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.822 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG11 ' HB2' ' A' ' 98' ' ' ALA . 63.8 t -151.53 143.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 33.43 111.074 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -110.96 115.97 30.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 111.139 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG21 ' CG ' ' A' ' 201' ' ' PLM . 84.2 t -100.83 129.94 50.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 74.329999999999998 111.146 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.98 107.47 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 73.530000000000001 111.144 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.748 HG22 ' HA ' ' A' ' 89' ' ' ILE . 66.2 t -129.49 141.05 47.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 111.163 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.85 167.16 54.91 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.671 -0.776 . . . . 73.140000000000001 112.492 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 33' ' ' ILE . 4.7 tp -65.08 -50.81 64.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.905 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.87 -57.32 7.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' OD1' HG13 ' A' ' 65' ' ' VAL . 15.6 t0 -52.06 -49.17 64.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.861 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.855 ' HE2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -52.45 -54.21 35.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.895 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.574 HD23 HD11 ' A' ' 6' ' ' ILE . 5.5 mt -59.87 -33.43 71.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 110.869 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.28 -54.78 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 111.103 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.623 HD12 ' H72' ' A' ' 202' ' ' PLM . 11.7 mt -68.62 -61.87 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 70.439999999999998 111.149 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.682 ' CB ' HG23 ' A' ' 6' ' ' ILE . 3.8 t -56.1 -24.55 41.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 43.530000000000001 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.74 2.51 73.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.766 -0.73 . . . . 72.549999999999997 112.448 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.9 mttt 65.64 12.36 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 72.219999999999999 110.891 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.1 p -90.83 -36.95 13.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.185 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 79' ' ' THR . 0.5 OUTLIER -122.01 169.26 11.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.962 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 78' ' ' LEU . 33.7 p -118.21 148.98 41.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.115 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.6 t -51.45 -43.11 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 72.019999999999996 111.135 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.01 94.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 72.430000000000007 112.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -53.83 53.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.835 0.35 . . . . 72.209999999999994 110.834 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -61.37 -34.78 75.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 111.144 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.634 HD22 HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.83 -51.93 59.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.955 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.32 86.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.894 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -62.56 -18.74 62.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 73.049999999999997 110.936 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.71 37.94 18.22 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.711 -0.757 . . . . 44.420000000000002 112.534 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 4.5 mmpt? -76.85 -33.57 57.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 75.340000000000003 110.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.748 ' HA ' HG22 ' A' ' 65' ' ' VAL . 4.4 mt -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 111.066 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.79 146.48 23.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 73.109999999999999 110.868 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD21 ' CG ' ' A' ' 202' ' ' PLM . 16.6 mt -122.68 122.74 39.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.987 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.75 110.93 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.299999999999997 110.868 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.43 -82.83 0.34 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 72.140000000000001 112.511 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.14 98.66 4.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.852 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.77 -28.23 55.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 63.240000000000002 111.098 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.18 -50.37 68.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.548 ' HB3' HG21 ' A' ' 61' ' ' VAL . 1.5 mt -55.97 -47.92 76.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 53.030000000000001 110.951 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -70.76 -28.78 64.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.340000000000003 111.099 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.433 ' HA ' ' HF2' ' A' ' 202' ' ' PLM . . . -63.99 -44.54 92.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.145 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.83 -34.1 65.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.897 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.586 ' O ' HG12 ' A' ' 104' ' ' VAL . 1.5 mt -56.05 -55.19 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.818 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.734 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -50.23 -29.87 10.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 64.239999999999995 111.046 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.14 -56.64 19.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.400000000000006 110.892 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 101' ' ' LEU . 2.7 p -59.91 -19.85 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 74.099999999999994 111.079 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.734 HD12 ' HA ' ' A' ' 102' ' ' ALA . 80.4 mt -79.55 -35.45 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 111.154 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -169.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.863 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 101.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 74.239999999999995 110.828 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.47 37.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 72.219999999999999 110.835 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -53.8 155.07 3.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.194 -0.457 . . . . 63.420000000000002 110.846 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -175.15 40.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 63.25 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.843 179.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.609 ' CG ' HG21 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.623 ' H72' HD12 ' A' ' 73' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mtm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 61.530000000000001 110.852 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.512 ' CA ' HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -172.98 179.06 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 70.219999999999999 110.813 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.0 m -63.84 -28.51 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 74.430000000000007 111.173 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -45.49 -36.78 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 73.400000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.38 -41.1 22.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 111.17 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' HA ' ' A' ' 71' ' ' LEU . 1.9 mp -63.62 -55.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 73.349999999999994 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' HA ' HD12 ' A' ' 10' ' ' ILE . 47.1 mm -59.67 -32.61 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.102 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -67.67 -37.64 82.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.881 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -32.7 69.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 63.409999999999997 110.868 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' HG22 ' A' ' 14' ' ' VAL . 48.2 mt -71.2 -55.35 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 74.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HB3' HG11 ' A' ' 51' ' ' VAL . 5.3 ptpt -49.45 -36.24 21.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.896 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.22 65.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 55.240000000000002 111.124 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -70.28 -52.75 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 110.873 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 10' ' ' ILE . 3.6 m -51.17 -47.13 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 65.129999999999995 111.161 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.7 0.06 72.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.25 112.436 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.24 -1.36 13.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 51.25 111.044 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.1 t -51.3 137.83 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 65.319999999999993 111.155 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 18.8 m-20 -103.65 145.33 30.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.629 0.728 . . . . 53.119999999999997 110.86 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -9.86 27.16 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.684 2.256 . . . . 65.120000000000005 112.362 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.29 -34.62 55.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.839 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.89 -91.37 0.65 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.726 -0.75 . . . . 62.509999999999998 112.491 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 18' ' ' ASP . 54.3 Cg_endo -69.76 -167.92 0.25 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.701 2.268 . . . . 62.450000000000003 112.363 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.7 mmt-85 -147.78 167.02 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 65.519999999999996 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -46.74 104.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 110.923 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.4 m -113.48 173.53 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.11 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.54 142.55 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 53.310000000000002 110.854 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.7 -176.43 21.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.523 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.6 t -148.9 150.03 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.865 0.364 . . . . 72.430000000000007 111.094 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 46' ' ' LEU . 29.1 m-85 -119.73 140.34 50.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 110.904 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -112.63 95.1 5.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 110.878 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.732 HD11 ' CE ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -81.1 126.7 31.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 65.019999999999996 110.935 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' N ' HD23 ' A' ' 31' ' ' LEU . 5.6 m-80 -125.29 107.95 11.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.873 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 67' ' ' LEU . 4.1 mp -105.21 135.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 72.219999999999999 111.129 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 146.57 31.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 53.340000000000003 110.877 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.57 165.96 28.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 111.201 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -12.2 41.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 70.239999999999995 111.132 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.96 23.61 12.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.905 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.85 -127.32 7.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 44.130000000000003 112.488 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 p -141.19 142.1 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.802 0.334 . . . . 53.130000000000003 111.161 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -102.84 127.54 49.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 60.43 110.936 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -97.44 151.96 19.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.938 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -151.57 144.69 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.049999999999997 110.941 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 mp -114.9 112.93 42.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 73.120000000000005 111.135 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 t -110.65 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.137 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.09 151.29 25.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 110.885 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.781 HD22 ' CE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -113.31 -13.03 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.453 . . . . 72.409999999999997 110.848 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -67.05 -50.26 62.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.875 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -111.42 0.06 16.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 72.310000000000002 110.912 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.613 HD11 ' C1 ' ' A' ' 201' ' ' PLM . 3.6 mm? 59.84 77.11 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.902 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.86 -179.09 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 73.120000000000005 110.854 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.557 HG11 ' HB3' ' A' ' 11' ' ' LYS . 2.8 p -148.11 144.23 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 74.540000000000006 111.107 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.1 168.21 20.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.887 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -94.67 162.48 13.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.049999999999997 110.85 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.39 -160.12 41.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.798 -0.715 . . . . 61.119999999999997 112.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.76 139.68 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.827 0.346 . . . . 63.32 111.151 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -69.61 158.59 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.866 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.51 -30.31 62.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.075 -0.511 . . . . 45.140000000000001 111.041 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.05 81.89 0.23 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 74.329999999999998 110.775 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 150.67 68.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.354 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -15.92 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 74.409999999999997 110.824 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 98' ' ' ALA . 97.5 t -150.3 148.61 15.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 33.43 111.09 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.88 104.94 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 64.239999999999995 111.16 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 201' ' ' PLM . 86.4 t -96.24 125.13 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.149 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 96.0 m -122.65 118.53 28.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 73.530000000000001 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG11 ' SD ' ' A' ' 70' ' ' MET . 7.4 p -141.01 124.45 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 72.430000000000007 111.127 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.55 168.41 1.27 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.744 . . . . 73.140000000000001 112.514 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.728 HD12 HG21 ' A' ' 33' ' ' ILE . 4.0 tp -62.4 -63.11 1.33 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.762 0.315 . . . . 52.229999999999997 110.862 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.555 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.4 mt-10 -54.49 -44.81 73.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 72.129999999999995 110.869 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -52.58 -50.29 63.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 71.200000000000003 110.843 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.732 ' CE ' HD11 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -69.08 -47.48 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.863 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 68' ' ' GLU . 9.5 mt -53.35 -36.04 60.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 110.965 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -64.68 -28.66 69.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 111.105 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.658 HD13 HG22 ' A' ' 80' ' ' VAL . 4.7 mt -71.12 -64.34 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 70.439999999999998 111.163 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 p -68.97 -16.64 63.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 43.530000000000001 110.875 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.13 -3.43 56.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.737 -0.744 . . . . 72.549999999999997 112.458 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.03 7.49 5.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.847 0.356 . . . . 72.219999999999999 110.951 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.598 ' O ' HD22 ' A' ' 78' ' ' LEU . 14.5 t -92.35 -28.6 16.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.133 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -144.22 169.03 18.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 64.409999999999997 110.961 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 HG22 ' ND1' ' A' ' 107' ' ' HIS . 17.5 p -123.14 153.86 39.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.155 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 73' ' ' ILE . 45.6 t -51.35 -37.19 18.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.019999999999996 111.096 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.7 -48.94 55.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 72.430000000000007 112.527 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -51.05 68.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.788 0.328 . . . . 72.209999999999994 110.841 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.46 -34.98 62.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.615 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -63.67 -51.89 63.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.293 -0.412 . . . . 72.409999999999997 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -46.38 73.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 110.934 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.15 -30.15 70.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 73.049999999999997 110.883 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.52 35.93 7.68 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 44.420000000000002 112.458 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -87.42 -33.23 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.75 0.309 . . . . 75.340000000000003 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.615 HD12 ' CD2' ' A' ' 84' ' ' LEU . 16.2 mt -88.12 121.27 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 73.310000000000002 111.077 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -99.58 146.19 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 73.109999999999999 110.915 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.668 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.9 pp -133.98 135.52 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.230000000000004 110.943 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.9 110.84 11.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 62.299999999999997 110.82 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.77 -87.71 0.31 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.685 -0.769 . . . . 72.140000000000001 112.466 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.97 94.17 3.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.772 0.32 . . . . 62.130000000000003 110.849 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.668 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -54.11 -27.43 33.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 111.077 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.67 -41.09 92.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.844 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 61' ' ' VAL . 2.6 mt -63.76 -49.07 74.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 53.030000000000001 110.882 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -68.49 -51.02 47.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.088 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.5 49.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 64.450000000000003 111.078 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -52.7 -50.84 62.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 110.939 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.628 HD11 ' H71' ' A' ' 201' ' ' PLM . 0.4 OUTLIER -54.83 -41.45 70.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 62.450000000000003 110.904 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.684 ' HB2' ' CE ' ' A' ' 202' ' ' PLM . . . -54.36 -30.33 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.239999999999995 111.101 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -61.13 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.854 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.7 m -53.07 -25.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 111.042 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 61.4 mt -71.98 -52.47 24.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.17 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 52.22 -169.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 110.905 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' ND1' HG22 ' A' ' 79' ' ' THR . 2.9 t60 -79.92 -49.98 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 74.239999999999995 110.898 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.03 157.44 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 110.846 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -123.39 179.11 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 63.420000000000002 110.888 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -116.92 -63.38 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 63.25 110.914 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 71.209999999999994 110.836 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.638 ' H91' HG23 ' A' ' 10' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.684 ' CE ' ' HB2' ' A' ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.356 . . . . 61.530000000000001 110.868 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 t -118.75 -172.08 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 70.219999999999999 110.83 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.5 p -50.3 -29.06 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 74.430000000000007 111.135 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -60.44 -36.11 77.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.905 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.1 -30.43 34.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.040000000000006 111.108 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.827 HD11 HD23 ' A' ' 71' ' ' LEU . 6.3 mm -72.8 -50.96 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 111.068 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 ' HA ' HD12 ' A' ' 10' ' ' ILE . 35.3 mm -67.22 -35.86 75.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 70.25 111.133 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -52.19 -38.9 59.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 75.25 110.824 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.23 -32.71 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 63.409999999999997 110.852 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 14' ' ' VAL . 38.6 mt -67.46 -58.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.092 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -53.3 -37.45 62.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.866 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.24 -53.26 60.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 55.240000000000002 111.094 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.619 HH22 HG22 ' A' ' 104' ' ' VAL . 0.0 OUTLIER -65.83 -38.5 89.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.293 -0.412 . . . . 75.409999999999997 110.863 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 10' ' ' ILE . 91.7 t -51.46 -46.12 35.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.129999999999995 111.153 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.77 11.75 65.63 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.74 -0.743 . . . . 73.25 112.41 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.64 4.14 10.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.859 0.362 . . . . 51.25 111.109 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 t -50.29 136.91 7.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 65.319999999999993 111.166 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -104.24 143.12 26.02 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.598 0.713 . . . . 53.119999999999997 110.858 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -15.24 37.2 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.662 2.241 . . . . 65.120000000000005 112.364 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.3 -37.96 81.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 64.430000000000007 110.903 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.32 -90.78 1.19 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.727 -0.749 . . . . 62.509999999999998 112.468 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.409 ' HB2' ' H21' ' A' ' 201' ' ' PLM . 53.1 Cg_endo -69.79 155.92 64.62 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.648 2.232 . . . . 62.450000000000003 112.378 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.37 166.21 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 65.519999999999996 110.909 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -48.29 114.1 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 110.86 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 23' ' ' ARG . 15.6 m -118.37 173.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 72.109999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.599 ' O ' HD11 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -139.11 149.72 44.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 53.310000000000002 110.969 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' C ' HD21 ' A' ' 46' ' ' LEU . . . 127.27 -172.33 18.68 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 74.5 112.502 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.21 151.58 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.92 0.391 . . . . 72.430000000000007 111.149 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.785 ' HB2' HG23 ' A' ' 44' ' ' VAL . 21.2 m-85 -119.04 145.44 45.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 74.319999999999993 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.412 ' HB3' HG23 ' A' ' 62' ' ' THR . 40.2 tp60 -120.29 99.23 6.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 73.099999999999994 110.897 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 63' ' ' VAL . 16.5 tp -85.76 130.58 34.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 65.019999999999996 110.957 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.438 HD21 HG23 ' A' ' 62' ' ' THR . 5.7 m-80 -126.93 110.14 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.913 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 HD12 ' A' ' 67' ' ' LEU . 4.2 mp -100.42 132.32 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.077 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -72.47 153.65 41.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 53.340000000000003 110.927 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.3 p -145.18 173.18 12.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.151 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.23 -14.93 59.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 70.239999999999995 111.085 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.89 8.19 14.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.879 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.09 -129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 44.130000000000003 112.502 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 p -143.9 139.34 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.759 0.314 . . . . 53.130000000000003 111.174 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -97.37 123.82 41.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 60.43 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -88.86 149.29 23.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.98 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -152.23 140.87 20.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 73.049999999999997 110.957 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 mt -111.21 127.2 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.421 . . . . 73.120000000000005 111.042 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -129.42 102.5 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.109999999999999 111.197 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.19 148.19 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 64.120000000000005 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.599 HD11 ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.4 -14.19 15.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 72.409999999999997 110.878 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -67.33 -49.28 64.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 73.409999999999997 110.955 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.47 -4.03 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.926 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.616 HD11 ' O2 ' ' A' ' 201' ' ' PLM . 3.3 mm? 59.11 76.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 75.099999999999994 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -177.23 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.859 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.607 HG13 HG13 ' A' ' 44' ' ' VAL . 1.8 t -144.66 146.9 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.142 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.63 166.71 29.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 62.439999999999998 110.898 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.54 149.65 21.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 63.049999999999997 110.9 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.6 -155.13 22.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.724 . . . . 61.119999999999997 112.492 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.62 147.59 27.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.798 0.332 . . . . 63.32 111.132 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -78.18 162.84 26.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.869 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.72 -30.54 68.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 45.140000000000001 111.113 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.7 t -178.34 80.8 0.23 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.695 0.76 . . . . 74.329999999999998 110.845 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 30' ' ' GLN . 54.1 Cg_endo -69.74 145.07 56.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.623 2.216 . . . . 73.319999999999993 112.39 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.46 -27.43 69.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 74.409999999999997 110.904 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.658 HG11 ' HB2' ' A' ' 98' ' ' ALA . 87.7 t -151.48 147.47 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 33.43 111.153 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.438 HG23 HD21 ' A' ' 32' ' ' ASN . 98.1 m -127.36 107.79 10.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.156 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 201' ' ' PLM . 5.1 p -86.45 140.57 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.134 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.07 108.36 13.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 73.530000000000001 111.09 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 89' ' ' ILE . 71.0 t -132.93 143.84 38.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 72.430000000000007 111.146 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.98 164.82 42.96 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.454 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.595 HD12 HG21 ' A' ' 33' ' ' ILE . 6.4 tp -57.84 -62.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.744 0.307 . . . . 52.229999999999997 110.862 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.764 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.6 mt-10 -51.41 -32.79 27.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 72.129999999999995 110.9 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.99 -46.78 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.200000000000003 110.861 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.767 ' HB3' HG21 ' A' ' 6' ' ' ILE . 1.5 mtt -72.4 -35.03 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.019999999999996 110.877 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.827 HD23 HD11 ' A' ' 6' ' ' ILE . 11.8 mt -62.12 -42.79 99.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.897 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.6 -38.92 72.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 111.104 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.03 -59.67 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.439999999999998 111.176 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -55.05 -24.98 27.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.530000000000001 110.868 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.92 -2.16 64.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.768 -0.729 . . . . 72.549999999999997 112.416 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER 68.62 7.58 6.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.854 0.359 . . . . 72.219999999999999 110.901 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -88.75 -36.41 16.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 79' ' ' THR . 0.4 OUTLIER -124.63 169.28 12.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.471 . . . . 64.409999999999997 110.971 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.505 ' O ' HD23 ' A' ' 78' ' ' LEU . 18.7 p -125.88 158.38 35.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 73.109999999999999 111.148 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -52.64 -39.23 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.455 . . . . 72.019999999999996 111.131 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.53 -55.07 24.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 72.430000000000007 112.499 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.79 -55.94 27.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 72.209999999999994 110.786 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 88' ' ' LYS . . . -52.88 -40.62 63.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 111.15 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.723 ' CD2' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -52.8 -51.86 59.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.409999999999997 110.933 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -47.03 87.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.109999999999999 110.942 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -62.46 -22.81 66.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 73.049999999999997 110.874 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.54 33.19 20.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 44.420000000000002 112.488 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 10.2 mmtt -76.96 -33.12 57.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 75.340000000000003 110.905 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.791 ' HA ' HG22 ' A' ' 65' ' ' VAL . 10.7 mt -94.93 123.22 46.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.138 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.27 149.36 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 73.109999999999999 110.917 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.015 HD13 ' HB2' ' A' ' 95' ' ' ALA . 1.1 pp -126.75 138.86 53.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 71.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.17 110.6 8.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 62.299999999999997 110.879 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.13 -86.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 72.140000000000001 112.493 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.91 93.22 3.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.79 0.329 . . . . 62.130000000000003 110.817 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 1.015 ' HB2' HD13 ' A' ' 91' ' ' LEU . . . -59.06 -27.66 65.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.240000000000002 111.09 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -39.07 93.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 71.109999999999999 110.885 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CB ' HG21 ' A' ' 61' ' ' VAL . 2.4 mt -68.25 -50.25 55.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 53.030000000000001 110.94 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.658 ' HB2' HG11 ' A' ' 61' ' ' VAL . . . -65.91 -50.09 65.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 74.340000000000003 111.13 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.0 -42.28 37.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 64.450000000000003 111.144 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -52.13 -42.26 63.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.969 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.686 ' O ' HG12 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -60.27 -54.43 45.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 62.450000000000003 110.943 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -48.95 -29.12 4.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 64.239999999999995 111.152 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -51.97 12.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 110.856 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 101' ' ' LEU . 6.0 p -60.1 -18.64 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 74.099999999999994 111.129 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 102' ' ' ALA . 96.0 mt -75.23 -27.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 74.010000000000005 111.105 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -74.24 74.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.848 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -165.26 -68.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.239999999999995 110.874 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -161.05 176.82 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.837 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -135.38 -174.12 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 63.420000000000002 110.883 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -134.73 -169.82 2.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 63.25 110.932 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 71.209999999999994 110.824 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PLM . . . . . 0.781 ' HG3' HG11 ' A' ' 63' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PLM . . . . . 0.671 ' HC2' HD13 ' A' ' 89' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_